[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 177
1. Corrigendum to "Reduced Genotoxicity of Avian Sarcoma Leukosis Virus Vectors in Rhesus Long-term Repopulating Cells Compared to Standard Murine Retrovirus Vectors". Mol Ther; 2008 Oct;16(10):1770

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Corrigendum to "Reduced Genotoxicity of Avian Sarcoma Leukosis Virus Vectors in Rhesus Long-term Repopulating Cells Compared to Standard Murine Retrovirus Vectors".

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28189005.001).
  • [ISSN] 1525-0024
  • [Journal-full-title] Molecular therapy : the journal of the American Society of Gene Therapy
  • [ISO-abbreviation] Mol. Ther.
  • [Language] eng
  • [Publication-type] Published Erratum
  • [Publication-country] United States
  •  go-up   go-down


2. Maciolek NL, McNally MT: Characterization of Rous sarcoma virus polyadenylation site use in vitro. Virology; 2008 May 10;374(2):468-76
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characterization of Rous sarcoma virus polyadenylation site use in vitro.
  • Polyadenylation of Rous sarcoma virus (RSV) RNA is inefficient, as approximately 15% of RSV RNAs represent read-through transcripts that use a downstream cellular polyadenylation site (poly(A) site).
  • Read-through transcription has implications for the virus and the host since it is associated with oncogene capture and tumor induction.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Cell Biol. 1989 Oct;9(10):4248-58 [2573828.001]
  • [Cites] RNA. 1997 Dec;3(12):1444-55 [9404895.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1403-7 [1741396.001]
  • [Cites] J Virol. 1992 Jul;66(7):4242-51 [1318403.001]
  • [Cites] RNA. 2000 Feb;6(2):170-7 [10688356.001]
  • [Cites] J Virol. 2001 Dec;75(23):11735-46 [11689654.001]
  • [Cites] Nucleic Acids Res. 2002 Feb 1;30(3):810-7 [11809895.001]
  • [Cites] Nature. 2002 Apr 4;416(6880):499-506 [11932736.001]
  • [Cites] Nucleic Acids Res. 2002 Apr 15;30(8):1842-50 [11937639.001]
  • [Cites] J Biol Chem. 2002 Nov 8;277(45):42733-40 [12200454.001]
  • [Cites] Virology. 2002 Oct 25;302(2):405-12 [12441084.001]
  • [Cites] EMBO J. 2003 Jun 2;22(11):2821-30 [12773396.001]
  • [Cites] EMBO J. 2004 Feb 11;23(3):616-26 [14749727.001]
  • [Cites] J Biol Chem. 2004 Feb 20;279(8):7009-13 [14625303.001]
  • [Cites] Nucleic Acids Res. 1983 Mar 11;11(5):1475-89 [6828386.001]
  • [Cites] Cell. 1983 Mar;32(3):853-69 [6299578.001]
  • [Cites] Cell. 1983 Jun;33(2):357-68 [6305505.001]
  • [Cites] Nucleic Acids Res. 1984 Sep 25;12(18):7035-56 [6091052.001]
  • [Cites] Cell. 1986 Mar 28;44(6):935-40 [2420470.001]
  • [Cites] J Virol. 1986 Nov;60(2):497-505 [3021984.001]
  • [Cites] J Virol. 1988 Apr;62(4):1423-32 [2831403.001]
  • [Cites] J Virol. 1988 Jul;62(7):2437-43 [2897475.001]
  • [Cites] J Virol. 1989 Aug;63(8):3301-6 [2473216.001]
  • [Cites] Mol Cell Biol. 1992 Sep;12(9):3699-705 [1508176.001]
  • [Cites] Mol Cell Biol. 1992 Dec;12(12):5386-93 [1333042.001]
  • [Cites] Cell. 1993 Mar 26;72(6):881-92 [8458082.001]
  • [Cites] Genes Dev. 1993 Apr;7(4):647-59 [8384583.001]
  • [Cites] Cell. 1994 Feb 11;76(3):531-41 [8313473.001]
  • [Cites] Genes Dev. 1994 Mar 1;8(5):576-86 [7926751.001]
  • [Cites] Mol Cell Biol. 1994 Oct;14(10):6647-54 [7935383.001]
  • [Cites] Mol Cell. 1998 Jan;1(2):255-64 [9659922.001]
  • [Cites] RNA. 1998 Dec;4(12):1493-9 [9848648.001]
  • [Cites] J Virol. 1999 Jan;73(1):81-91 [9847310.001]
  • [Cites] J Virol. 1999 Mar;73(3):2385-93 [9971822.001]
  • [Cites] J Virol. 1999 Mar;73(3):2394-400 [9971823.001]
  • [Cites] RNA. 1999 Mar;5(3):333-43 [10094303.001]
  • [Cites] Microbiol Mol Biol Rev. 1999 Jun;63(2):405-45 [10357856.001]
  • [Cites] Nucleic Acids Res. 2005;33(1):201-12 [15647503.001]
  • [Cites] J Virol. 2005 Apr;79(7):4270-88 [15767428.001]
  • [Cites] Mol Cell Biol. 2005 Jun;25(11):4397-405 [15899846.001]
  • [Cites] Genes Dev. 2005 Jun 1;19(11):1315-27 [15937220.001]
  • [Cites] RNA. 2005 Oct;11(10):1485-93 [16131587.001]
  • [Cites] J Biol Chem. 2006 Feb 3;281(5):2478-88 [16308319.001]
  • [Cites] Retrovirology. 2006;3:18 [16545126.001]
  • [Cites] J Virol. 2006 Oct;80(19):9634-40 [16973567.001]
  • [Cites] EMBO J. 2007 Jun 6;26(11):2658-69 [17464285.001]
  • [Cites] J Virol. 2007 Oct;81(20):11208-17 [17670832.001]
  • [Cites] Genes Dev. 1995 Jan 1;9(1):72-83 [7828853.001]
  • [Cites] Nucleic Acids Res. 1995 May 11;23(9):1625-31 [7784220.001]
  • [Cites] Nucleic Acids Res. 1995 Jul 25;23(14):2614-20 [7651822.001]
  • [Cites] Genes Dev. 1995 Nov 1;9(21):2672-83 [7590244.001]
  • [Cites] Genes Dev. 1996 Feb 1;10(3):325-37 [8595883.001]
  • [Cites] J Virol. 1996 Mar;70(3):1612-7 [8627681.001]
  • [Cites] Cell. 1996 Nov 29;87(5):941-52 [8945520.001]
  • [Cites] Genes Dev. 1990 Dec;4(12A):2112-20 [1980119.001]
  • (PMID = 18272196.001).
  • [ISSN] 0042-6822
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA078709-10; United States / NCI NIH HHS / CA / CA078709-08; United States / NCI NIH HHS / CA / R01 CA078709; United States / NCI NIH HHS / CA / R01 CA078709-09; United States / NCI NIH HHS / CA / R01 CA78709; United States / NCI NIH HHS / CA / R01 CA078709-08; United States / NCI NIH HHS / CA / R01 CA078709-10; United States / NCI NIH HHS / CA / CA078709-09
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / 3' Untranslated Regions; 0 / Cleavage Stimulation Factor; 0 / RNA, Messenger; 0 / RNA, Viral
  • [Other-IDs] NLM/ NIHMS50251; NLM/ PMC2413101
  •  go-up   go-down


3. Weil JE, Hadjithomas M, Beemon KL: Structural characterization of the Rous sarcoma virus RNA stability element. J Virol; 2009 Mar;83(5):2119-29
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Structural characterization of the Rous sarcoma virus RNA stability element.
  • We previously identified the Rous sarcoma virus (RSV) stability element (RSE), an RNA element downstream of the gag natural translation termination codon that prevents degradation of the unspliced viral RNA.
  • The overall secondary structure of the RSE appears to be conserved among 20 different avian retroviruses.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Biol Cell. 1999 Nov;10(11):3971-8 [10564284.001]
  • [Cites] Annu Rev Genet. 1999;33:229-60 [10690409.001]
  • [Cites] Cell. 2000 Jun 23;101(7):741-51 [10892745.001]
  • [Cites] Am J Hum Genet. 2000 Aug;67(2):345-56 [10889045.001]
  • [Cites] Gene. 2001 Oct 3;276(1-2):73-81 [11591473.001]
  • [Cites] Nucleic Acids Res. 2003 Jul 1;31(13):3406-15 [12824337.001]
  • [Cites] EMBO J. 2003 Aug 1;22(15):3960-70 [12881430.001]
  • [Cites] Genome Biol. 2003;5(1):R2 [14709174.001]
  • [Cites] J Virol. 2004 May;78(10):5139-46 [15113896.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 May 11;101(19):7287-92 [15123812.001]
  • [Cites] Nat Genet. 2004 Oct;36(10):1073-8 [15448691.001]
  • [Cites] J Biol Chem. 1981 Jun 25;256(12):6430-4 [6165717.001]
  • [Cites] J Gen Virol. 1983 Oct;64 (Pt 10):2191-202 [6311951.001]
  • [Cites] J Virol. 1986 Nov;60(2):450-9 [2430109.001]
  • [Cites] Cell. 1988 Nov 4;55(3):447-58 [2846182.001]
  • [Cites] Mol Cell Biol. 1991 May;11(5):2760-8 [1850103.001]
  • [Cites] Mol Cell Biol. 1993 Jun;13(6):3340-9 [8497255.001]
  • [Cites] Mol Cell Biol. 1994 Mar;14(3):1986-96 [8114730.001]
  • [Cites] Methods Mol Biol. 1994;25:307-18 [8004173.001]
  • [Cites] EMBO J. 1997 Jul 1;16(13):4107-16 [9233819.001]
  • [Cites] J Mol Biol. 1998 Nov 27;284(2):205-25 [9813113.001]
  • [Cites] Nature. 2004 Nov 4;432(7013):112-8 [15525991.001]
  • [Cites] Genome Biol. 2005;6(1):R6 [15642098.001]
  • [Cites] J Mol Biol. 2005 Feb 18;346(2):477-92 [15670598.001]
  • [Cites] J Am Chem Soc. 2005 Nov 16;127(45):15714-5 [16277508.001]
  • [Cites] RNA. 2006 Jan;12(1):102-10 [16301601.001]
  • [Cites] Nucleic Acids Res. 2005;33(22):7138-50 [16391004.001]
  • [Cites] Nat Struct Mol Biol. 2006 May;13(5):462-4 [16622410.001]
  • [Cites] RNA. 2006 Jul;12(7):1304-14 [16682565.001]
  • [Cites] J Am Chem Soc. 2007 Apr 11;129(14):4144-5 [17367143.001]
  • [Cites] Nat Protoc. 2006;1(3):1610-6 [17406453.001]
  • [Cites] FEBS Lett. 2007 Jun 19;581(15):2845-53 [17531985.001]
  • [Cites] Cell. 2008 Jan 11;132(1):9-14 [18191211.001]
  • [Cites] Mol Cell. 2008 Jan 18;29(1):134-40 [18206975.001]
  • [Cites] PLoS Biol. 2008 Apr 29;6(4):e92 [18447580.001]
  • [Cites] PLoS Biol. 2008 Apr 29;6(4):e96 [18447581.001]
  • [Cites] PLoS Biol. 2008 Apr 29;6(4):e111 [18447585.001]
  • [Cites] RNA. 2008 Jul;14(7):1255-63 [18515544.001]
  • (PMID = 19091866.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA048746; United States / NIGMS NIH HHS / GM / T32 GM007231; United States / NIGMS NIH HHS / GM / 5T32 GM007231-33; United States / NCI NIH HHS / CA / R01 CA48746
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Messenger; 0 / RNA, Viral
  • [Other-IDs] NLM/ PMC2643715
  •  go-up   go-down


Advertisement
4. Natesan S, Kataria JM, Dhama K, Bhardwaj N, Sylvester A: Anti-neoplastic effect of chicken anemia virus VP3 protein (apoptin) in Rous sarcoma virus-induced tumours in chicken. J Gen Virol; 2006 Oct;87(Pt 10):2933-40
Genetic Alliance. consumer health - Anemia.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anti-neoplastic effect of chicken anemia virus VP3 protein (apoptin) in Rous sarcoma virus-induced tumours in chicken.
  • The anti-neoplastic effect of chicken anemia virus VP3 protein (apoptin) was investigated in vitro in Rous sarcoma virus (RSV)-transformed chicken embryo fibroblast (CEF) cells and in RSV-induced tumours of specific-pathogen-free (SPF) chicks in vivo.
  • [MeSH-major] Antineoplastic Agents / metabolism. Avian Sarcoma Viruses / physiology. Capsid Proteins / metabolism. Poultry Diseases / pathology. Poultry Diseases / virology. Sarcoma, Avian / pathology. Sarcoma, Avian / virology
  • [MeSH-minor] Animals. Cell Line, Tumor. Chickens / virology. Gene Expression. Humans. Specific Pathogen-Free Organisms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16963752.001).
  • [ISSN] 0022-1317
  • [Journal-full-title] The Journal of general virology
  • [ISO-abbreviation] J. Gen. Virol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Capsid Proteins; 0 / VP3 protein, Chicken anemia virus
  •  go-up   go-down


5. Sanjuán R: Quantifying antagonistic epistasis in a multifunctional RNA secondary structure of the Rous sarcoma virus. J Gen Virol; 2006 Jun;87(Pt 6):1595-602

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Quantifying antagonistic epistasis in a multifunctional RNA secondary structure of the Rous sarcoma virus.
  • Here, by re-analysing previously published data from a random viral library, selection and epistasis coefficients were estimated in the U5-IR stem and loop of the Rous sarcoma virus, a region that adopts a conserved secondary structure and is involved in various essential steps of viral infection.
  • [MeSH-major] Avian Sarcoma Viruses / genetics. Epistasis, Genetic. RNA, Small Nuclear / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16690924.001).
  • [ISSN] 0022-1317
  • [Journal-full-title] The Journal of general virology
  • [ISO-abbreviation] J. Gen. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / RNA, Small Nuclear; 0 / RNA, Viral; 0 / U5 small nuclear RNA
  •  go-up   go-down


6. Hu J, Renaud G, Golmes T, Ferris A, Hendrie PC, Donahue RE, Hughes SH, Wolfsberg TG, Russell DW, Dunbar CE: Reduced Genotoxicity of Avian Sarcoma Leukosis Virus Vectors in Rhesus Long-term Repopulating Cells Compared to Standard Murine Retrovirus Vectors. Mol Ther; 2008 Sep;16(9):1617-1623

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Reduced Genotoxicity of Avian Sarcoma Leukosis Virus Vectors in Rhesus Long-term Repopulating Cells Compared to Standard Murine Retrovirus Vectors.
  • In this study, we report for the first time a systematic analysis of 198 avian sarcoma leukosis virus (ASLV) insertion sites identified in rhesus long-term repopulating cells, and a comparison of ASLV insertion patterns to Moloney murine leukemia virus (MLV) (n = 396) and simian immunodeficiency virus (SIV) (n = 289) using the newly released rhesus genome databank.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2008 The American Society of Gene Therapy. Published by Elsevier Inc. All rights reserved.
  • (PMID = 28189014.001).
  • [ISSN] 1525-0024
  • [Journal-full-title] Molecular therapy : the journal of the American Society of Gene Therapy
  • [ISO-abbreviation] Mol. Ther.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


7. Oh J, Chang KW, Alvord WG, Hughes SH: Alternate polypurine tracts affect rous sarcoma virus integration in vivo. J Virol; 2006 Oct;80(20):10281-4
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Alternate polypurine tracts affect rous sarcoma virus integration in vivo.
  • When the endogenous polypurine tract (PPT) of the Rous sarcoma virus (RSV)-derived vector RSVP(A)Z was replaced with alternate retroviral PPTs, the fraction of unintegrated viral DNA with the normal consensus ends significantly decreased and the retention of part of the PPT significantly increased.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Nov;74(22):10293-303 [11044073.001]
  • [Cites] J Virol. 2002 Feb;76(4):1762-8 [11799171.001]
  • [Cites] J Virol. 2003 Oct;77(20):11150-7 [14512562.001]
  • [Cites] Nucleic Acids Res. 2004;32(4):1539-47 [15004241.001]
  • [Cites] J Mol Biol. 1989 Aug 5;208(3):445-56 [2477553.001]
  • [Cites] J Virol. 2006 Jan;80(1):451-9 [16352569.001]
  • [Cites] J Virol. 1996 Aug;70(8):5288-96 [8764039.001]
  • [Cites] J Virol. 1999 Feb;73(2):948-57 [9882295.001]
  • [Cites] J Virol. 2004 Dec;78(23):13315-24 [15542682.001]
  • [Cites] J Virol. 2005 Nov;79(21):13694-704 [16227289.001]
  • [Cites] J Virol. 1989 Dec;63(12):5319-27 [2555556.001]
  • (PMID = 17005708.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.7.- / Integrases
  • [Other-IDs] NLM/ PMC1617299
  •  go-up   go-down


8. Dalton AK, Murray PS, Murray D, Vogt VM: Biochemical characterization of rous sarcoma virus MA protein interaction with membranes. J Virol; 2005 May;79(10):6227-38
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Biochemical characterization of rous sarcoma virus MA protein interaction with membranes.
  • We have used an in vitro flotation assay to directly measure Rous sarcoma virus (RSV) MA-membrane interaction in the absence of host cell factors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 1996 Apr;70(4):2664-8 [8642704.001]
  • [Cites] Biochemistry. 1996 Apr 2;35(13):3933-43 [8672424.001]
  • [Cites] Biophys J. 1996 Aug;71(2):561-75 [8842196.001]
  • [Cites] J Virol. 1996 Dec;70(12):8540-8 [8970978.001]
  • [Cites] Virology. 1972 Nov;50(2):550-7 [4344196.001]
  • [Cites] J Mol Biol. 1979 Jul 15;131(4):819-37 [229234.001]
  • [Cites] J Biol Chem. 1980 Oct 10;255(19):9044-50 [6251073.001]
  • [Cites] Biochim Biophys Acta. 1982 Jul 28;689(2):393-402 [6288099.001]
  • [Cites] Protein Eng. 1998 Sep;11(9):739-47 [9796821.001]
  • [Cites] Cell. 1998 Dec 11;95(6):847-58 [9865702.001]
  • [Cites] J Virol. 1999 Mar;73(3):1902-8 [9971769.001]
  • [Cites] J Virol. 1999 Apr;73(4):2604-12 [10074105.001]
  • [Cites] J Virol. 1999 May;73(5):4136-44 [10196310.001]
  • [Cites] Biochemistry. 1999 Jun 22;38(25):8056-63 [10387050.001]
  • [Cites] J Virol. 1999 Aug;73(8):7050-5 [10400808.001]
  • [Cites] Biophys J. 1999 Dec;77(6):3176-88 [10585939.001]
  • [Cites] Virology. 2000 Feb 15;267(2):289-98 [10662624.001]
  • [Cites] J Mol Biol. 2000 Feb 25;296(3):887-98 [10677289.001]
  • [Cites] J Virol. 2000 Mar;74(6):2855-66 [10684302.001]
  • [Cites] J Virol. 2000 Apr;74(7):3264-72 [10708443.001]
  • [Cites] J Virol. 2000 Jun;74(11):5142-50 [10799589.001]
  • [Cites] J Virol. 1997 May;71(5):3474-83 [9094619.001]
  • [Cites] J Virol. 1997 Jun;71(6):4425-35 [9151833.001]
  • [Cites] J Virol. 1997 Sep;71(9):6582-92 [9261380.001]
  • [Cites] Structure. 1997 Aug 15;5(8):985-9 [9309215.001]
  • [Cites] Biophys J. 1997 Oct;73(4):1717-27 [9336168.001]
  • [Cites] Science. 1997 Oct 31;278(5339):849-53 [9346481.001]
  • [Cites] Pac Symp Biocomput. 1996;:53-72 [9390223.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2580-5 [9482929.001]
  • [Cites] Biochemistry. 1998 Feb 24;37(8):2145-59 [9485361.001]
  • [Cites] J Mol Biol. 1998 Mar 27;277(2):161-9 [9514761.001]
  • [Cites] J Virol. 1998 Apr;72(4):2723-32 [9525590.001]
  • [Cites] EMBO J. 1998 May 1;17(9):2699-708 [9564051.001]
  • [Cites] J Mol Biol. 1998 Jun 19;279(4):921-8 [9642071.001]
  • [Cites] Biophys J. 1998 Aug;75(2):769-76 [9675178.001]
  • [Cites] J Virol. 1998 Sep;72(9):7659-63 [9696871.001]
  • [Cites] J Virol. 2003 Apr;77(8):4805-17 [12663787.001]
  • [Cites] Traffic. 2003 Apr;4(4):201-13 [12694559.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 May 13;100(10):5795-800 [12721375.001]
  • [Cites] J Biol Chem. 2003 Jul 25;278(30):27923-9 [12761222.001]
  • [Cites] J Cell Biol. 2003 Sep 29;162(7):1233-44 [14517204.001]
  • [Cites] Proteins. 2003;53 Suppl 6:430-5 [14579332.001]
  • [Cites] Traffic. 2003 Nov;4(11):785-801 [14617360.001]
  • [Cites] Traffic. 2003 Dec;4(12):902-10 [14617353.001]
  • [Cites] Cell. 2003 Nov 14;115(4):377-88 [14622593.001]
  • [Cites] J Mol Biol. 2004 Jan 2;335(1):275-82 [14659756.001]
  • [Cites] J Virol. 2004 Feb;78(3):1552-63 [14722309.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):517-22 [14699046.001]
  • [Cites] Physiol Rev. 2004 Jul;84(3):699-730 [15269334.001]
  • [Cites] J Virol. 2004 Sep;78(17):9560-3 [15308748.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14889-94 [15465916.001]
  • [Cites] Virology. 1971 Oct;46(1):106-16 [4108030.001]
  • [Cites] Anal Biochem. 1972 Jun;47(2):614-9 [4338619.001]
  • [Cites] J Mol Biol. 2000 May 19;298(5):841-57 [10801353.001]
  • [Cites] J Mol Biol. 2000 Jun 2;299(2):499-520 [10860755.001]
  • [Cites] J Mol Biol. 2000 Jun 30;300(1):103-12 [10864502.001]
  • [Cites] Bioinformatics. 2000 Apr;16(4):404-5 [10869041.001]
  • [Cites] J Mol Biol. 2000 Aug 4;301(1):173-90 [10926500.001]
  • [Cites] J Virol. 2000 Dec;74(23):11222-9 [11070020.001]
  • [Cites] J Virol. 2001 Mar;75(6):2753-64 [11222698.001]
  • [Cites] Virus Res. 2001 Jul;76(1):103-13 [11376850.001]
  • [Cites] J Mol Biol. 2001 Jun 29;310(1):243-57 [11419950.001]
  • [Cites] J Virol. 2001 Sep;75(17):7913-24 [11483736.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10875-9 [11526217.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13925-30 [11717449.001]
  • [Cites] J Virol. 2002 Feb;76(4):1876-83 [11799182.001]
  • [Cites] Mol Cell. 2002 Jan;9(1):145-54 [11804593.001]
  • [Cites] Proteins. 2002 May 1;47(2):228-35 [11933069.001]
  • [Cites] J Clin Invest. 2002 Sep;110(5):597-603 [12208858.001]
  • [Cites] Structure. 2002 Dec;10(12):1627-36 [12467570.001]
  • [Cites] J Virol. 2003 Mar;77(5):3058-66 [12584331.001]
  • [Cites] Methods Biochem Anal. 2003;44:427-40 [12647398.001]
  • [Cites] J Virol. 1984 Oct;52(1):145-53 [6090691.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Jan;87(2):523-7 [2405382.001]
  • [Cites] AIDS. 1991 Jun;5(6):639-54 [1883539.001]
  • [Cites] Proteins. 1991;11(4):281-96 [1758883.001]
  • [Cites] Biochemistry. 1992 Feb 18;31(6):1767-73 [1737030.001]
  • [Cites] Nature. 1992 Mar 5;356(6364):83-5 [1538787.001]
  • [Cites] Proteins. 1992 Apr;13(2):112-9 [1620693.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5181-5 [8389472.001]
  • [Cites] J Virol. 1993 Sep;67(9):5550-61 [8394460.001]
  • [Cites] Biochemistry. 1993 Oct 5;32(39):10436-43 [8399188.001]
  • [Cites] J Virol. 1993 Nov;67(11):6387-94 [8411340.001]
  • [Cites] J Virol. 1993 Nov;67(11):6487-98 [8411352.001]
  • [Cites] J Virol. 1994 Apr;68(4):2556-69 [8139035.001]
  • [Cites] J Virol. 1994 May;68(5):3232-42 [8151785.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 May 10;91(10):4594-8 [8183954.001]
  • [Cites] J Virol. 1994 Aug;68(8):5311-20 [8035531.001]
  • [Cites] J Virol. 1994 Oct;68(10):6644-54 [7521919.001]
  • [Cites] Biochemistry. 1994 Nov 8;33(44):13093-101 [7947714.001]
  • [Cites] J Mol Biol. 1994 Nov 25;244(2):198-223 [7966331.001]
  • [Cites] Virology. 1994 Nov 15;205(1):336-44 [7975229.001]
  • [Cites] Science. 1995 May 26;268(5214):1144-9 [7761829.001]
  • [Cites] Trends Biochem Sci. 1995 Jul;20(7):272-6 [7667880.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3099-104 [8610175.001]
  • [Cites] J Virol. 1996 Apr;70(4):2269-76 [8642653.001]
  • (PMID = 15858007.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA020081; United States / NIAID NIH HHS / AI / AI54167
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Liposomes; 0 / MA protein, Rous sarcoma virus; 0 / Phosphoproteins; 0 / Viral Matrix Proteins
  • [Other-IDs] NLM/ PMC1091718
  •  go-up   go-down


9. Schulten ES, Briles WE, Taylor RL Jr: Rous sarcoma growth in lines congenic for major histocompatibility (B) complex recombinants. Poult Sci; 2009 Aug;88(8):1601-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rous sarcoma growth in lines congenic for major histocompatibility (B) complex recombinants.
  • Rous sarcoma virus (RSV)-induced tumor growth was examined in congenic lines of chickens with different major histocompatibility (B) complex recombinant haplotypes on the highly inbred line UCD 003 (B17B17) genetic background.
  • Each bird was assigned a tumor profile index (TPI) based on the 6 tumor size scores.
  • Least squares ANOVA was used to evaluate rank-transformed TPI values and mean tumor sizes through a repeated measures design.
  • Tumor growth and TPI values were greater for 003.R1 and 003.R4 chickens than for the other 3 congenic lines.
  • Among serologically similar recombinants 003.R2 and 003.R4, higher tumor growth and TPI in 003.R4 indicate unique genetic variation affecting RSV tumors compared with 003.R2.
  • The similar tumor growth of 003.R5 and 003.R6 chickens, which have BF/BL21 but different BG regions, demonstrated no BG effect on RSV tumors.
  • [MeSH-major] Chickens / genetics. Genetic Predisposition to Disease. Major Histocompatibility Complex / genetics. Poultry Diseases / genetics. Sarcoma, Avian / genetics

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19590074.001).
  • [ISSN] 0032-5791
  • [Journal-full-title] Poultry science
  • [ISO-abbreviation] Poult. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


10. Briggs JA, Johnson MC, Simon MN, Fuller SD, Vogt VM: Cryo-electron microscopy reveals conserved and divergent features of gag packing in immature particles of Rous sarcoma virus and human immunodeficiency virus. J Mol Biol; 2006 Jan 6;355(1):157-68
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cryo-electron microscopy reveals conserved and divergent features of gag packing in immature particles of Rous sarcoma virus and human immunodeficiency virus.
  • Here we have used cryo-electron microscopy (cryo-EM) and image processing to determine the lateral and radial arrangement of Gag in in vivo and in vitro assembled Rous sarcoma virus (RSV) particles and to compare these features with those of HIV-1.
  • [MeSH-major] Avian Sarcoma Viruses / chemistry. Gene Products, gag / chemistry. HIV / chemistry. Virion / chemistry

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16289202.001).
  • [ISSN] 0022-2836
  • [Journal-full-title] Journal of molecular biology
  • [ISO-abbreviation] J. Mol. Biol.
  • [Language] eng
  • [Grant] United States / NIBIB NIH HHS / EB / 5-P41-EB2181; United States / NCI NIH HHS / CA / CA20081; United Kingdom / Wellcome Trust / /
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Gene Products, gag
  •  go-up   go-down


11. Portsmouth D, Deitermann D, Salmons B, Günzburg WH, Renner M: Transgene expression facilitated by the v-src splice acceptor can impair replication kinetics and lead to genomic instability of Rous sarcoma virus-based vectors. J Virol; 2008 Feb;82(3):1610-4
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transgene expression facilitated by the v-src splice acceptor can impair replication kinetics and lead to genomic instability of Rous sarcoma virus-based vectors.
  • Rous sarcoma virus (RSV) can be used for the simple generation of high-titer replication-competent retroviral (RCR) vectors.
  • [MeSH-major] Genetic Vectors. Genomic Instability. RNA Splice Sites. Recombinant Proteins / biosynthesis. Rous sarcoma virus / genetics. Transgenes

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Trends Biochem Sci. 2000 Mar;25(3):106-10 [10694877.001]
  • [Cites] J Virol. 2001 Jun;75(11):4973-83 [11333876.001]
  • [Cites] Folia Biol (Praha). 2004;50(3-4):107-19 [15373344.001]
  • [Cites] J Exp Med. 1977 Dec 1;146(6):1735-47 [200700.001]
  • [Cites] Proc Natl Acad Sci U S A. 1978 Dec;75(12):5812-6 [215998.001]
  • [Cites] J Virol. 1979 Nov;32(2):546-56 [228078.001]
  • [Cites] Hum Gene Ther. 2007 Aug;18(8):691-700 [17655493.001]
  • [Cites] Virology. 1984 Jul 15;136(1):89-99 [6330999.001]
  • [Cites] Genes Dev. 1990 Sep;4(9):1560-72 [2174810.001]
  • [Cites] J Virol. 1991 Jul;65(7):3728-37 [2041092.001]
  • [Cites] J Virol. 1996 Jun;70(6):3922-9 [8648729.001]
  • [Cites] Mol Biotechnol. 1997 Jun;7(3):289-98 [9219242.001]
  • [Cites] Gene. 1997 Nov 20;202(1-2):23-9 [9427541.001]
  • [Cites] Proc Natl Acad Sci U S A. 1979 Sep;76(9):4479-83 [92031.001]
  • (PMID = 18057258.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA Splice Sites; 0 / Recombinant Proteins
  • [Other-IDs] NLM/ PMC2224446
  •  go-up   go-down


12. Wilusz JE, Beemon KL: The negative regulator of splicing element of Rous sarcoma virus promotes polyadenylation. J Virol; 2006 Oct;80(19):9634-40
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The negative regulator of splicing element of Rous sarcoma virus promotes polyadenylation.
  • The Rous sarcoma virus gag gene contains a cis-acting negative regulator of splicing (NRS) element that is implicated in viral polyadenylation regulation.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] RNA. 2004 Sep;10(9):1388-98 [15317975.001]
  • [Cites] Genes Dev. 1990 Sep;4(9):1552-9 [1701407.001]
  • [Cites] Cell. 1988 Jan 29;52(2):221-8 [2830023.001]
  • [Cites] J Virol. 1988 Nov;62(11):4003-8 [2459410.001]
  • [Cites] Mol Cell Biol. 1988 Nov;8(11):4858-67 [2850470.001]
  • [Cites] J Virol. 1992 Jul;66(7):4242-51 [1318403.001]
  • [Cites] Genes Dev. 1993 Oct;7(10):1926-36 [8405999.001]
  • [Cites] Microbiol Rev. 1993 Sep;57(3):511-21 [7902524.001]
  • [Cites] Genes Dev. 1994 Feb 1;8(3):363-75 [7906237.001]
  • [Cites] J Virol. 1996 Feb;70(2):1163-72 [8551577.001]
  • [Cites] Genes Dev. 1996 Feb 1;10(3):325-37 [8595883.001]
  • [Cites] J Virol. 1996 Jun;70(6):3834-43 [8648719.001]
  • [Cites] Nature. 1997 Jan 23;385(6614):357-61 [9002523.001]
  • [Cites] Nucleic Acids Res. 1997 Jul 1;25(13):2547-61 [9185563.001]
  • [Cites] J Virol. 1997 Sep;71(9):6526-33 [9261372.001]
  • [Cites] J Virol. 1997 Sep;71(9):6534-40 [9261373.001]
  • [Cites] Mol Cell Biol. 1998 Jun;18(6):3103-11 [9584151.001]
  • [Cites] Nucleic Acids Res. 1998 Jun 15;26(12):2891-8 [9611233.001]
  • [Cites] Mol Cell. 1998 Jan;1(2):255-64 [9659922.001]
  • [Cites] Nature. 1998 Sep 3;395(6697):93-6 [9738505.001]
  • [Cites] Nucleic Acids Res. 1998 Dec 1;26(23):5343-50 [9826757.001]
  • [Cites] J Virol. 1999 Mar;73(3):2385-93 [9971822.001]
  • [Cites] J Virol. 1999 Mar;73(3):2394-400 [9971823.001]
  • [Cites] RNA. 1999 Mar;5(3):333-43 [10094303.001]
  • [Cites] Mol Cell. 2005 Mar 4;17(5):613-5 [15749011.001]
  • [Cites] Mol Cell Biol. 2005 Jun;25(11):4397-405 [15899846.001]
  • [Cites] J Virol. 1992 Jan;66(1):6-11 [1309264.001]
  • [Cites] Methods Mol Biol. 1999;118:309-14 [10549533.001]
  • [Cites] Genes Dev. 2000 Feb 15;14(4):403-13 [10691733.001]
  • [Cites] RNA. 2000 Sep;6(9):1197-211 [10999598.001]
  • [Cites] J Biol Chem. 2000 Oct 13;275(41):32371-8 [10934202.001]
  • [Cites] J Virol. 2001 Aug;75(16):7763-8 [11462052.001]
  • [Cites] Nucleic Acids Res. 2002 Feb 1;30(3):810-7 [11809895.001]
  • [Cites] Nucleic Acids Res. 2002 Apr 15;30(8):1842-50 [11937639.001]
  • [Cites] Mol Cell Endocrinol. 2002 Apr 25;190(1-2):1-8 [11997173.001]
  • [Cites] Virology. 2002 Oct 25;302(2):405-12 [12441084.001]
  • [Cites] J Virol. 2003 Sep;77(17):9378-87 [12915553.001]
  • [Cites] J Biol Chem. 2003 Nov 7;278(45):44153-60 [12944400.001]
  • [Cites] J Biol Chem. 2004 Apr 9;279(15):14889-98 [14749332.001]
  • [Cites] Mol Cell Biol. 1990 Feb;10(2):696-704 [2153921.001]
  • [Cites] Cell. 1990 Sep 7;62(5):889-99 [2168293.001]
  • [Cites] J Virol. 1986 Nov;60(2):497-505 [3021984.001]
  • (PMID = 16973567.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA048746; United States / NIGMS NIH HHS / GM / T32 GM007231; United States / NCI NIH HHS / CA / R01 CA238796
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Heterogeneous-Nuclear Ribonucleoproteins; 0 / Ribonucleoproteins, Small Nuclear
  • [Other-IDs] NLM/ PMC1617230
  •  go-up   go-down


13. Hyun JK, Radjainia M, Kingston RL, Mitra AK: Proton-driven assembly of the Rous Sarcoma virus capsid protein results in the formation of icosahedral particles. J Biol Chem; 2010 May 14;285(20):15056-64
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Proton-driven assembly of the Rous Sarcoma virus capsid protein results in the formation of icosahedral particles.
  • We have developed an efficient in vitro protocol for studying the assembly of Rous sarcoma virus (RSV) CA that involves mild acidification and produces structures modeling the authentic viral capsid.
  • [MeSH-major] Capsid / chemistry. Protons. Rous sarcoma virus / chemistry

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2006 Apr;80(8):3712-20 [16571788.001]
  • [Cites] FEBS J. 2009 Nov;276(21):6098-109 [19825044.001]
  • [Cites] EMBO J. 2003 Apr 1;22(7):1707-15 [12660176.001]
  • [Cites] J Biochem Biophys Methods. 2003 Jun 30;56(1-3):15-52 [12834967.001]
  • [Cites] J Virol. 2004 Mar;78(5):2606-8 [14963166.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):676-7 [15208693.001]
  • [Cites] J Comput Chem. 2004 Oct;25(13):1605-12 [15264254.001]
  • [Cites] Nature. 2004 Sep 23;431(7007):481-5 [15386017.001]
  • [Cites] Biochim Biophys Acta. 1966 Feb 7;112(2):346-62 [5329026.001]
  • [Cites] Nature. 1970 May 2;226(5244):421-5 [4314822.001]
  • [Cites] Adv Protein Chem. 1970;24:343-446 [4916268.001]
  • [Cites] Biochemistry. 1974 Jan 15;13(2):384-9 [4810059.001]
  • [Cites] Biochemistry. 1974 Apr 23;13(9):1868-74 [4840831.001]
  • [Cites] J Mol Biol. 1974 Sep 15;88(2):327-41 [4452998.001]
  • [Cites] Biophys J. 1989 Jun;55(6):1155-67 [2765653.001]
  • [Cites] Biophys J. 1989 Nov;56(5):887-900 [2557933.001]
  • [Cites] J Virol. 1992 Aug;66(8):4874-83 [1629958.001]
  • [Cites] J Mol Biol. 1994 Aug 5;241(1):59-67 [8051707.001]
  • [Cites] Protein Sci. 1995 Nov;4(11):2411-23 [8563639.001]
  • [Cites] J Struct Biol. 1996 Jan-Feb;116(1):48-55 [8742722.001]
  • [Cites] J Struct Biol. 1996 Jan-Feb;116(1):120-30 [8742733.001]
  • [Cites] Science. 1997 Oct 31;278(5339):849-53 [9346481.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7299-304 [9636143.001]
  • [Cites] Acta Crystallogr D Biol Crystallogr. 1999 Jan;55(Pt 1):85-92 [10089398.001]
  • [Cites] J Struct Biol. 1999 Apr-May;125(2-3):185-95 [10222274.001]
  • [Cites] J Mol Biol. 2005 Feb 18;346(2):577-88 [15670606.001]
  • [Cites] Methods Mol Biol. 2005;299:153-74 [15980600.001]
  • [Cites] Retrovirology. 2004;1:9 [15169567.001]
  • [Cites] J Virol. 2005 Nov;79(22):14271-81 [16254362.001]
  • [Cites] Langmuir. 2005 Dec 20;21(26):12085-9 [16342976.001]
  • [Cites] Structure. 2006 Jan;14(1):15-20 [16407061.001]
  • [Cites] Biophys J. 2006 Sep 1;91(5):1591-603 [16714342.001]
  • [Cites] J Struct Biol. 2007 Jan;157(1):3-18 [17011211.001]
  • [Cites] Retrovirology. 2007;4:40 [17565686.001]
  • [Cites] AIDS Rev. 2007 Apr-Jun;9(2):114-25 [17694678.001]
  • [Cites] Cell. 2007 Oct 5;131(1):70-9 [17923088.001]
  • [Cites] J Virol. 2007 Nov;81(22):12337-47 [17855544.001]
  • [Cites] J Mol Biol. 2008 Feb 29;376(4):1168-81 [18206161.001]
  • [Cites] Curr Opin Struct Biol. 2008 Apr;18(2):203-17 [18406133.001]
  • [Cites] J Virol. 2008 Jun;82(12):5951-61 [18400856.001]
  • [Cites] Nat Rev Immunol. 2008 Nov;8(11):849-60 [18836477.001]
  • [Cites] Trends Microbiol. 2008 Dec;16(12):612-9 [18976920.001]
  • [Cites] Microbiol Mol Biol Rev. 1999 Dec;63(4):862-922, table of contents [10585969.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):633-49 [10669613.001]
  • [Cites] Structure. 2000 Jun 15;8(6):617-28 [10873863.001]
  • [Cites] Nature. 2000 Sep 21;407(6802):409-13 [11014200.001]
  • [Cites] EMBO J. 2001 Apr 2;20(7):1498-507 [11285214.001]
  • [Cites] J Virol. 2001 Aug;75(15):6850-6 [11435564.001]
  • [Cites] J Struct Biol. 2001 Feb-Mar;133(2-3):156-69 [11472087.001]
  • [Cites] J Struct Biol. 2001 Oct;136(1):67-80 [11858708.001]
  • [Cites] J Virol. 2002 Jun;76(11):5667-77 [11991995.001]
  • [Cites] J Virol. 2002 Jul;76(14):6900-8 [12072491.001]
  • [Cites] Biochemistry. 2002 Oct 1;41(39):11525-31 [12269796.001]
  • [Cites] Nature. 2009 Feb 5;457(7230):694-8 [19194444.001]
  • [Cites] J Mol Biol. 2009 Mar 27;387(2):376-89 [19356593.001]
  • [Cites] Structure. 2009 May 13;17(5):737-48 [19446529.001]
  • [Cites] J Mol Biol. 2009 Jun 5;389(2):438-51 [19361521.001]
  • [Cites] Cell. 2009 Jun 26;137(7):1282-92 [19523676.001]
  • [Cites] Acta Crystallogr D Biol Crystallogr. 2002 Oct;58(Pt 10 Pt 2):1820-5 [12351826.001]
  • (PMID = 20228062.001).
  • [ISSN] 1083-351X
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Protons
  • [Other-IDs] NLM/ PMC2865289
  •  go-up   go-down


14. Spidel JL, Wilson CB, Craven RC, Wills JW: Genetic Studies of the beta-hairpin loop of Rous sarcoma virus capsid protein. J Virol; 2007 Feb;81(3):1288-96
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Genetic Studies of the beta-hairpin loop of Rous sarcoma virus capsid protein.
  • The first few residues of the Rous sarcoma virus (RSV) CA protein comprise a structurally dynamic region that forms part of a Gag-Gag interface in immature virus particles.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Virology. 2000 Mar 15;268(2):294-307 [10704338.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):633-49 [10669613.001]
  • [Cites] Cell. 2002 Feb 8;108(3):345-56 [11853669.001]
  • [Cites] J Mol Biol. 2002 Feb 22;316(3):667-78 [11866525.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3944-9 [11891341.001]
  • [Cites] J Virol. 2002 Jun;76(11):5667-77 [11991995.001]
  • [Cites] J Mol Biol. 2002 Apr 26;318(2):519-31 [12051856.001]
  • [Cites] Nat Struct Biol. 2002 Jul;9(7):537-43 [12032547.001]
  • [Cites] J Cell Biol. 2002 Nov 11;159(3):441-52 [12417576.001]
  • [Cites] J Mol Biol. 2003 Jan 24;325(4):759-72 [12507478.001]
  • [Cites] Virology. 2003 Jan 20;305(2):288-97 [12573574.001]
  • [Cites] Virus Res. 2003 Mar;92(1):37-45 [12606074.001]
  • [Cites] J Virol. 2003 May;77(9):5439-50 [12692245.001]
  • [Cites] EMBO J. 2003 Jun 16;22(12):2886-92 [12805204.001]
  • [Cites] J Virol. 2003 Sep;77(17):9388-98 [12915554.001]
  • [Cites] Nat Rev Mol Cell Biol. 2003 Sep;4(9):690-9 [14506472.001]
  • [Cites] Virology. 2003 Sep 15;314(1):62-73 [14517060.001]
  • [Cites] J Virol. 2003 Dec;77(23):12592-602 [14610182.001]
  • [Cites] J Mol Biol. 2004 Jan 2;335(1):275-82 [14659756.001]
  • [Cites] J Virol. 2004 May;78(10):5423-37 [15113921.001]
  • [Cites] J Virol. 2004 Jun;78(11):6005-12 [15140998.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):676-7 [15208693.001]
  • [Cites] J Virol. 2004 Sep;78(18):9592-8 [15331691.001]
  • [Cites] J Virol. 2004 Oct;78(19):10606-16 [15367628.001]
  • [Cites] Nature. 2004 Sep 23;431(7007):481-5 [15386017.001]
  • [Cites] J Mol Biol. 1967 Jun 14;26(2):365-9 [4291934.001]
  • [Cites] Cell. 1977 May;11(1):95-103 [194709.001]
  • [Cites] J Virol. 1982 Apr;42(1):346-51 [6283156.001]
  • [Cites] Cell. 1983 Mar;32(3):853-69 [6299578.001]
  • [Cites] Genes Dev. 1989 Apr;3(4):469-78 [2721960.001]
  • [Cites] J Virol. 1992 Dec;66(12):7021-32 [1279197.001]
  • [Cites] J Virol. 1993 Jul;67(7):4264-73 [7685414.001]
  • [Cites] J Virol. 1993 Oct;67(10):6246-52 [8396679.001]
  • [Cites] J Virol. 1994 Aug;68(8):4927-36 [8035491.001]
  • [Cites] Virology. 1994 Sep;203(2):211-20 [8053145.001]
  • [Cites] J Virol. 1994 Dec;68(12):8180-7 [7966609.001]
  • [Cites] J Virol. 1995 Jul;69(7):4213-27 [7769681.001]
  • [Cites] J Virol. 1995 Oct;69(10):6430-8 [7666544.001]
  • [Cites] Science. 1996 Jul 12;273(5272):231-5 [8662505.001]
  • [Cites] Virology. 1996 Aug 15;222(2):339-51 [8806518.001]
  • [Cites] J Virol. 1996 Dec;70(12):8645-52 [8970990.001]
  • [Cites] Curr Biol. 1997 Oct 1;7(10):729-38 [9368755.001]
  • [Cites] EMBO J. 1998 Mar 16;17(6):1555-68 [9501077.001]
  • [Cites] J Biol Chem. 1998 Mar 27;273(13):7177-80 [9516405.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7299-304 [9636143.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] Acta Crystallogr D Biol Crystallogr. 1999 Jan;55(Pt 1):85-92 [10089398.001]
  • [Cites] J Virol. 1999 Nov;73(11):8919-25 [10515996.001]
  • [Cites] J Biol Chem. 2004 Dec 24;279(52):53899-902 [15448161.001]
  • [Cites] J Virol. 2006 Jan;80(1):342-52 [16352559.001]
  • [Cites] Virology. 2006 Apr 10;347(2):364-71 [16427108.001]
  • [Cites] Structure. 2000 Jun 15;8(6):617-28 [10873863.001]
  • [Cites] Nature. 2000 Sep 21;407(6802):409-13 [11014200.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12295-9 [11027299.001]
  • [Cites] J Virol. 2000 Dec;74(23):11222-9 [11070020.001]
  • [Cites] J Virol. 2001 Jan;75(1):242-50 [11119594.001]
  • [Cites] J Virol. 2001 Mar;75(6):2753-64 [11222698.001]
  • [Cites] J Virol. 2001 Apr;75(8):3626-35 [11264352.001]
  • [Cites] J Biol Chem. 2001 Jun 15;276(24):21664-9 [11259410.001]
  • [Cites] J Virol. 2001 Aug;75(15):6850-6 [11435564.001]
  • [Cites] J Virol. 2000 Jan;74(1):164-72 [10590103.001]
  • [Cites] J Virol. 2001 Oct;75(19):9357-66 [11533199.001]
  • (PMID = 17093186.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA47482; United States / NCI NIH HHS / CA / R01 CA047482; United States / NCI NIH HHS / CA / R01 CA100322; United States / NCI NIH HHS / CA / R37 CA047482; United States / NCI NIH HHS / CA / CA100322
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC1797520
  •  go-up   go-down


15. Masker K, Golden A, Gaffney CJ, Mazack V, Schwindinger WF, Zhang W, Wang LH, Carey DJ, Sudol M: Transcriptional profile of Rous Sarcoma Virus transformed chicken embryo fibroblasts reveals new signaling targets of viral-src. Virology; 2007 Jul 20;364(1):10-20
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transcriptional profile of Rous Sarcoma Virus transformed chicken embryo fibroblasts reveals new signaling targets of viral-src.
  • Transformation of chicken fibroblasts in vitro by Rous Sarcoma Virus represents a model of cancer in which a single oncogene, viral src, uniformly and rapidly transforms primary cells in culture.
  • We experimentally surveyed the transcriptional program affected by Rous Sarcoma Virus (RSV) in primary culture of chicken embryo fibroblasts.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5472-6 [1608957.001]
  • [Cites] Cell Biol Int Rep. 1992 Oct;16(10):1003-14 [1384993.001]
  • [Cites] Nucleic Acids Res. 1992 Dec 11;20(23):6377-83 [1475199.001]
  • [Cites] Oncogene. 1993 Apr;8(4):823-31 [8455940.001]
  • [Cites] Biochem Cell Biol. 1992 Oct-Nov;70(10-11):980-97 [1297357.001]
  • [Cites] Oncogene. 1994 Sep;9(9):2729-32 [7520150.001]
  • [Cites] Biochem Biophys Res Commun. 1995 Jan 26;206(3):916-26 [7832805.001]
  • [Cites] Cancer Res. 2006 Feb 15;66(4):2028-37 [16489002.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):502-8 [16537708.001]
  • [Cites] J Biol Chem. 2006 Apr 7;281(14):9450-9 [16461772.001]
  • [Cites] Cancer Res. 2006 Jun 1;66(11):5686-95 [16740706.001]
  • [Cites] Int J Oncol. 2006 Jul;29(1):25-32 [16773181.001]
  • [Cites] J Biol Chem. 2006 Jul 28;281(30):20891-901 [16728406.001]
  • [Cites] Nat Cell Biol. 2006 Sep;8(9):945-56 [16892055.001]
  • [Cites] J Hepatol. 2006 Nov;45(5):673-80 [16935389.001]
  • [Cites] Expert Opin Ther Targets. 2007 Jan;11(1):91-100 [17150037.001]
  • [Cites] Cardiovasc Res. 2007 Jan 1;73(1):19-25 [17045254.001]
  • [Cites] Oncogene. 2007 Jan 4;26(1):1-10 [16799638.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4053-8 [15007166.001]
  • [Cites] Oncogene. 2004 Jul 8;23(31):5330-9 [15064726.001]
  • [Cites] Nat Med. 2004 Aug;10(8):789-99 [15286780.001]
  • [Cites] Mol Cell Proteomics. 2004 Oct;3(10):960-9 [15238602.001]
  • [Cites] Oncogene. 2004 Oct 18;23(48):7910-7 [15489909.001]
  • [Cites] Proc Natl Acad Sci U S A. 1969 Jun;63(2):318-25 [4308272.001]
  • [Cites] J Exp Med. 1973 Jan 1;137(1):85-111 [4347290.001]
  • [Cites] Cell. 1977 Jul;11(3):513-21 [195741.001]
  • [Cites] Nature. 1977 Sep 22;269(5626):346-8 [198667.001]
  • [Cites] J Biol Chem. 1978 Aug 25;253(16):5869-74 [78927.001]
  • [Cites] Cancer Res. 1980 Jul;40(7):2300-9 [7190062.001]
  • [Cites] J Biol Chem. 1981 Jan 10;256(1):520-5 [6256355.001]
  • [Cites] Proc Natl Acad Sci U S A. 1981 Sep;78(9):5633-7 [6272310.001]
  • [Cites] J Virol. 1984 Mar;49(3):881-91 [6321772.001]
  • [Cites] Cell. 1984 Oct;38(3):757-65 [6091899.001]
  • [Cites] Mol Cell Endocrinol. 1985 May;40(2-3):245-55 [2408939.001]
  • [Cites] Proc Natl Acad Sci U S A. 1987 Apr;84(8):2251-5 [2436227.001]
  • [Cites] Cell. 1987 May 8;49(3):321-8 [3032449.001]
  • [Cites] Proc Natl Acad Sci U S A. 1987 Oct;84(19):6715-9 [2821543.001]
  • [Cites] Annu Rev Cell Biol. 1987;3:31-56 [2446642.001]
  • [Cites] J Virol. 1989 Jul;63(7):2929-35 [2542604.001]
  • [Cites] J Biol Chem. 1990 Jan 25;265(3):1339-44 [2295632.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Jan;87(2):558-62 [2105487.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Nov;87(21):8592-6 [1700434.001]
  • [Cites] Oncogene. 1991 Jul;6(7):1259-68 [1861868.001]
  • [Cites] Mol Cell Biol. 1996 Feb;16(2):481-6 [8552074.001]
  • [Cites] Cell Growth Differ. 1997 Jan;8(1):113-9 [8993840.001]
  • [Cites] Oncogene. 1997 Oct 16;15(16):1929-36 [9365239.001]
  • [Cites] Biochim Biophys Acta. 1998 Feb 11;1395(3):288-92 [9512662.001]
  • [Cites] Gastroenterology. 1998 Jun;114(6):1287-95 [9609766.001]
  • [Cites] Oncogene. 2004 Nov 4;23(52):8455-63 [15378015.001]
  • [Cites] Carcinogenesis. 2004 Dec;25(12):2467-72 [15308583.001]
  • [Cites] Exp Cell Res. 2001 May 1;265(2):339-47 [11302700.001]
  • [Cites] Nature. 2001 May 17;411(6835):355-65 [11357143.001]
  • [Cites] Oncogene. 2001 Apr 30;20(19):2365-77 [11402333.001]
  • [Cites] Cell. 2002 Jan 25;108(2):135-44 [11832204.001]
  • [Cites] Biochim Biophys Acta. 2002 Jun 21;1602(2):114-30 [12020799.001]
  • [Cites] Nat Rev Cancer. 2002 Oct;2(10):740-9 [12360277.001]
  • [Cites] Oncogene. 2002 Oct 17;21(47):7256-65 [12370817.001]
  • [Cites] Genome Biol. 2003;4(1):R7 [12540299.001]
  • [Cites] Genome Biol. 2003;4(5):P3 [12734009.001]
  • [Cites] Front Biosci. 2004 Jan 1;9:139-44 [14766353.001]
  • [Cites] Nature. 2004 Dec 9;432(7018):695-716 [15592404.001]
  • [Cites] Nature. 2004 Dec 9;432(7018):761-4 [15592415.001]
  • [Cites] Front Biosci. 2005;10:998-1009 [15769600.001]
  • [Cites] FEBS Lett. 2005 Dec 19;579(30):6705-15 [16313905.001]
  • [Cites] Genome Res. 2005 Dec;15(12):1692-8 [16339367.001]
  • [Cites] Cell Commun Adhes. 2005 Jan-Apr;12(1-2):41-57 [16371345.001]
  • [Cites] Cancer Res. 2006 Feb 1;66(3):1543-52 [16452211.001]
  • [Cites] Mol Cell Biol. 1991 Sep;11(9):4448-54 [1875932.001]
  • [Cites] Cell. 1991 Nov 15;67(4):731-40 [1682056.001]
  • [Cites] Oncogene. 1991 Nov;6(11):2129-35 [1682867.001]
  • [Cites] Mol Cell Biol. 1992 Jan;12(1):10-21 [1309586.001]
  • (PMID = 17448514.001).
  • [ISSN] 0042-6822
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA029339; United States / NCI NIH HHS / CA / CA29339; United States / NIDDK NIH HHS / DK / DK062345-02; United States / NIDDK NIH HHS / DK / P01 DK062345-02; United States / NIDDK NIH HHS / DK / P01 DK062345-03; United States / NIDDK NIH HHS / DK / P01 DK062345; United States / NIDDK NIH HHS / DK / DK062345-03; United States / NIDDK NIH HHS / DK / DK62345
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA Primers; 0 / DNA, Viral
  • [Other-IDs] NLM/ NIHMS25800; NLM/ PMC1974879
  •  go-up   go-down


16. Johnson MC, Spidel JL, Ako-Adjei D, Wills JW, Vogt VM: The C-terminal half of TSG101 blocks Rous sarcoma virus budding and sequesters Gag into unique nonendosomal structures. J Virol; 2005 Mar;79(6):3775-86
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The C-terminal half of TSG101 blocks Rous sarcoma virus budding and sequesters Gag into unique nonendosomal structures.
  • Rous sarcoma virus (RSV) and murine leukemia virus (MLV) Gag proteins are selectively recruited to these structures, but HIV type 1 Gag is completely excluded.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Biol Cell. 2000 Jan;11(1):227-39 [10637304.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] J Virol. 2000 Sep;74(18):8670-9 [10954568.001]
  • [Cites] J Virol. 2000 Nov;74(21):10260-8 [11024160.001]
  • [Cites] J Virol. 2000 Dec;74(23):11222-9 [11070020.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13057-62 [11087859.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13069-74 [11087861.001]
  • [Cites] Trends Cell Biol. 2000 Dec;10(12):524-30 [11121744.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7724-9 [11427703.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11199-204 [11562473.001]
  • [Cites] Cell. 2001 Oct 5;107(1):55-65 [11595185.001]
  • [Cites] J Cell Biol. 2002 Feb 4;156(3):511-8 [11827983.001]
  • [Cites] J Virol. 2002 Mar;76(6):2641-7 [11861830.001]
  • [Cites] J Virol. 2002 Mar;76(6):3038-44 [11861870.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3944-9 [11891341.001]
  • [Cites] J Virol. 2002 May;76(10):4679-87 [11967285.001]
  • [Cites] Nature. 2002 May 9;417(6885):177-82 [12000969.001]
  • [Cites] Methods Enzymol. 1998;298:570-92 [9751908.001]
  • [Cites] J Cell Biol. 1999 Sep 20;146(6):1239-54 [10491388.001]
  • [Cites] Traffic. 2002 Jun;3(6):388-96 [12010457.001]
  • [Cites] J Virol. 2002 Nov;76(22):11177-85 [12388677.001]
  • [Cites] Nat Rev Mol Cell Biol. 2002 Dec;3(12):893-905 [12461556.001]
  • [Cites] J Virol. 2003 Jun;77(11):6507-19 [12743307.001]
  • [Cites] Curr Opin Cell Biol. 2003 Aug;15(4):446-55 [12892785.001]
  • [Cites] J Virol. 2003 Sep;77(17):9173-82 [12915533.001]
  • [Cites] J Virol. 2003 Sep;77(17):9388-98 [12915554.001]
  • [Cites] Cell. 2003 Sep 19;114(6):689-99 [14505569.001]
  • [Cites] Cell. 2003 Sep 19;114(6):701-13 [14505570.001]
  • [Cites] J Cell Biol. 2003 Sep 29;162(7):1233-44 [14517204.001]
  • [Cites] Traffic. 2003 Nov;4(11):785-801 [14617360.001]
  • [Cites] J Virol. 2004 Jan;78(2):724-32 [14694104.001]
  • [Cites] J Cell Biol. 2004 Mar 1;164(5):667-75 [14981091.001]
  • [Cites] J Cell Sci. 2004 Mar 1;117(Pt 7):1033-45 [14970261.001]
  • [Cites] Mol Cell. 2004 Mar 26;13(6):783-9 [15053872.001]
  • [Cites] J Virol. 2004 Jun;78(12):6636-48 [15163754.001]
  • [Cites] J Virol. 2004 Oct;78(19):10606-16 [15367628.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Jan;87(2):523-7 [2405382.001]
  • [Cites] J Virol. 1990 Sep;64(9):4169-79 [2166812.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195-9 [2014240.001]
  • [Cites] J Virol. 1994 Oct;68(10):6605-18 [8083996.001]
  • [Cites] J Virol. 1995 Nov;69(11):6810-8 [7474093.001]
  • [Cites] J Virol. 1996 Aug;70(8):5695-700 [8764091.001]
  • [Cites] J Virol. 1997 Sep;71(9):6541-6 [9261374.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] J Virol. 2000 Aug;74(16):7250-60 [10906179.001]
  • (PMID = 15731271.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA47482; United States / NCI NIH HHS / CA / R01 CA047482; United States / NCI NIH HHS / CA / R37 CA047482; United States / NCI NIH HHS / CA / R01 CA020081; United States / NCI NIH HHS / CA / CA20081
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / Endosomal Sorting Complexes Required for Transport; 0 / Gag protein p12, moloney murine leukemia virus; 0 / Gene Products, gag; 0 / Macromolecular Substances; 0 / Recombinant Fusion Proteins; 0 / Transcription Factors; 0 / Tsg101 protein; 0 / Ubiquitin; 0 / gag protein p19, Rous sarcoma virus; 147336-22-9 / Green Fluorescent Proteins
  • [Other-IDs] NLM/ PMC1075695
  •  go-up   go-down


17. Keller PW, Johnson MC, Vogt VM: Mutations in the spacer peptide and adjoining sequences in Rous sarcoma virus Gag lead to tubular budding. J Virol; 2008 Jul;82(14):6788-97
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mutations in the spacer peptide and adjoining sequences in Rous sarcoma virus Gag lead to tubular budding.
  • The Gag proteins of Rous sarcoma virus (RSV) and human immunodeficiency virus type 1 (HIV-1) contain a short spacer peptide (SP or SP1, respectively) separating the capsid (CA) and nucleocapsid (NC) domains.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 2005 Dec 23;280(51):42149-55 [16251182.001]
  • [Cites] J Virol. 2006 Jun;80(12):5716-22 [16731910.001]
  • [Cites] J Virol. 2006 Nov;80(22):10957-71 [16956950.001]
  • [Cites] Virology. 2006 Dec 5-20;356(1-2):217-24 [16930665.001]
  • [Cites] PLoS Biol. 2006 Dec;4(12):e435 [17147474.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4353-8 [17360528.001]
  • [Cites] Virology. 2007 Apr 10;360(2):388-97 [17156810.001]
  • [Cites] EMBO J. 2007 Apr 18;26(8):2218-26 [17396149.001]
  • [Cites] Cell. 2007 Oct 5;131(1):70-9 [17923088.001]
  • [Cites] EMBO J. 2008 May 7;27(9):1411-20 [18401344.001]
  • [Cites] EMBO J. 1998 May 1;17(9):2699-708 [9564051.001]
  • [Cites] J Virol. 1994 Dec;68(12):8017-27 [7966591.001]
  • [Cites] J Virol. 1995 Jun;69(6):3407-19 [7745687.001]
  • [Cites] J Virol. 1995 Oct;69(10):6430-8 [7666544.001]
  • [Cites] J Virol. 1997 Jun;71(6):4425-35 [9151833.001]
  • [Cites] Science. 1997 Oct 31;278(5339):849-53 [9346481.001]
  • [Cites] Eur J Biochem. 1997 Oct 15;249(2):592-600 [9370371.001]
  • [Cites] J Virol. 1998 Jan;72(1):564-77 [9420260.001]
  • [Cites] J Virol. 1998 Mar;72(3):1782-9 [9499028.001]
  • [Cites] J Virol. 1998 Mar;72(3):2072-8 [9499062.001]
  • [Cites] EMBO J. 1998 Mar 16;17(6):1555-68 [9501077.001]
  • [Cites] J Virol. 1998 Apr;72(4):2846-54 [9525604.001]
  • [Cites] J Virol. 1998 Jul;72(7):5877-85 [9621049.001]
  • [Cites] Virology. 1998 Aug 1;247(2):160-9 [9705909.001]
  • [Cites] Science. 1999 Jan 1;283(5398):80-3 [9872746.001]
  • [Cites] Acta Crystallogr D Biol Crystallogr. 1999 Jan;55(Pt 1):85-92 [10089398.001]
  • [Cites] J Cell Biol. 1963 Apr;17:208-12 [13986422.001]
  • [Cites] Mol Cell. 2005 Jan 7;17(1):137-43 [15629724.001]
  • [Cites] J Virol. 2000 Jan;74(1):16-23 [10590086.001]
  • [Cites] EMBO J. 2000 Jan 4;19(1):103-13 [10619849.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):633-49 [10669613.001]
  • [Cites] J Virol. 2000 Jun;74(12):5395-402 [10823843.001]
  • [Cites] Structure. 2000 Jun 15;8(6):617-28 [10873863.001]
  • [Cites] Nature. 2000 Sep 21;407(6802):409-13 [11014200.001]
  • [Cites] J Virol. 2001 Mar;75(6):2753-64 [11222698.001]
  • [Cites] Antimicrob Agents Chemother. 2001 Apr;45(4):1225-30 [11257038.001]
  • [Cites] J Virol. 2001 May;75(9):4407-12 [11287591.001]
  • [Cites] J Virol. 2001 Jul;75(13):6016-21 [11390603.001]
  • [Cites] Biophys J. 2001 Jul;81(1):586-94 [11423440.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10875-9 [11526217.001]
  • [Cites] Cell. 2001 Oct 5;107(1):55-65 [11595185.001]
  • [Cites] Virology. 2002 Jun 20;298(1):30-8 [12093170.001]
  • [Cites] J Virol. 2002 Nov;76(22):11177-85 [12388677.001]
  • [Cites] J Virol. 2002 Nov;76(22):11729-37 [12388733.001]
  • [Cites] J Mol Biol. 2003 Jan 24;325(4):759-72 [12507478.001]
  • [Cites] J Virol. 2003 Feb;77(3):1772-83 [12525611.001]
  • [Cites] EMBO J. 2003 Apr 1;22(7):1707-15 [12660176.001]
  • [Cites] J Virol. 2003 Apr;77(8):4794-804 [12663786.001]
  • [Cites] J Virol. 2003 May;77(9):5439-50 [12692245.001]
  • [Cites] J Virol. 2003 Jun;77(12):7058-66 [12768025.001]
  • [Cites] EMBO J. 2003 Jun 16;22(12):2886-92 [12805204.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13555-60 [14573704.001]
  • [Cites] J Virol. 2003 Dec;77(24):12986-95 [14645555.001]
  • [Cites] J Virol. 2004 Jan;78(1):52-60 [14671087.001]
  • [Cites] J Virol. 2004 Jan;78(2):551-60 [14694086.001]
  • [Cites] J Virol. 2004 Jan;78(2):724-32 [14694104.001]
  • [Cites] J Virol. 2004 Jan;78(2):922-9 [14694123.001]
  • [Cites] J Virol. 2004 Mar;78(5):2545-52 [14963157.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):672-5 [15208690.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):676-7 [15208693.001]
  • [Cites] Protein Sci. 2004 Aug;13(8):2101-7 [15238640.001]
  • [Cites] J Virol. 2004 Sep;78(18):9675-88 [15331700.001]
  • [Cites] J Biol Chem. 2004 Sep 17;279(38):39886-94 [15247214.001]
  • [Cites] Nature. 2004 Sep 23;431(7007):481-5 [15386017.001]
  • [Cites] J Ultrastruct Res. 1969 Jan;26(1):31-43 [4887011.001]
  • [Cites] J Virol. 1993 Oct;67(10):6246-52 [8396679.001]
  • [Cites] J Virol. 2005 Feb;79(3):1803-12 [15650204.001]
  • [Cites] Protein Sci. 2005 Feb;14(2):375-86 [15659370.001]
  • [Cites] J Virol. 2005 Apr;79(7):4159-69 [15767417.001]
  • [Cites] Virology. 2005 May 10;335(2):232-41 [15840522.001]
  • [Cites] Traffic. 2005 Oct;6(10):880-94 [16138902.001]
  • [Cites] J Virol. 2005 Nov;79(21):13463-72 [16227267.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15453-8 [16230638.001]
  • [Cites] Virology. 2005 Dec 20;343(2):190-200 [16183096.001]
  • [Cites] J Mol Biol. 2006 Jan 6;355(1):157-68 [16289202.001]
  • (PMID = 18448521.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI073098-02; United States / NCI NIH HHS / CA / R01 CA020081; United States / NIAID NIH HHS / AI / AI73098; United States / NIAID NIH HHS / AI / R01 AI073098; United States / NCI NIH HHS / CA / CA20081
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag; 0 / gag protein p19, Rous sarcoma virus
  • [Other-IDs] NLM/ PMC2446955
  •  go-up   go-down


18. Scheifele LZ, Ryan EP, Parent LJ: Detailed mapping of the nuclear export signal in the Rous sarcoma virus Gag protein. J Virol; 2005 Jul;79(14):8732-41
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Detailed mapping of the nuclear export signal in the Rous sarcoma virus Gag protein.
  • The Rous sarcoma virus (RSV) Gag polyprotein undergoes transient nuclear trafficking as an intrinsic part of the virus assembly pathway.
  • Consistent with a role for the NES sequence in viral replication, this cluster of hydrophobic residues in p10 is conserved across a wide range of avian retroviruses.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] EMBO J. 2003 Jun 2;22(11):2841-51 [12773398.001]
  • [Cites] EMBO J. 1997 Aug 1;16(15):4531-9 [9303297.001]
  • [Cites] Virus Res. 2003 Sep;95(1-2):3-12 [12921991.001]
  • [Cites] Trends Biochem Sci. 2003 Aug;28(8):419-24 [12932730.001]
  • [Cites] Cell. 1997 Sep 19;90(6):1041-50 [9323132.001]
  • [Cites] Cell. 1997 Sep 19;90(6):1051-60 [9323133.001]
  • [Cites] J Virol. 1998 Jan;72(1):564-77 [9420260.001]
  • [Cites] J Cell Biochem. 1998 Aug 1;70(2):231-9 [9671229.001]
  • [Cites] J Virol. 1998 Sep;72(9):7593-7 [9696859.001]
  • [Cites] J Virol. 1999 Jan;73(1):120-7 [9847314.001]
  • [Cites] J Virol. 1999 Apr;73(4):2667-74 [10074112.001]
  • [Cites] J Virol. 1999 Aug;73(8):6282-92 [10400719.001]
  • [Cites] Mol Cell Biol. 1999 Sep;19(9):6276-85 [10454574.001]
  • [Cites] Genes Dev. 1999 Aug 15;13(16):2118-33 [10465789.001]
  • [Cites] J Biol Chem. 2004 Nov 12;279(46):47473-9 [15364930.001]
  • [Cites] Trends Cell Biol. 2005 Mar;15(3):121-4 [15752974.001]
  • [Cites] J Cell Sci. 2003 Jun 15;116(Pt 12):2409-19 [12724356.001]
  • [Cites] J Virol. 2000 Jan;74(1):164-72 [10590103.001]
  • [Cites] Nature. 1999 Dec 9;402(6762):681-5 [10604476.001]
  • [Cites] Annu Rev Cell Dev Biol. 1999;15:607-60 [10611974.001]
  • [Cites] J Virol. 2000 Mar;74(6):2814-25 [10684298.001]
  • [Cites] Cell Struct Funct. 1999 Dec;24(6):425-33 [10698256.001]
  • [Cites] J Virol. 2000 May;74(9):3984-95 [10756010.001]
  • [Cites] Cell. 2000 Apr 14;101(2):187-98 [10786834.001]
  • [Cites] J Virol. 2000 Jul;74(13):5845-55 [10846064.001]
  • [Cites] J Mol Biol. 2000 Jun 2;299(2):359-68 [10860744.001]
  • [Cites] J Cell Biol. 2000 Aug 7;150(3):433-46 [10931858.001]
  • [Cites] Mol Cell Biol. 2000 Oct;20(20):7798-812 [11003674.001]
  • [Cites] J Cell Biol. 2000 Oct 2;151(1):1-14 [11018049.001]
  • [Cites] J Virol. 2000 Nov;74(21):10260-8 [11024160.001]
  • [Cites] J Cell Biol. 2003 Jul 21;162(2):173-83 [12860972.001]
  • [Cites] Virology. 2003 Sep 30;314(2):591-600 [14554087.001]
  • [Cites] J Biol Chem. 2004 Apr 9;279(15):15356-67 [14729678.001]
  • [Cites] Mol Cell. 2004 Jun 4;14(5):599-610 [15175155.001]
  • [Cites] Microbes Infect. 2004 Jul;6(8):715-24 [15207818.001]
  • [Cites] EMBO J. 2004 Sep 15;23(18):3643-52 [15329671.001]
  • [Cites] Protein Eng Des Sel. 2004 Jun;17(6):527-36 [15314210.001]
  • [Cites] Cell. 1977 May;11(1):95-103 [194709.001]
  • [Cites] Nucleic Acids Res. 1988 Nov 25;16(22):10881-90 [2849754.001]
  • [Cites] J Virol. 2000 Dec;74(23):11222-9 [11070020.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5246-51 [11320254.001]
  • [Cites] Traffic. 2001 Aug;2(8):544-55 [11489212.001]
  • [Cites] Mol Cell. 2001 Aug;8(2):397-406 [11545741.001]
  • [Cites] Microbiol Mol Biol Rev. 2001 Dec;65(4):570-94, table of contents [11729264.001]
  • [Cites] Mol Cell. 2000 Nov;6(5):1243-52 [11106761.001]
  • [Cites] Nat Cell Biol. 2001 Dec;3(12):1092-100 [11781571.001]
  • [Cites] Mol Cell Biol. 2002 Apr;22(7):2057-67 [11884594.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3944-9 [11891341.001]
  • [Cites] J Virol. 2002 Jul;76(14):7220-7 [12072521.001]
  • [Cites] J Virol. 2003 Jun;77(11):6376-84 [12743295.001]
  • [Cites] J Virol. 1990 Sep;64(9):4169-79 [2166812.001]
  • [Cites] J Virol. 1993 Mar;67(3):1350-6 [8437220.001]
  • [Cites] J Virol. 1993 Jul;67(7):3826-34 [7685400.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6125-9 [7687060.001]
  • [Cites] J Virol. 1995 Jun;69(6):3949-54 [7745752.001]
  • [Cites] J Virol. 1995 Jul;69(7):4213-27 [7769681.001]
  • [Cites] J Virol. 1995 Sep;69(9):5455-60 [7636991.001]
  • [Cites] J Virol. 1996 Feb;70(2):1016-26 [8551559.001]
  • [Cites] J Virol. 1996 Apr;70(4):2269-76 [8642653.001]
  • [Cites] J Virol. 1996 Sep;70(9):6442-5 [8709278.001]
  • [Cites] J Virol. 1996 Dec;70(12):8255-62 [8970944.001]
  • [Cites] J Virol. 1997 Jun;71(6):4425-35 [9151833.001]
  • [Cites] J Cell Biol. 2000 Oct 30;151(3):653-62 [11062265.001]
  • (PMID = 15994767.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA076534; United States / NCI NIH HHS / CA / R01 CA76534
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag; 0 / Karyopherins; 0 / Nuclear Localization Signals; 0 / Receptors, Cytoplasmic and Nuclear; 0 / exportin 1 protein
  • [Other-IDs] NLM/ PMC1168749
  •  go-up   go-down


19. Withers JB, Beemon KL: Structural features in the Rous sarcoma virus RNA stability element are necessary for sensing the correct termination codon. Retrovirology; 2010;7:65
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Structural features in the Rous sarcoma virus RNA stability element are necessary for sensing the correct termination codon.
  • In the case of the Rous sarcoma virus (RSV), we identified a stability element (RSE), which resides immediately downstream of the gag termination codon and facilitates NMD evasion.
  • [MeSH-major] Codon, Nonsense. Protein Biosynthesis. RNA Stability. RNA, Viral / genetics. RNA, Viral / metabolism. Rous sarcoma virus / physiology. Virus Replication

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] EMBO J. 2000 Dec 15;19(24):6860-9 [11118221.001]
  • [Cites] Microbiology. 2001 Feb;147(Pt 2):255-69 [11158343.001]
  • [Cites] Science. 2001 Mar 9;291(5510):1959-62 [11239155.001]
  • [Cites] RNA. 2001 Mar;7(3):445-56 [11333024.001]
  • [Cites] Gene. 2001 Oct 3;276(1-2):73-81 [11591473.001]
  • [Cites] Life Sci. 2001 Oct 26;69(23):2697-709 [11720075.001]
  • [Cites] Science. 2002 Oct 11;298(5592):419-22 [12228722.001]
  • [Cites] Nat Genet. 2004 Apr;36(4):361-9 [15004559.001]
  • [Cites] J Virol. 2004 May;78(10):5139-46 [15113896.001]
  • [Cites] Ann Neurol. 2004 May;55(5):740-4 [15122717.001]
  • [Cites] Oncogene. 2004 Oct 18;23(48):7910-7 [15489909.001]
  • [Cites] J Virol. 1977 Oct;24(1):47-63 [198585.001]
  • [Cites] Virology. 1978 Mar;85(1):241-52 [77076.001]
  • [Cites] Proc Natl Acad Sci U S A. 1978 Mar;75(3):1284-8 [206893.001]
  • [Cites] J Biol Chem. 1979 Aug 25;254(16):8015-22 [224042.001]
  • [Cites] J Gen Virol. 1983 Oct;64 (Pt 10):2191-202 [6311951.001]
  • [Cites] J Virol. 1988 Sep;62(9):3328-33 [2841485.001]
  • [Cites] Nucleic Acids Res. 1988 Nov 11;16(21):9893-908 [3057449.001]
  • [Cites] Mol Cell Biol. 1988 Nov;8(11):4858-67 [2850470.001]
  • [Cites] Mol Cell Biol. 1991 May;11(5):2760-8 [1850103.001]
  • [Cites] Genet Anal Tech Appl. 1991 Nov;8(7):191-205 [1663382.001]
  • [Cites] EMBO J. 1992 Oct;11(10):3747-57 [1327749.001]
  • [Cites] Mol Cell Biol. 1994 Mar;14(3):1835-44 [8114716.001]
  • [Cites] Mol Cell Biol. 1994 Mar;14(3):1986-96 [8114730.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5431-5 [7777525.001]
  • [Cites] J Virol. 1996 Jun;70(6):3834-43 [8648719.001]
  • [Cites] Biochem Cell Biol. 1995 Nov-Dec;73(11-12):1095-103 [8722026.001]
  • [Cites] Biochimie. 1996;78(11-12):945-52 [9150871.001]
  • [Cites] EMBO J. 1998 Jun 15;17(12):3484-94 [9628884.001]
  • [Cites] Mol Cell Biol. 1998 Sep;18(9):5272-83 [9710612.001]
  • [Cites] J Mol Biol. 1998 Nov 27;284(2):205-25 [9813113.001]
  • [Cites] Mol Gen Genet. 1998 Nov;260(2-3):176-84 [9862469.001]
  • [Cites] Genome Biol. 2005;6(1):R6 [15642098.001]
  • [Cites] Biochem Soc Trans. 2006 Feb;34(Pt 1):39-42 [16246174.001]
  • [Cites] RNA. 2006 Jan;12(1):102-10 [16301601.001]
  • [Cites] Genes Dev. 2006 Feb 1;20(3):355-67 [16452507.001]
  • [Cites] Cell. 2006 Jun 16;125(6):1125-36 [16777602.001]
  • [Cites] Nucleic Acids Res. 2006;34(21):6147-57 [17088291.001]
  • [Cites] EMBO J. 2008 Mar 5;27(5):736-47 [18256688.001]
  • [Cites] PLoS Biol. 2008 Apr 29;6(4):e92 [18447580.001]
  • [Cites] PLoS Biol. 2008 Apr 29;6(4):e111 [18447585.001]
  • [Cites] J Virol. 2009 Mar;83(5):2119-29 [19091866.001]
  • [Cites] Nucleic Acids Res. 2009 May;37(9):2771-8 [19270062.001]
  • [Cites] Biochim Biophys Acta. 2009 Sep-Oct;1789(9-10):558-70 [19539793.001]
  • [Cites] RNA. 1999 Oct;5(10):1299-307 [10573121.001]
  • [Cites] Am J Hum Genet. 2000 May;66(5):1496-503 [10762540.001]
  • [Cites] J Virol. 2000 Oct;74(20):9507-14 [11000220.001]
  • (PMID = 20687936.001).
  • [ISSN] 1742-4690
  • [Journal-full-title] Retrovirology
  • [ISO-abbreviation] Retrovirology
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA048746; United States / NCI NIH HHS / CA / R01 CA048746
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / 3' Untranslated Regions; 0 / Codon, Nonsense; 0 / RNA, Viral
  • [Other-IDs] NLM/ PMC2925335
  •  go-up   go-down


20. Zhou J, Bean RL, Vogt VM, Summers M: Solution structure of the Rous sarcoma virus nucleocapsid protein: muPsi RNA packaging signal complex. J Mol Biol; 2007 Jan 12;365(2):453-67

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Solution structure of the Rous sarcoma virus nucleocapsid protein: muPsi RNA packaging signal complex.
  • The Rous sarcoma virus (RSV) is an exception, in that its genome can be packaged efficiently by a relatively short, 82 nt segment of the 5'-UTR called muPsi.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Prog Nucleic Acid Res Mol Biol. 1996;54:1-34 [8768071.001]
  • [Cites] J Virol. 2000 Dec;74(24):11581-8 [11090156.001]
  • [Cites] Curr Top Microbiol Immunol. 1996;214:177-218 [8791728.001]
  • [Cites] J Virol. 1996 Oct;70(10):6642-52 [8794299.001]
  • [Cites] Biochimie. 1996;78(7):639-53 [8955907.001]
  • [Cites] J Mol Biol. 1997 Feb 28;266(3):493-506 [9067606.001]
  • [Cites] EMBO J. 1997 Jun 2;16(11):3289-302 [9214644.001]
  • [Cites] J Mol Biol. 1997 Oct 17;273(1):283-98 [9367762.001]
  • [Cites] J Biol Chem. 2002 May 31;277(22):19967-75 [11896057.001]
  • [Cites] Nucleic Acids Res. 2002 Jun 15;30(12):2647-55 [12060681.001]
  • [Cites] Nucleic Acids Res. 2002 Oct 15;30(20):4371-9 [12384583.001]
  • [Cites] J Virol. 2003 Feb;77(3):2010-20 [12525635.001]
  • [Cites] J Mol Biol. 2004 Mar 19;337(2):427-42 [15003457.001]
  • [Cites] Nat Rev Microbiol. 2004 Jun;2(6):461-72 [15152202.001]
  • [Cites] J Virol. 2004 Aug;78(16):8486-95 [15280457.001]
  • [Cites] Nature. 2004 Sep 30;431(7008):586-90 [15457265.001]
  • [Cites] Microbiol Rev. 1983 Dec;47(4):621-69 [6363901.001]
  • [Cites] Mol Cell Biol. 1985 Feb;5(2):281-90 [2983187.001]
  • [Cites] J Virol. 1985 May;54(2):401-7 [3989912.001]
  • [Cites] J Virol. 1986 Jul;59(1):163-7 [3012114.001]
  • [Cites] Nucleic Acids Res. 1988;16 Suppl:r175-269 [3368328.001]
  • [Cites] J Virol. 1988 Oct;62(10):3622-30 [2458484.001]
  • [Cites] J Virol. 1990 Feb;64(2):774-83 [2153242.001]
  • [Cites] Biochemistry. 1990 Jan 16;29(2):329-40 [2105740.001]
  • [Cites] Nature. 1990 Aug 16;346(6285):613-4 [1696683.001]
  • [Cites] Nature. 1990 Aug 16;346(6285):680-2 [1696688.001]
  • [Cites] J Virol. 1990 Oct;64(10):5076-92 [1697912.001]
  • [Cites] J Mol Biol. 1990 Dec 5;216(3):585-610 [2258934.001]
  • [Cites] J Virol. 1991 Jan;65(1):71-80 [1985218.001]
  • [Cites] Biochemistry. 1991 Apr 2;30(13):3280-9 [1706937.001]
  • [Cites] J Virol. 1991 Jul;65(7):3864-72 [1710292.001]
  • [Cites] Nucleic Acids Res. 1991 Dec 25;19(24):6929-34 [1662367.001]
  • [Cites] J Virol. 1992 Aug;66(8):4662-70 [1378506.001]
  • [Cites] EMBO J. 1992 Oct;11(10):3747-57 [1327749.001]
  • [Cites] Crit Rev Oncog. 1992;3(4):401-46 [1384720.001]
  • [Cites] J Virol. 1993 Jan;67(1):178-88 [8380070.001]
  • [Cites] J Biomol NMR. 1992 Nov;2(6):661-5 [1490109.001]
  • [Cites] Protein Sci. 1993 Jan;2(1):3-19 [8443588.001]
  • [Cites] J Virol. 1993 Jul;67(7):4337-49 [7685415.001]
  • [Cites] J Mol Biol. 1994 Feb 11;236(1):49-63 [8107125.001]
  • [Cites] J Mol Biol. 1994 Mar 11;236(5):1271-6 [7510342.001]
  • [Cites] Arch Virol Suppl. 1994;9:513-22 [8032280.001]
  • [Cites] Science. 1998 Jan 16;279(5349):384-8 [9430589.001]
  • [Cites] J Virol. 1998 Jul;72(7):6190-4 [9621088.001]
  • [Cites] J Virol. 1998 Oct;72(10):8073-82 [9733847.001]
  • [Cites] J Gen Virol. 1998 Dec;79 ( Pt 12):2877-82 [9880000.001]
  • [Cites] J Virol. 1999 Aug;73(8):6282-92 [10400719.001]
  • [Cites] J Virol. 1999 Nov;73(11):8926-33 [10515997.001]
  • [Cites] J Mol Biol. 2005 Jun 24;349(5):976-88 [15907938.001]
  • [Cites] Retrovirology. 2004;1:22 [15317659.001]
  • [Cites] Nat Rev Microbiol. 2005 Aug;3(8):643-55 [16064056.001]
  • [Cites] Nature. 1994 Nov 3;372(6501):111-3 [7526219.001]
  • [Cites] Nucleic Acids Res. 1995 Mar 11;23(5):861-8 [7708504.001]
  • [Cites] J Mol Biol. 1995 Jul 14;250(3):333-53 [7608979.001]
  • [Cites] J Biomol NMR. 1995 Nov;6(3):277-93 [8520220.001]
  • [Cites] J Virol. 2000 Jan;74(1):456-64 [10590135.001]
  • [Cites] J Mol Biol. 2000 Aug 11;301(2):491-511 [10926523.001]
  • [Cites] J Virol. 2000 Oct;74(19):9167-74 [10982363.001]
  • [Cites] J Mol Biol. 2000 Nov 17;304(1):35-42 [11071808.001]
  • [Cites] Science. 1996 Sep 20;273(5282):1678-85 [8781224.001]
  • (PMID = 17070546.001).
  • [ISSN] 0022-2836
  • [Journal-full-title] Journal of molecular biology
  • [ISO-abbreviation] J. Mol. Biol.
  • [Language] ENG
  • [Databank-accession-numbers] PDB/ 2IHX
  • [Grant] United States / NCI NIH HHS / CA / R01 CA020081; United States / NIGMS NIH HHS / GM / R01 GM042561; United States / NCI NIH HHS / CA / CA20081; United States / NIGMS NIH HHS / GM / GM42561
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Nucleocapsid Proteins; 0 / RNA, Viral; 0 / Solutions
  • [Other-IDs] NLM/ NIHMS15191; NLM/ PMC1764217
  •  go-up   go-down


21. Maciolek NL, McNally MT: Serine/arginine-rich proteins contribute to negative regulator of splicing element-stimulated polyadenylation in rous sarcoma virus. J Virol; 2007 Oct;81(20):11208-17
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Serine/arginine-rich proteins contribute to negative regulator of splicing element-stimulated polyadenylation in rous sarcoma virus.
  • Rous sarcoma virus (RSV) requires large amounts of unspliced RNA for replication.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. L-SERINE .
  • Hazardous Substances Data Bank. (L)-ARGININE .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Virology. 2002 Oct 25;302(2):405-12 [12441084.001]
  • [Cites] J Virol. 1989 Apr;63(4):1669-76 [2538650.001]
  • [Cites] J Biol Chem. 2003 Nov 7;278(45):44153-60 [12944400.001]
  • [Cites] J Biol Chem. 2004 Aug 20;279(34):35788-97 [15169763.001]
  • [Cites] RNA. 2004 Sep;10(9):1388-98 [15317975.001]
  • [Cites] Mol Cell Biol. 1990 Feb;10(2):696-704 [2153921.001]
  • [Cites] Genes Dev. 1990 Sep;4(9):1552-9 [1701407.001]
  • [Cites] Genes Dev. 1991 Feb;5(2):211-20 [1847346.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9784-8 [1835087.001]
  • [Cites] J Virol. 1992 Jan;66(1):6-11 [1309264.001]
  • [Cites] Genes Dev. 1992 May;6(5):837-47 [1577277.001]
  • [Cites] J Virol. 1992 Jul;66(7):4242-51 [1318403.001]
  • [Cites] Genes Dev. 1993 Apr;7(4):647-59 [8384583.001]
  • [Cites] Mol Cell Biol. 1993 Jun;13(6):3135-45 [7684489.001]
  • [Cites] Genes Dev. 1993 Oct;7(10):1926-36 [8405999.001]
  • [Cites] Cell. 1993 Dec 17;75(6):1061-70 [8261509.001]
  • [Cites] Nature. 1994 Mar 10;368(6467):119-24 [8139654.001]
  • [Cites] Virology. 1995 Feb 1;206(2):1099-107 [7856084.001]
  • [Cites] J Virol. 1995 Aug;69(8):5068-76 [7609076.001]
  • [Cites] EMBO J. 1995 Jul 17;14(14):3540-51 [7543047.001]
  • [Cites] J Virol. 1996 Feb;70(2):1163-72 [8551577.001]
  • [Cites] Genes Dev. 1996 Feb 1;10(3):325-37 [8595883.001]
  • [Cites] Virology. 1998 Mar 1;242(1):211-20 [9501036.001]
  • [Cites] Mol Cell Biol. 1998 Jun;18(6):3103-11 [9584151.001]
  • [Cites] Genes Dev. 1998 Jul 1;12(13):1998-2012 [9649504.001]
  • [Cites] Mol Cell. 1998 Jan;1(2):243-53 [9659921.001]
  • [Cites] Nucleic Acids Res. 1998 Dec 1;26(23):5343-50 [9826757.001]
  • [Cites] J Virol. 1999 Mar;73(3):2385-93 [9971822.001]
  • [Cites] J Virol. 1999 Mar;73(3):2394-400 [9971823.001]
  • [Cites] RNA. 1999 Mar;5(3):333-43 [10094303.001]
  • [Cites] RNA. 1999 Mar;5(3):468-83 [10094314.001]
  • [Cites] RNA. 2000 Feb;6(2):178-88 [10688357.001]
  • [Cites] Genes Dev. 2000 Feb 15;14(4):403-13 [10691733.001]
  • [Cites] Genome Res. 2000 Jul;10(7):1001-10 [10899149.001]
  • [Cites] J Biol Chem. 2000 Oct 13;275(41):32371-8 [10934202.001]
  • [Cites] Mol Cell Biol. 2002 Jan;22(1):148-60 [11739730.001]
  • [Cites] Nucleic Acids Res. 2002 Feb 1;30(3):810-7 [11809895.001]
  • [Cites] Genes Dev. 2002 Mar 1;16(5):594-607 [11877379.001]
  • [Cites] Nature. 2002 Apr 4;416(6880):499-506 [11932736.001]
  • [Cites] Nucleic Acids Res. 2002 Apr 15;30(8):1842-50 [11937639.001]
  • [Cites] Mol Cell Biol. 2002 Jul;22(13):4579-86 [12052867.001]
  • [Cites] Mol Cell Biol. 1999 Jul;19(7):4971-9 [10373547.001]
  • [Cites] Mol Cell. 2004 Nov 19;16(4):597-607 [15546619.001]
  • [Cites] Nucleic Acids Res. 2005;33(1):201-12 [15647503.001]
  • [Cites] Mol Cell Biol. 2005 Jun;25(11):4397-405 [15899846.001]
  • [Cites] RNA. 2005 Oct;11(10):1485-93 [16131587.001]
  • [Cites] J Biol Chem. 2006 Feb 3;281(5):2478-88 [16308319.001]
  • [Cites] Retrovirology. 2006;3:18 [16545126.001]
  • [Cites] Mol Cell. 2006 Jul 21;23(2):195-205 [16857586.001]
  • [Cites] J Virol. 2006 Oct;80(19):9634-40 [16973567.001]
  • [Cites] EMBO J. 2006 Oct 18;25(20):4854-64 [17024186.001]
  • [Cites] EMBO J. 2007 Jun 6;26(11):2658-69 [17464285.001]
  • [Cites] J Biol Chem. 2004 Sep 10;279(37):38201-8 [15252020.001]
  • [Cites] Cell. 1983 Mar;32(3):853-69 [6299578.001]
  • [Cites] Nucleic Acids Res. 1984 Sep 25;12(18):7035-56 [6091052.001]
  • [Cites] J Virol. 1986 Nov;60(2):497-505 [3021984.001]
  • [Cites] J Virol. 1987 Jan;61(1):177-84 [3023695.001]
  • [Cites] Mol Cell Biol. 1988 Nov;8(11):4858-67 [2850470.001]
  • [Cites] RNA. 2003 Nov;9(11):1400-9 [14561889.001]
  • (PMID = 17670832.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA078709; United States / NCI NIH HHS / CA / R01 CA78709
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Proteins; 0 / RNA, Viral; 452VLY9402 / Serine; 94ZLA3W45F / Arginine
  • [Other-IDs] NLM/ PMC2045511
  •  go-up   go-down


22. Scheifele LZ, Kenney SP, Cairns TM, Craven RC, Parent LJ: Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology. J Virol; 2007 Oct;81(19):10718-28
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology.
  • Nucleocytoplasmic shuttling of the Rous sarcoma virus (RSV) Gag polyprotein is an integral step in virus particle assembly.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Jan;74(1):16-23 [10590086.001]
  • [Cites] J Exp Med. 1960 Nov 1;112:945-52 [13693270.001]
  • [Cites] Nature. 1999 Dec 9;402(6762):681-5 [10604476.001]
  • [Cites] EMBO J. 2000 Jan 4;19(1):103-13 [10619849.001]
  • [Cites] J Virol. 2000 Aug;74(16):7250-60 [10906179.001]
  • [Cites] J Virol. 2000 Nov;74(21):10260-8 [11024160.001]
  • [Cites] J Virol. 2001 Jan;75(1):260-8 [11119596.001]
  • [Cites] J Virol. 2001 Jul;75(13):6016-21 [11390603.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3944-9 [11891341.001]
  • [Cites] J Virol. 2002 May;76(10):4679-87 [11967285.001]
  • [Cites] J Virol. 2002 Nov;76(22):11177-85 [12388677.001]
  • [Cites] Virology. 2002 Dec 5;304(1):89-96 [12490406.001]
  • [Cites] J Virol. 2003 Feb;77(3):1820-9 [12525616.001]
  • [Cites] J Gen Virol. 2003 Mar;84(Pt 3):517-27 [12604801.001]
  • [Cites] J Virol. 2003 Sep;77(17):9388-98 [12915554.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11678-83 [14504385.001]
  • [Cites] J Mol Biol. 2004 Jan 2;335(1):275-82 [14659756.001]
  • [Cites] J Virol. 2004 Feb;78(3):1411-20 [14722296.001]
  • [Cites] J Gen Virol. 2004 Jul;85(Pt 7):1885-93 [15218173.001]
  • [Cites] J Virol. 1990 Sep;64(9):4169-79 [2166812.001]
  • [Cites] J Virol. 1991 Jan;65(1):272-80 [1845888.001]
  • [Cites] Arch Virol. 1991;118(3-4):279-84 [2069508.001]
  • [Cites] AIDS. 1991 Jun;5(6):639-54 [1883539.001]
  • [Cites] J Virol. 1993 Mar;67(3):1350-6 [8437220.001]
  • [Cites] J Virol. 1993 Jul;67(7):3826-34 [7685400.001]
  • [Cites] J Virol. 1993 Oct;67(10):6246-52 [8396679.001]
  • [Cites] Nature. 1993 Oct 14;365(6447):666-9 [8105392.001]
  • [Cites] J Virol. 1995 Jul;69(7):4213-27 [7769681.001]
  • [Cites] J Virol. 1995 Oct;69(10):6430-8 [7666544.001]
  • [Cites] J Cell Sci. 1995 Sep;108 ( Pt 9):3039-50 [8537443.001]
  • [Cites] J Virol. 1996 Feb;70(2):1016-26 [8551559.001]
  • [Cites] J Exp Med. 1960 Mar 1;111:387-406 [13755924.001]
  • [Cites] J Virol. 2005 Jan;79(2):1262-70 [15613353.001]
  • [Cites] J Virol. 2005 Jul;79(14):8732-41 [15994767.001]
  • [Cites] J Mol Biol. 2006 Jan 6;355(1):157-68 [16289202.001]
  • [Cites] J Virol. 2006 Feb;80(3):1242-9 [16415001.001]
  • [Cites] Nature. 2006 Jan 26;439(7075):490-2 [16437116.001]
  • [Cites] J Virol. 2006 Feb;80(4):1798-806 [16439536.001]
  • [Cites] J Virol. 2006 Jun;80(11):5233-40 [16699003.001]
  • [Cites] J Virol. 2000 Jan;74(1):164-72 [10590103.001]
  • [Cites] Curr Top Microbiol Immunol. 1996;214:65-94 [8791725.001]
  • [Cites] J Virol. 1997 Jun;71(6):4425-35 [9151833.001]
  • [Cites] Curr Biol. 1997 Oct 1;7(10):729-38 [9368755.001]
  • [Cites] J Virol. 1998 Jan;72(1):564-77 [9420260.001]
  • [Cites] Virology. 1998 Jan 5;240(1):127-37 [9448697.001]
  • [Cites] J Virol. 1998 Jun;72(6):4798-810 [9573245.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 May 12;95(10):5746-51 [9576955.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7299-304 [9636143.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Science. 1999 Jan 1;283(5398):80-3 [9872746.001]
  • [Cites] EMBO J. 2007 Apr 18;26(8):2218-26 [17396149.001]
  • (PMID = 17634229.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA076534; United States / NCI NIH HHS / CA / R01 CA100322; United States / NCI NIH HHS / CA / R01 CA76534
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag; 0 / Nuclear Export Signals; 0 / RNA, Viral; 0 / Recombinant Fusion Proteins; 147336-22-9 / Green Fluorescent Proteins
  • [Other-IDs] NLM/ PMC2045444
  •  go-up   go-down


23. Konsavage WM Jr, Burkholder S, Sudol M, Harper AL, Katzman M: A substitution in rous sarcoma virus integrase that separates its two biologically relevant enzymatic activities. J Virol; 2005 Apr;79(8):4691-9
Hazardous Substances Data Bank. MANGANESE, ELEMENTAL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A substitution in rous sarcoma virus integrase that separates its two biologically relevant enzymatic activities.
  • However, it has been known since the processing assay was first described that avian integrases frequently nick 3 nucleotides, as well as 2 nucleotides, from viral DNA ends when reaction mixtures contain Mn2+.
  • We now report that specificity for the biologically relevant "-2" site is enhanced when the serine at amino acid 124 of Rous sarcoma virus (RSV) integrase is replaced by alanine, valine, glycine, lysine, or aspartate.
  • [MeSH-major] Avian Sarcoma Viruses / enzymology. Integrases / metabolism

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. MAGNESIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Virus Res. 2000 Jan;66(1):87-100 [10653920.001]
  • [Cites] Adv Virus Res. 1999;52:371-95 [10384243.001]
  • [Cites] J Gen Virol. 2000 Mar;81(Pt 3):839-49 [10675422.001]
  • [Cites] J Biol Chem. 2001 Jan 5;276(1):114-24 [11024025.001]
  • [Cites] J Virol. 2001 Aug;75(16):7756-62 [11462051.001]
  • [Cites] J Acquir Immune Defic Syndr. 2001 Nov 1;28(3):203-10 [11694825.001]
  • [Cites] Arch Virol. 2002 Sep;147(9):1761-78 [12209315.001]
  • [Cites] J Virol. 2003 Mar;77(6):3838-45 [12610159.001]
  • [Cites] Nucleic Acids Res. 2004;32(4):1527-38 [14999095.001]
  • [Cites] Cell. 1977 May;11(1):95-103 [194709.001]
  • [Cites] Nucleic Acids Res. 1985 Sep 11;13(17):6205-21 [2995920.001]
  • [Cites] Cell. 1987 May 8;49(3):347-56 [3032450.001]
  • [Cites] J Virol. 1988 Jul;62(7):2358-65 [2836618.001]
  • [Cites] Cell. 1988 Aug 12;54(4):497-504 [3401925.001]
  • [Cites] J Virol. 1989 Dec;63(12):5319-27 [2555556.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Jul;87(13):5119-23 [2164223.001]
  • [Cites] Cell. 1990 Aug 24;62(4):829-37 [2167180.001]
  • [Cites] Cell. 1990 Oct 5;63(1):87-95 [2170022.001]
  • [Cites] J Virol. 1990 Nov;64(11):5656-9 [2214031.001]
  • [Cites] Cell. 1991 Dec 20;67(6):1211-21 [1760846.001]
  • [Cites] Nucleic Acids Res. 1991 Dec 25;19(24):6691-8 [1662361.001]
  • [Cites] J Virol. 1992 Feb;66(2):865-74 [1370559.001]
  • [Cites] Science. 1992 Feb 7;255(5045):723-6 [1738845.001]
  • [Cites] J Biol Chem. 1992 Aug 15;267(23):16037-40 [1322888.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9598-602 [1409671.001]
  • [Cites] J Virol. 1993 Jan;67(1):425-37 [8416376.001]
  • [Cites] J Biol Chem. 1993 Jan 25;268(3):2113-9 [8420982.001]
  • [Cites] Nucleic Acids Res. 1993 Mar 25;21(6):1419-25 [8464733.001]
  • [Cites] Methods Enzymol. 1993;217:270-9 [8474334.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3428-32 [8386373.001]
  • [Cites] J Virol. 1994 Jun;68(6):3558-69 [8189495.001]
  • [Cites] Virology. 1995 Jan 10;206(1):448-56 [7831800.001]
  • [Cites] J Virol. 1995 Sep;69(9):5687-96 [7637015.001]
  • [Cites] J Virol. 1996 Apr;70(4):2598-604 [8642692.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] J Mol Biol. 2000 Jan 28;295(4):755-65 [10656788.001]
  • (PMID = 15795255.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Recombinant Proteins; 42Z2K6ZL8P / Manganese; EC 2.7.7.- / Integrases; I38ZP9992A / Magnesium
  • [Other-IDs] NLM/ PMC1069555
  •  go-up   go-down


24. Garbitt-Hirst R, Kenney SP, Parent LJ: Genetic evidence for a connection between Rous sarcoma virus gag nuclear trafficking and genomic RNA packaging. J Virol; 2009 Jul;83(13):6790-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Genetic evidence for a connection between Rous sarcoma virus gag nuclear trafficking and genomic RNA packaging.
  • We discovered that the Rous sarcoma virus (RSV) Gag protein transiently localizes to the nucleus, although the roles of Gag nuclear trafficking in virus replication have not been fully elucidated.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dev Cell. 2003 Jul;5(1):161-74 [12852860.001]
  • [Cites] J Virol. 2005 Jul;79(14):8732-41 [15994767.001]
  • [Cites] J Virol. 2003 Sep;77(17):9431-8 [12915558.001]
  • [Cites] Traffic. 2005 Sep;6(9):741-55 [16101678.001]
  • [Cites] Retrovirology. 2005;2:68 [16274484.001]
  • [Cites] J Virol. 2006 Feb;80(4):1798-806 [16439536.001]
  • [Cites] Traffic. 2006 Sep;7(9):1177-93 [17004321.001]
  • [Cites] Traffic. 2006 Nov;7(11):1440-50 [16984406.001]
  • [Cites] Traffic. 2007 Apr;8(4):347-58 [17286805.001]
  • [Cites] Virology. 2007 Jul 5;363(2):376-86 [17328934.001]
  • [Cites] Retrovirology. 2007;4:54 [17683545.001]
  • [Cites] J Virol. 2007 Oct;81(20):11226-35 [17686839.001]
  • [Cites] J Virol. 2008 Jan;82(2):683-91 [17977961.001]
  • [Cites] J Virol. 2008 Mar;82(5):2501-14 [18094177.001]
  • [Cites] Traffic. 2008 Sep;9(10):1717-27 [18627573.001]
  • [Cites] J Virol. 2003 Sep;77(17):9388-98 [12915554.001]
  • [Cites] EMBO J. 2004 Jul 7;23(13):2632-40 [15201866.001]
  • [Cites] J Virol. 2000 Jan;74(1):164-72 [10590103.001]
  • [Cites] Nature. 1999 Dec 9;402(6762):681-5 [10604476.001]
  • [Cites] Cell. 1999 Dec 23;99(7):677-90 [10619422.001]
  • [Cites] Structure. 2000 Mar 15;8(3):329-38 [10745017.001]
  • [Cites] J Virol. 2000 Oct;74(19):9167-74 [10982363.001]
  • [Cites] J Virol. 2000 Oct;74(20):9507-14 [11000220.001]
  • [Cites] J Virol. 2000 Dec;74(23):11222-9 [11070020.001]
  • [Cites] EMBO J. 2000 Dec 15;19(24):6751-8 [11118210.001]
  • [Cites] J Virol. 2001 Jan;75(1):260-8 [11119596.001]
  • [Cites] J Virol. 2001 Jan;75(1):408-19 [11119609.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3944-9 [11891341.001]
  • [Cites] J Virol. 2003 Feb;77(3):2010-20 [12525635.001]
  • [Cites] Genes Dev. 2004 Sep 1;18(17):2046-59 [15342487.001]
  • [Cites] Virology. 1978 Jan;84(1):87-98 [74124.001]
  • [Cites] J Cell Biol. 1988 Sep;107(3):841-9 [3417784.001]
  • [Cites] J Biol Chem. 1988 Dec 5;263(34):18545-52 [3192548.001]
  • [Cites] Nature. 1989 Mar 16;338(6212):254-7 [2784194.001]
  • [Cites] Cell. 1989 Jun 30;57(7):1155-65 [2736624.001]
  • [Cites] J Virol. 1990 Feb;64(2):847-55 [2153248.001]
  • [Cites] J Virol. 1990 Sep;64(9):4169-79 [2166812.001]
  • [Cites] Cell. 1991 Feb 8;64(3):615-23 [1991323.001]
  • [Cites] Cell. 1991 Oct 4;67(1):117-30 [1913813.001]
  • [Cites] J Virol. 1992 Aug;66(8):4662-70 [1378506.001]
  • [Cites] J Virol. 1993 Mar;67(3):1350-6 [8437220.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1256-60 [8108397.001]
  • [Cites] J Virol. 1994 Aug;68(8):4946-54 [8035493.001]
  • [Cites] J Virol. 1994 Dec;68(12):7944-52 [7966585.001]
  • [Cites] J Virol. 1995 Jul;69(7):4213-27 [7769681.001]
  • [Cites] Cell. 1995 Aug 11;82(3):475-83 [7543368.001]
  • [Cites] J Virol. 1995 Sep;69(9):5716-22 [7637017.001]
  • [Cites] J Virol. 1995 Oct;69(10):6445-56 [7666546.001]
  • [Cites] J Virol. 1996 Apr;70(4):2269-76 [8642653.001]
  • [Cites] J Virol. 1996 Jun;70(6):3834-43 [8648719.001]
  • [Cites] J Virol. 1996 Aug;70(8):5255-65 [8764035.001]
  • [Cites] Curr Top Microbiol Immunol. 1996;214:177-218 [8791728.001]
  • [Cites] EMBO J. 1997 Jul 16;16(14):4276-84 [9250671.001]
  • [Cites] Cell. 1997 Sep 19;90(6):1051-60 [9323133.001]
  • [Cites] Curr Biol. 1997 Oct 1;7(10):767-75 [9368759.001]
  • [Cites] EMBO J. 1997 Dec 15;16(24):7500-10 [9405378.001]
  • [Cites] EMBO J. 1998 Jan 2;17(1):288-96 [9427762.001]
  • [Cites] Genes Dev. 1998 Mar 15;12(6):868-79 [9512520.001]
  • [Cites] Virology. 1998 Jun 20;246(1):1-23 [9656989.001]
  • [Cites] Mol Cell. 1998 Apr;1(5):649-59 [9660949.001]
  • [Cites] J Virol. 2004 Dec;78(24):13534-42 [15564464.001]
  • [Cites] J Biol Chem. 2009 May 22;284(21):14572-85 [19286658.001]
  • (PMID = 19369339.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA076534; United States / NCI NIH HHS / CA / R01 CA76534
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag; 0 / Nuclear Localization Signals; 0 / RNA, Viral
  • [Other-IDs] NLM/ PMC2698546
  •  go-up   go-down


25. Dilley KA, Gregory D, Johnson MC, Vogt VM: An LYPSL late domain in the gag protein contributes to the efficient release and replication of Rous sarcoma virus. J Virol; 2010 Jul;84(13):6276-87
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An LYPSL late domain in the gag protein contributes to the efficient release and replication of Rous sarcoma virus.
  • The major late domain of Rous sarcoma virus (RSV) has been mapped to a PPPY motif in Gag that binds members of the Nedd4 family of ubiquitin ligases.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2009 Jul;83(14):7185-93 [19403673.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10541-6 [18641129.001]
  • [Cites] Virology. 2009 Sep 1;391(2):284-92 [19596386.001]
  • [Cites] J Cell Biol. 2005 Jan 3;168(1):89-101 [15623582.001]
  • [Cites] J Virol. 2005 Mar;79(5):2988-97 [15709019.001]
  • [Cites] Dev Cell. 2005 Jun;8(6):937-47 [15935782.001]
  • [Cites] J Virol. 2005 Jul;79(14):9038-45 [15994797.001]
  • [Cites] Traffic. 2005 Oct;6(10):880-94 [16138902.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15453-8 [16230638.001]
  • [Cites] Virology. 2006 Jan 5;344(1):55-63 [16364736.001]
  • [Cites] Virology. 2006 Mar 30;347(1):226-33 [16406458.001]
  • [Cites] J Virol. 2006 Oct;80(19):9634-40 [16973567.001]
  • [Cites] Retrovirology. 2006;3:77 [17083721.001]
  • [Cites] J Biol Chem. 2007 Feb 9;282(6):3847-55 [17158451.001]
  • [Cites] Nat Struct Mol Biol. 2007 Mar;14(3):194-9 [17277784.001]
  • [Cites] Cell. 2007 Mar 9;128(5):841-52 [17350572.001]
  • [Cites] J Virol. 2008 Oct;82(19):9770-5 [18667521.001]
  • [Cites] Biochem Soc Trans. 2009 Feb;37(Pt 1):181-4 [19143627.001]
  • [Cites] PLoS Pathog. 2009 Mar;5(3):e1000339 [19282983.001]
  • [Cites] J Virol. 2000 Aug;74(16):7250-60 [10906179.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13871-6 [11095724.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7724-9 [11427703.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11199-204 [11562473.001]
  • [Cites] Cell. 2001 Oct 5;107(1):55-65 [11595185.001]
  • [Cites] Nat Med. 2001 Dec;7(12):1313-9 [11726971.001]
  • [Cites] J Virol. 2002 Jan;76(1):105-17 [11739676.001]
  • [Cites] J Virol. 2002 Feb;76(4):1569-77 [11799151.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):955-60 [11805336.001]
  • [Cites] Virology. 2002 Oct 25;302(2):405-12 [12441084.001]
  • [Cites] J Virol. 2003 Feb;77(3):1812-9 [12525615.001]
  • [Cites] J Virol. 2003 Sep;77(17):9474-85 [12915562.001]
  • [Cites] Cell. 2003 Sep 19;114(6):689-99 [14505569.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12414-9 [14519844.001]
  • [Cites] J Virol. 2003 Nov;77(22):11882-95 [14581525.001]
  • [Cites] J Virol. 2003 Nov;77(22):12373-7 [14581576.001]
  • [Cites] J Virol. 2004 Feb;78(3):1503-12 [14722305.001]
  • [Cites] Nat Rev Mol Cell Biol. 2004 Apr;5(4):317-23 [15071556.001]
  • [Cites] J Virol. 2004 Jun;78(11):5554-63 [15140952.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195-9 [2014240.001]
  • [Cites] Virology. 1991 Nov;185(1):99-108 [1656608.001]
  • [Cites] J Virol. 2007 Jun;81(12):6614-22 [17428861.001]
  • [Cites] Science. 2007 Jun 29;316(5833):1908-12 [17556548.001]
  • [Cites] Nat Rev Microbiol. 2007 Dec;5(12):912-6 [17982468.001]
  • [Cites] Nat Struct Mol Biol. 2008 Jan;15(1):43-9 [18066081.001]
  • [Cites] J Virol. 2008 Feb;82(3):1389-98 [18032513.001]
  • [Cites] J Virol. 1992 Jan;66(1):6-11 [1309264.001]
  • [Cites] J Virol. 1994 Oct;68(10):6605-18 [8083996.001]
  • [Cites] J Virol. 1995 Sep;69(9):5455-60 [7636991.001]
  • [Cites] J Virol. 1996 Aug;70(8):5695-700 [8764091.001]
  • [Cites] J Virol. 1997 Sep;71(9):6541-6 [9261374.001]
  • [Cites] Methods Cell Biol. 1997;52:179-214 [9379950.001]
  • [Cites] J Virol. 2004 Dec;78(24):13943-53 [15564502.001]
  • [Cites] Virus Res. 2004 Dec;106(2):87-102 [15567490.001]
  • [Cites] J Virol. 2008 Feb;82(3):1610-4 [18057258.001]
  • [Cites] Virology. 2008 Jun 5;375(2):637-45 [18355887.001]
  • [Cites] Retrovirology. 2008;5:39 [18477395.001]
  • [Cites] Nature. 2008 Jul 10;454(7201):236-40 [18500329.001]
  • [Cites] PLoS Biol. 2009 Jul;7(7):e1000163 [19636361.001]
  • (PMID = 20392845.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / AI073098; United States / NIAID NIH HHS / AI / R01 AI073098-03; United States / NCI NIH HHS / CA / R01 CA020081; United States / NIAID NIH HHS / AI / R01 AI073098; United States / NCI NIH HHS / CA / CA20081
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Calcium-Binding Proteins; 0 / Cell Cycle Proteins; 0 / Endosomal Sorting Complexes Required for Transport; 0 / Gene Products, gag; 0 / PDCD6IP protein, human
  • [Other-IDs] NLM/ PMC2903267
  •  go-up   go-down


26. Wallny HJ, Avila D, Hunt LG, Powell TJ, Riegert P, Salomonsen J, Skjødt K, Vainio O, Vilbois F, Wiles MV, Kaufman J: Peptide motifs of the single dominantly expressed class I molecule explain the striking MHC-determined response to Rous sarcoma virus in chickens. Proc Natl Acad Sci U S A; 2006 Jan 31;103(5):1434-9
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peptide motifs of the single dominantly expressed class I molecule explain the striking MHC-determined response to Rous sarcoma virus in chickens.
  • Finally, having shown for three haplotypes that there is a single dominantly expressed class I molecule at the level of RNA, protein, and antigenic peptide, we show that the motifs can explain the striking MHC-determined resistance and susceptibility to Rous sarcoma virus.
  • [MeSH-major] Avian Sarcoma Viruses / genetics. Genes, MHC Class I. Peptides / chemistry
  • [MeSH-minor] Amino Acid Motifs. Amino Acid Sequence. Animals. Antigen Presentation. Chickens. DNA, Complementary / metabolism. Electrophoresis, Gel, Two-Dimensional. Flow Cytometry. Genes, Dominant. Haplotypes. Models, Molecular. Molecular Sequence Data. Poultry Diseases / virology. Sarcoma, Avian / virology. Sequence Homology, Amino Acid. Time Factors

  • COS Scholar Universe. author profiles.
  • SciCrunch. OMIA - Online Mendelian Inheritance in Animals: Data: Gene Expression .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nature. 1999 Oct 28;401(6756):923-5 [10553909.001]
  • [Cites] Immunogenetics. 2005 May;57(3-4):232-47 [15900495.001]
  • [Cites] Anim Genet. 2000 Aug;31(4):252-61 [11086534.001]
  • [Cites] Vaccine. 2003 Dec 1;21(32):4694-9 [14585677.001]
  • [Cites] Anim Genet. 2004 Feb;35(1):18-27 [14731225.001]
  • [Cites] Poult Sci. 2004 Apr;83(4):638-49 [15109061.001]
  • [Cites] Immunogenetics. 2004 Jun;56(3):192-203 [15205935.001]
  • [Cites] J Biol Chem. 1975 May 25;250(10):4007-21 [236308.001]
  • [Cites] Cell. 1983 Mar;32(3):853-69 [6299578.001]
  • [Cites] J Exp Med. 1986 Jul 1;164(1):375-80 [2425031.001]
  • [Cites] EMBO J. 1988 Sep;7(9):2775-85 [3141149.001]
  • [Cites] Immunogenetics. 1989;29(2):127-30 [2563355.001]
  • [Cites] J Immunol. 1990 Mar 15;144(6):2258-72 [2313093.001]
  • [Cites] Nature. 1991 May 23;351(6324):290-6 [1709722.001]
  • [Cites] Immunogenetics. 1991;34(2):110-20 [1869304.001]
  • [Cites] Nature. 1991 Sep 26;353(6342):321-5 [1922337.001]
  • [Cites] J Immunol. 1992 Mar 1;148(5):1532-46 [1538136.001]
  • [Cites] Science. 1992 Mar 6;255(5049):1261-3 [1546328.001]
  • [Cites] J Exp Med. 1992 Jul 1;176(1):147-56 [1613456.001]
  • [Cites] Science. 1992 Aug 14;257(5072):927-34 [1323878.001]
  • [Cites] Cell. 1992 Sep 18;70(6):1035-48 [1525820.001]
  • [Cites] Crit Rev Immunol. 1992;12(1-2):47-79 [1358107.001]
  • [Cites] Mol Cell Biol. 1993 Jan;13(1):473-86 [8417345.001]
  • [Cites] J Immunol Methods. 1993 Feb 3;158(2):161-71 [7679131.001]
  • [Cites] Avian Dis. 1993 Jan-Mar;37(1):53-9 [8383961.001]
  • [Cites] Nature. 1993 Sep 16;365(6443):262-4 [8371781.001]
  • [Cites] Nature. 1993 Sep 16;365(6443):264-7 [8396732.001]
  • [Cites] Cell. 1993 Sep 10;74(5):929-37 [8104103.001]
  • [Cites] Immunogenetics. 1994;40(4):257-65 [8082891.001]
  • [Cites] Nature. 1994 Oct 13;371(6498):626-9 [7935798.001]
  • [Cites] Immunogenetics. 1995;41(4):178-228 [7890324.001]
  • [Cites] Annu Rev Immunol. 1995;13:587-622 [7612235.001]
  • [Cites] Immunol Rev. 1995 Feb;143:63-88 [7558083.001]
  • [Cites] Nature. 1996 Nov 14;384(6605):134-41 [8906788.001]
  • [Cites] Immunogenetics. 1998 May;47(6):456-67 [9553152.001]
  • [Cites] Immunol Rev. 1999 Feb;167:101-17 [10319254.001]
  • [Cites] Nature. 2004 Dec 9;432(7018):695-716 [15592404.001]
  • [Cites] Immunogenetics. 2000 Feb;51(2):138-47 [10663576.001]
  • (PMID = 16432226.001).
  • [ISSN] 0027-8424
  • [Journal-full-title] Proceedings of the National Academy of Sciences of the United States of America
  • [ISO-abbreviation] Proc. Natl. Acad. Sci. U.S.A.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ Z54314/ Z54315/ Z54316/ Z54317/ Z54318/ Z54319/ Z54320/ Z54321/ Z54322/ Z54323/ Z54324/ Z54325/ Z54326/ Z54329/ Z54330/ Z54359/ Z54360/ Z54361/ Z54362/ Z54363
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Complementary; 0 / Peptides
  • [Other-IDs] NLM/ PMC1360531
  •  go-up   go-down


27. Suzuki K, Matsumoto T, Kobayashi E, Uenishi H, Churkina I, Plastow G, Yamashita H, Hamasima N, Mitsuhashi T: Genotypes of chicken major histocompatibility complex B locus associated with regression of Rous sarcoma virus J-strain tumors. Poult Sci; 2010 Apr;89(4):651-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Genotypes of chicken major histocompatibility complex B locus associated with regression of Rous sarcoma virus J-strain tumors.
  • The chicken MHC-B locus affects the response to several strains of Rous sarcoma virus (RSV).
  • We evaluated the association between haplotypes of the MHC-B locus and responses to the J strain of RSV by using an F(2) experimental resource family constructed with tumor-regressive (White Leghorn) and tumor-progressive (Rhode Island Red) chickens.
  • Two haplotypes in the resource family, one associated with tumor regression and one with progression, were defined by these 2 markers.
  • [MeSH-major] Chickens / genetics. Major Histocompatibility Complex / genetics. Sarcoma, Avian / genetics
  • [MeSH-minor] Animals. Chromosome Mapping. DNA Primers. Genetic Markers. Genotype. Haplotypes / genetics. Haplotypes / immunology. Polymorphism, Single Nucleotide. Rous sarcoma virus / immunology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20308396.001).
  • [ISSN] 0032-5791
  • [Journal-full-title] Poultry science
  • [ISO-abbreviation] Poult. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA Primers; 0 / Genetic Markers
  •  go-up   go-down


28. LeBlanc JJ, Uddowla S, Abraham B, Clatterbuck S, Beemon KL: Tap and Dbp5, but not Gag, are involved in DR-mediated nuclear export of unspliced Rous sarcoma virus RNA. Virology; 2007 Jul 5;363(2):376-86
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tap and Dbp5, but not Gag, are involved in DR-mediated nuclear export of unspliced Rous sarcoma virus RNA.
  • While the unspliced RNA export pathways for HIV and Mason-Pfizer monkey virus are well characterized, that of Rous sarcoma virus (RSV) is not.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] RNA. 1999 Dec;5(12):1645-55 [10606274.001]
  • [Cites] J Virol. 1996 Jun;70(6):3834-43 [8648719.001]
  • [Cites] J Virol. 2000 Oct;74(20):9507-14 [11000220.001]
  • [Cites] Nature. 2000 Sep 21;407(6802):401-5 [11014198.001]
  • [Cites] Mol Cell. 2001 Apr;7(4):899-905 [11336712.001]
  • [Cites] EMBO J. 2001 Sep 3;20(17):4987-97 [11532962.001]
  • [Cites] Curr Biol. 2001 Oct 30;11(21):1716-21 [11696332.001]
  • [Cites] RNA. 2001 Dec;7(12):1768-80 [11780633.001]
  • [Cites] EMBO J. 2002 Mar 1;21(5):1177-87 [11867546.001]
  • [Cites] Mol Cell Biol. 1997 Jan;17(1):135-44 [8972193.001]
  • [Cites] EMBO J. 1997 Feb 17;16(4):807-16 [9049309.001]
  • [Cites] Cell. 1997 Sep 19;90(6):1051-60 [9323133.001]
  • [Cites] Curr Biol. 1997 Oct 1;7(10):767-75 [9368759.001]
  • [Cites] J Virol. 1997 Dec;71(12):9150-6 [9371572.001]
  • [Cites] EMBO J. 1997 Dec 15;16(24):7500-10 [9405378.001]
  • [Cites] J Virol. 1998 Apr;72(4):3407-11 [9525671.001]
  • [Cites] EMBO J. 1998 May 1;17(9):2663-76 [9564048.001]
  • [Cites] Mol Cell. 1998 Apr;1(5):649-59 [9660949.001]
  • [Cites] Virology. 1998 Jul 20;247(1):86-96 [9683574.001]
  • [Cites] Mol Cell Biol. 1998 Nov;18(11):6826-38 [9774696.001]
  • [Cites] J Biol Chem. 1998 Dec 11;273(50):33414-22 [9837918.001]
  • [Cites] EMBO J. 1999 Apr 1;18(7):1953-65 [10202158.001]
  • [Cites] Genes Dev. 1999 May 1;13(9):1126-39 [10323864.001]
  • [Cites] EMBO J. 1999 Aug 2;18(15):4332-47 [10428971.001]
  • [Cites] J Virol. 1999 Sep;73(9):7421-9 [10438832.001]
  • [Cites] EMBO J. 1999 Oct 15;18(20):5778-88 [10523319.001]
  • [Cites] Mol Cell. 2005 Nov 23;20(4):645-51 [16307927.001]
  • [Cites] J Mol Biol. 2005 Dec 16;354(5):1118-28 [16289115.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3944-9 [11891341.001]
  • [Cites] Cell. 2002 Feb 22;108(4):523-31 [11909523.001]
  • [Cites] J Virol. 2002 Dec;76(24):12877-89 [12438613.001]
  • [Cites] Mol Cell. 2003 Mar;11(3):837-43 [12667464.001]
  • [Cites] Genes Dev. 2003 Dec 15;17(24):3075-86 [14701875.001]
  • [Cites] Mol Cell. 2004 Jan 30;13(2):201-12 [14759366.001]
  • [Cites] Exp Cell Res. 2004 May 15;296(1):12-20 [15120988.001]
  • [Cites] Curr Opin Cell Biol. 2004 Jun;16(3):285-92 [15145353.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9666-70 [15210956.001]
  • [Cites] EMBO J. 2004 Jul 7;23(13):2632-40 [15201866.001]
  • [Cites] J Biol Chem. 2004 Jul 23;279(30):31745-9 [15184380.001]
  • [Cites] Cell. 2004 Oct 29;119(3):381-92 [15507209.001]
  • [Cites] Mol Cell Biol. 1982 Sep;2(9):1044-51 [6960240.001]
  • [Cites] J Virol. 1983 Dec;48(3):667-75 [6313966.001]
  • [Cites] Nature. 1989 Mar 16;338(6212):254-7 [2784194.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Oct;87(19):7787-91 [2217212.001]
  • [Cites] Methods Cell Biol. 1991;35:73-99 [1723481.001]
  • [Cites] Mol Cell Biol. 1992 May;12(5):2331-8 [1314954.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1256-60 [8108397.001]
  • [Cites] J Virol. 1994 Dec;68(12):7944-52 [7966585.001]
  • [Cites] RNA. 2000 Apr;6(4):638-50 [10786854.001]
  • (PMID = 17328934.001).
  • [ISSN] 0042-6822
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / T32 GM007231; United States / NCI NIH HHS / CA / R01 CA048746-19; United States / NCI NIH HHS / CA / CA048746-19; United States / NCI NIH HHS / CA / R01 CA048746-18; United States / NCI NIH HHS / CA / CA048746-17; United States / NCI NIH HHS / CA / CA048746-18; United States / NCI NIH HHS / CA / R01 CA048746-17; United States / NIGMS NIH HHS / GM / T32GM07231; United States / NCI NIH HHS / CA / R01 CA048746; United States / NCI NIH HHS / CA / R01 CA48746
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag; 0 / Nucleocytoplasmic Transport Proteins; 0 / RNA, Viral; 0 / Transcription Factors
  • [Other-IDs] NLM/ NIHMS25189; NLM/ PMC2564995
  •  go-up   go-down


29. Weil JE, Beemon KL: A 3' UTR sequence stabilizes termination codons in the unspliced RNA of Rous sarcoma virus. RNA; 2006 Jan;12(1):102-10
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A 3' UTR sequence stabilizes termination codons in the unspliced RNA of Rous sarcoma virus.
  • We termed this 3' UTR region the Rous sarcoma virus (RSV) stability element (RSE).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] EMBO J. 2002 Jan 15;21(1-2):125-34 [11782432.001]
  • [Cites] Nature. 2005 Mar 17;434(7031):338-45 [15735639.001]
  • [Cites] EMBO Rep. 2002 Mar;3(3):274-9 [11850396.001]
  • [Cites] Science. 2002 Oct 11;298(5592):419-22 [12228722.001]
  • [Cites] Mol Cell Biol. 2002 Dec;22(23):8114-21 [12417715.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):189-92 [12502788.001]
  • [Cites] Mol Cell Biol. 2003 Feb;23(3):842-51 [12529390.001]
  • [Cites] Nucleic Acids Res. 2003 Jul 1;31(13):3406-15 [12824337.001]
  • [Cites] EMBO J. 2003 Aug 1;22(15):3960-70 [12881430.001]
  • [Cites] RNA. 2004 Feb;10(2):200-9 [14730019.001]
  • [Cites] Nucleic Acids Res. 2004;32(2):784-90 [14762205.001]
  • [Cites] Nat Rev Mol Cell Biol. 2004 Feb;5(2):89-99 [15040442.001]
  • [Cites] Genome Biol. 2004;5(4):218 [15059251.001]
  • [Cites] J Virol. 2004 May;78(10):5139-46 [15113896.001]
  • [Cites] Curr Opin Cell Biol. 2004 Jun;16(3):279-84 [15145352.001]
  • [Cites] Nucleic Acids Res. 2004;32(11):3304-15 [15210863.001]
  • [Cites] Nat Struct Mol Biol. 2004 Oct;11(10):992-1000 [15361857.001]
  • [Cites] Nat Genet. 2004 Oct;36(10):1073-8 [15448691.001]
  • [Cites] Proc Natl Acad Sci U S A. 1979 Oct;76(10):5134-7 [388431.001]
  • [Cites] J Virol. 1988 Sep;62(9):3328-33 [2841485.001]
  • [Cites] Mol Cell Biol. 1991 May;11(5):2760-8 [1850103.001]
  • [Cites] Genes Dev. 1991 Dec;5(12A):2303-14 [1748286.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):482-6 [8421679.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10091-5 [8234261.001]
  • [Cites] Mol Cell Biol. 1994 Mar;14(3):1986-96 [8114730.001]
  • [Cites] Mol Cell Biol. 1995 Apr;15(4):2231-44 [7891717.001]
  • [Cites] J Biol Chem. 1995 Dec 1;270(48):28995-9003 [7499432.001]
  • [Cites] EMBO J. 1996 Nov 1;15(21):5965-75 [8918474.001]
  • [Cites] EMBO J. 1998 Jan 15;17(2):575-89 [9430648.001]
  • [Cites] RNA. 1998 Jul;4(7):801-15 [9671053.001]
  • [Cites] Mol Cell Biol. 1998 Sep;18(9):5272-83 [9710612.001]
  • [Cites] Mol Biol Cell. 1999 Mar;10(3):515-24 [10069800.001]
  • [Cites] Mol Cell. 2005 Apr 29;18(3):307-17 [15866173.001]
  • [Cites] Curr Opin Cell Biol. 2005 Jun;17(3):309-15 [15901502.001]
  • [Cites] Curr Opin Cell Biol. 2005 Jun;17(3):316-25 [15901503.001]
  • [Cites] Nucleic Acids Res. 2000 Jan 1;28(1):85-6 [10592188.001]
  • [Cites] Annu Rev Genet. 1999;33:229-60 [10690409.001]
  • [Cites] Genes Dev. 2000 May 1;14(9):1098-108 [10809668.001]
  • [Cites] Mol Cell. 2000 Mar;5(3):489-99 [10882134.001]
  • [Cites] EMBO J. 2000 Sep 1;19(17):4734-44 [10970865.001]
  • [Cites] EMBO J. 2000 Dec 15;19(24):6860-9 [11118221.001]
  • [Cites] Cell. 2000 Dec 22;103(7):1121-31 [11163187.001]
  • [Cites] Mol Cell Biol. 2001 Mar;21(5):1515-30 [11238889.001]
  • [Cites] EMBO J. 2001 Apr 17;20(8):2062-8 [11296238.001]
  • [Cites] RNA. 2001 Mar;7(3):445-56 [11333024.001]
  • [Cites] Science. 2001 Sep 7;293(5536):1832-6 [11546873.001]
  • [Cites] Gene. 2001 Aug 22;274(1-2):15-25 [11674994.001]
  • [Cites] EMBO Rep. 2001 Dec;2(12):1119-24 [11743026.001]
  • [Cites] Nucleic Acids Res. 2005;33(3):825-37 [15701754.001]
  • [Cites] Nature. 2004 Nov 4;432(7013):112-8 [15525991.001]
  • [Cites] Mol Cell. 2004 Nov 19;16(4):597-607 [15546619.001]
  • [Cites] Nature. 2004 Dec 9;432(7018):695-716 [15592404.001]
  • [Cites] Cell. 2005 Jan 28;120(2):195-208 [15680326.001]
  • [Cites] Trends Genet. 2005 Mar;21(3):143-8 [15734573.001]
  • [Cites] Hum Mol Genet. 2002 Feb 1;11(3):331-5 [11823452.001]
  • (PMID = 16301601.001).
  • [ISSN] 1355-8382
  • [Journal-full-title] RNA (New York, N.Y.)
  • [ISO-abbreviation] RNA
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA048746; United States / NIGMS NIH HHS / GM / T32 GM007231; United States / NCI NIH HHS / CA / R01 CA48746; United States / NIGMS NIH HHS / GM / T32GM07231
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / 3' Untranslated Regions; 0 / Codon, Nonsense; 0 / Codon, Terminator; 63231-63-0 / RNA
  • [Other-IDs] NLM/ PMC1370890
  •  go-up   go-down


30. Oh J, Chang KW, Wierzchoslawski R, Alvord WG, Hughes SH: Rous sarcoma virus (RSV) integration in vivo: a CA dinucleotide is not required in U3, and RSV linear DNA does not autointegrate. J Virol; 2008 Jan;82(1):503-12
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rous sarcoma virus (RSV) integration in vivo: a CA dinucleotide is not required in U3, and RSV linear DNA does not autointegrate.
  • We made mutations in the 5' end of the U3 sequence of the Rous sarcoma virus (RSV)-derived vector RSVP(A)Z.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2005 Nov;79(21):13694-704 [16227289.001]
  • [Cites] EMBO J. 1998 Oct 1;17(19):5832-43 [9755183.001]
  • [Cites] J Virol. 2006 Oct;80(20):10281-4 [17005708.001]
  • [Cites] J Virol. 2001 Feb;75(3):1359-70 [11152509.001]
  • [Cites] J Virol. 2002 Feb;76(4):1762-8 [11799171.001]
  • [Cites] Proc Natl Acad Sci U S A. 1980 Jul;77(7):3937-41 [6254003.001]
  • [Cites] Cell. 1980 Nov;22(2 Pt 2):379-86 [6256079.001]
  • [Cites] Proc Natl Acad Sci U S A. 1981 Jul;78(7):4299-303 [6270669.001]
  • [Cites] Nature. 1983 Nov 10-16;306(5939):155-60 [6316141.001]
  • [Cites] Cell. 1984 Jul;37(3):1043-52 [6204767.001]
  • [Cites] Proc Natl Acad Sci U S A. 1984 Oct;81(20):6461-5 [6208550.001]
  • [Cites] Cell. 1985 Sep;42(2):573-80 [4028161.001]
  • [Cites] J Virol. 1986 Jan;57(1):37-45 [2416955.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 May;86(9):3065-9 [2524066.001]
  • [Cites] Cell. 1989 Jul 14;58(1):47-54 [2546673.001]
  • [Cites] Cell. 1990 Aug 24;62(4):829-37 [2167180.001]
  • [Cites] J Virol. 1990 Nov;64(11):5475-84 [2170682.001]
  • [Cites] J Virol. 1990 Dec;64(12):5958-65 [2173775.001]
  • [Cites] Mol Cell Biol. 1991 Mar;11(3):1419-30 [1847499.001]
  • [Cites] J Virol. 1991 Sep;65(9):4636-44 [1870194.001]
  • [Cites] J Virol. 1991 Oct;65(10):5624-30 [1895409.001]
  • [Cites] J Virol. 1992 Apr;66(4):2359-68 [1548767.001]
  • [Cites] J Virol. 1992 Dec;66(12):7414-9 [1433523.001]
  • [Cites] J Virol. 1994 Aug;68(8):4768-75 [8035478.001]
  • [Cites] J Virol. 1995 May;69(5):3216-9 [7707554.001]
  • [Cites] J Virol. 1995 Nov;69(11):6687-96 [7474078.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] J Virol. 1998 Oct;72(10):8396-402 [9733892.001]
  • [Cites] J Virol. 2004 Dec;78(23):13315-24 [15542682.001]
  • [Cites] J Virol. 1999 Nov;73(11):9011-20 [10516007.001]
  • [Cites] J Virol. 2006 Jan;80(1):451-9 [16352569.001]
  • (PMID = 17959663.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / RNA, Viral; EC 2.7.7.- / Integrases
  • [Other-IDs] NLM/ PMC2224354
  •  go-up   go-down


31. Chang KW, Oh J, Alvord WG, Hughes SH: The effects of alternate polypurine tracts (PPTs) and mutations of sequences adjacent to the PPT on viral replication and cleavage specificity of the Rous sarcoma virus reverse transcriptase. J Virol; 2008 Sep;82(17):8592-604
Hazardous Substances Data Bank. GUANINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The effects of alternate polypurine tracts (PPTs) and mutations of sequences adjacent to the PPT on viral replication and cleavage specificity of the Rous sarcoma virus reverse transcriptase.
  • We previously reported that a mutant Rous sarcoma virus (RSV) with an alternate polypurine tract (PPT), DuckHepBFlipPPT, had unexpectedly high titers and that the PPT was miscleaved primarily at one position following a GA dinucleotide by the RNase H of reverse transcriptase (RT).

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Nov;74(22):10293-303 [11044073.001]
  • [Cites] J Virol. 2008 Jan;82(1):503-12 [17959663.001]
  • [Cites] J Virol. 2001 Jun;75(11):4973-83 [11333876.001]
  • [Cites] EMBO J. 2001 Jun 15;20(12):3272-81 [11406603.001]
  • [Cites] Biochemistry. 2002 Apr 16;41(15):4856-65 [11939780.001]
  • [Cites] J Biol Chem. 2002 May 10;277(19):16689-96 [11875059.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9515-20 [12093908.001]
  • [Cites] J Virol. 2008 Jan;82(2):719-27 [17989171.001]
  • [Cites] J Virol. 2003 Oct;77(20):11150-7 [14512562.001]
  • [Cites] J Mol Biol. 2003 Dec 5;334(4):653-65 [14636594.001]
  • [Cites] Nucleic Acids Res. 2004;32(4):1539-47 [15004241.001]
  • [Cites] Int J Biochem Cell Biol. 2004 Sep;36(9):1752-66 [15183342.001]
  • [Cites] EMBO J. 1990 Apr;9(4):1171-6 [1691093.001]
  • [Cites] J Acquir Immune Defic Syndr. 1990;3(9):852-8 [2384863.001]
  • [Cites] J Virol. 1990 Oct;64(10):4903-6 [1697909.001]
  • [Cites] Biochemistry. 1990 Nov 6;29(44):10141-7 [1703002.001]
  • [Cites] Biochemistry. 1991 Jul 23;30(29):7041-6 [1713059.001]
  • [Cites] J Virol. 1992 Jan;66(1):367-73 [1370087.001]
  • [Cites] J Biol Chem. 1992 Jul 25;267(21):15071-9 [1378844.001]
  • [Cites] Annu Rev Cell Biol. 1992;8:275-306 [1282352.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6320-4 [7687065.001]
  • [Cites] EMBO J. 1998 Jul 1;17(13):3766-74 [9649446.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] J Virol. 1999 Feb;73(2):948-57 [9882295.001]
  • [Cites] J Virol. 2004 Dec;78(23):13315-24 [15542682.001]
  • [Cites] J Virol. 2005 Jun;79(11):6859-67 [15890925.001]
  • [Cites] J Biol Chem. 2005 May 20;280(20):20154-62 [15778225.001]
  • [Cites] J Virol. 2005 Nov;79(21):13694-704 [16227289.001]
  • [Cites] J Virol. 2006 Jan;80(1):451-9 [16352569.001]
  • [Cites] J Biol Chem. 2006 Jan 27;281(4):1943-55 [16306040.001]
  • [Cites] Nucleic Acids Res. 2007;35(1):256-68 [17164285.001]
  • [Cites] Virology. 2007 Apr 10;360(2):341-9 [17123564.001]
  • [Cites] EMBO J. 2001 Mar 15;20(6):1449-61 [11250910.001]
  • (PMID = 18562520.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Purines; 5Z93L87A1R / Guanine; EC 2.7.7.49 / RNA-Directed DNA Polymerase; EC 3.1.26.4 / Ribonuclease H; JAC85A2161 / Adenine
  • [Other-IDs] NLM/ PMC2519663
  •  go-up   go-down


32. Taylor GM, Ma L, Vogt VM, Post CB: NMR relaxation studies of an RNA-binding segment of the rous sarcoma virus gag polyprotein in free and bound states: a model for autoinhibition of assembly. Biochemistry; 2010 May 18;49(19):4006-17
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] NMR relaxation studies of an RNA-binding segment of the rous sarcoma virus gag polyprotein in free and bound states: a model for autoinhibition of assembly.
  • NMR relaxation studies were conducted to investigate the initial steps of Rous sarcoma virus (RSV) assembly by examining the association with nucleic acid of a fragment of Gag comprising the C-terminal domain of CA (CTD) postulated to mediate Gag dimerization, the spacer region between CA and NC (SP), and NC.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Protein Sci. 1992 May;1(5):563-74 [1304355.001]
  • [Cites] Structure. 2000 Jun 15;8(6):617-28 [10873863.001]
  • [Cites] J Magn Reson. 2000 Nov;147(1):138-46 [11042057.001]
  • [Cites] J Magn Reson. 2001 Apr;149(2):204-17 [11318619.001]
  • [Cites] J Am Chem Soc. 2001 May 2;123(17):3953-9 [11457145.001]
  • [Cites] J Am Chem Soc. 2001 Nov 21;123(46):11484-5 [11707129.001]
  • [Cites] J Virol. 2002 Jun;76(11):5452-62 [11991973.001]
  • [Cites] J Virol. 2002 Nov;76(22):11177-85 [12388677.001]
  • [Cites] J Virol. 2002 Nov;76(22):11729-37 [12388733.001]
  • [Cites] Biochemistry. 2003 Jan 21;42(2):320-30 [12525159.001]
  • [Cites] J Virol. 2003 Feb;77(3):1772-83 [12525611.001]
  • [Cites] J Virol. 2003 Jun;77(12):7058-66 [12768025.001]
  • [Cites] J Mol Biol. 2004 Jan 2;335(1):275-82 [14659756.001]
  • [Cites] J Virol. 2004 Jan;78(1):52-60 [14671087.001]
  • [Cites] Protein Sci. 2004 Aug;13(8):2101-7 [15238640.001]
  • [Cites] J Virol. 2004 Sep;78(18):9675-88 [15331700.001]
  • [Cites] Biochemistry. 1989 Nov 14;28(23):8972-9 [2690953.001]
  • [Cites] Biochemistry. 1990 Jan 16;29(2):329-40 [2105740.001]
  • [Cites] EMBO J. 1992 Aug;11(8):3059-65 [1639074.001]
  • [Cites] Biochemistry. 1992 Sep 15;31(36):8571-86 [1390643.001]
  • [Cites] J Virol. 1993 Jul;67(7):4027-36 [8510214.001]
  • [Cites] Biochemistry. 1994 May 17;33(19):5984-6003 [7514039.001]
  • [Cites] J Mol Biol. 1994 Nov 25;244(2):198-223 [7966331.001]
  • [Cites] J Virol. 1995 Oct;69(10):6430-8 [7666544.001]
  • [Cites] J Virol. 1995 Oct;69(10):6487-97 [7666550.001]
  • [Cites] Cell. 1996 Dec 27;87(7):1285-94 [8980234.001]
  • [Cites] J Mol Biol. 1996 Dec 20;264(5):1117-31 [9000634.001]
  • [Cites] Biochemistry. 1997 Jul 22;36(29):8977-91 [9220986.001]
  • [Cites] Science. 1997 Oct 31;278(5339):849-53 [9346481.001]
  • [Cites] Curr Biol. 1997 Oct 1;7(10):729-38 [9368755.001]
  • [Cites] J Virol. 1998 Mar;72(3):1902-9 [9499042.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7299-304 [9636143.001]
  • [Cites] J Mol Biol. 1998 Jun 19;279(4):921-8 [9642071.001]
  • [Cites] J Mol Biol. 1998 Jun 12;279(3):633-49 [9641983.001]
  • [Cites] Protein Sci. 1998 Nov;7(11):2265-80 [9827993.001]
  • [Cites] Mol Cell. 2005 Jan 7;17(1):137-43 [15629724.001]
  • [Cites] Protein Sci. 2005 Feb;14(2):375-86 [15659370.001]
  • [Cites] Nat Struct Mol Biol. 2005 Aug;12(8):678-82 [16041386.001]
  • [Cites] Nat Struct Mol Biol. 2005 Aug;12(8):671-7 [16041387.001]
  • [Cites] Structure. 2005 Oct;13(10):1521-31 [16216583.001]
  • [Cites] EMBO J. 2007 Apr 18;26(8):2218-26 [17396149.001]
  • [Cites] Cell. 2007 Oct 5;131(1):70-9 [17923088.001]
  • [Cites] J Virol. 2008 Jul;82(14):6788-97 [18448521.001]
  • [Cites] J Biol Chem. 2008 Nov 14;283(46):32024-33 [18772135.001]
  • [Cites] Structure. 2009 May 13;17(5):737-48 [19446529.001]
  • [Cites] Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11090-5 [19549863.001]
  • [Cites] J Biomol NMR. 2000 Jan;16(1):23-8 [10718609.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):633-49 [10669613.001]
  • [Cites] Biochemistry. 2000 Feb 22;39(7):1604-12 [10677209.001]
  • [Cites] J Biomol NMR. 1995 Nov;6(3):277-93 [8520220.001]
  • [Cites] J Mol Biol. 1995 Dec 8;254(4):523-37 [7500330.001]
  • [Cites] Nature. 1995 Dec 14;378(6558):743-7 [7501025.001]
  • [Cites] Science. 1996 Jul 12;273(5272):231-5 [8662505.001]
  • (PMID = 20387899.001).
  • [ISSN] 1520-4995
  • [Journal-full-title] Biochemistry
  • [ISO-abbreviation] Biochemistry
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / GM039478-16; United States / NIGMS NIH HHS / GM / R01 GM039478-16; United States / NIAID NIH HHS / AI / AI45976; United States / NCI NIH HHS / CA / CA020081-24; United States / NCI NIH HHS / CA / R01 CA020081-24; United States / NIGMS NIH HHS / GM / R01 GM039478; United States / NCI NIH HHS / CA / CA 23568; United States / NIAID NIH HHS / AI / P01 AI045976; United States / NIAID NIH HHS / AI / P01 AI045976-050004; United States / NCI NIH HHS / CA / R01 CA020081; United States / NIAID NIH HHS / AI / AI045976-050004; United States / NCI NIH HHS / CA / CA20081
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag; 0 / RNA, Viral
  • [Other-IDs] NLM/ NIHMS199668; NLM/ PMC2891057
  •  go-up   go-down


33. Wayne CM, Fan HY, Cheng X, Richards JS: Follicle-stimulating hormone induces multiple signaling cascades: evidence that activation of Rous sarcoma oncogene, RAS, and the epidermal growth factor receptor are critical for granulosa cell differentiation. Mol Endocrinol; 2007 Aug;21(8):1940-57
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Follicle-stimulating hormone induces multiple signaling cascades: evidence that activation of Rous sarcoma oncogene, RAS, and the epidermal growth factor receptor are critical for granulosa cell differentiation.
  • Specifically, FSH activation of RAS required Rous sarcoma oncogene (SRC) family tyrosine kinase (SFK) and epidermal growth factor receptor (EGFR) tyrosine kinase activities but not PKA.


34. Zhou J, McAllen JK, Tailor Y, Summers MF: High affinity nucleocapsid protein binding to the muPsi RNA packaging signal of Rous sarcoma virus. J Mol Biol; 2005 Jun 24;349(5):976-88

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High affinity nucleocapsid protein binding to the muPsi RNA packaging signal of Rous sarcoma virus.
  • Recently, a relatively short, 82 nucleotide region of the Rous sarcoma virus (RSV) genome, called muPsi, was shown to be sufficient to direct efficient packaging of heterologous RNAs into RSV-like particles.
  • [MeSH-major] Avian Sarcoma Viruses / chemistry. Nucleocapsid Proteins / chemistry. RNA, Viral / chemistry

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15907938.001).
  • [ISSN] 0022-2836
  • [Journal-full-title] Journal of molecular biology
  • [ISO-abbreviation] J. Mol. Biol.
  • [Language] eng
  • [Grant] United States / NIGMS NIH HHS / GM / GM08663; United States / NIGMS NIH HHS / GM / GM42561
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Nucleocapsid Proteins; 0 / RNA, Viral
  •  go-up   go-down


35. Oh J, Chang KW, Hughes SH: Mutations in the U5 sequences adjacent to the primer binding site do not affect tRNA cleavage by rous sarcoma virus RNase H but do cause aberrant integrations in vivo. J Virol; 2006 Jan;80(1):451-9
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mutations in the U5 sequences adjacent to the primer binding site do not affect tRNA cleavage by rous sarcoma virus RNase H but do cause aberrant integrations in vivo.
  • We changed the two nucleotides (TT) between the PBS and the CA dinucleotide of the Rous sarcoma virus (RSV)-derived vector RSVP(A)Z to match the HIV-1 sequence (G) and the HIV-2 sequence (GGT), and we changed the CA dinucleotide to TC.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2001 Feb;75(3):1132-41 [11152486.001]
  • [Cites] J Virol. 2004 Dec;78(23):13315-24 [15542682.001]
  • [Cites] J Virol. 2002 Feb;76(4):1762-8 [11799171.001]
  • [Cites] J Virol. 2002 Dec;76(24):13111-5 [12438642.001]
  • [Cites] J Virol. 2003 Oct;77(20):11150-7 [14512562.001]
  • [Cites] Virology. 2004 Jan 20;318(2):566-81 [14972525.001]
  • [Cites] Nucleic Acids Res. 2004;32(4):1539-47 [15004241.001]
  • [Cites] J Virol. 1973 Dec;12(6):1226-37 [4357505.001]
  • [Cites] Prog Nucleic Acid Res Mol Biol. 1977;20:131-60 [71747.001]
  • [Cites] Proc Natl Acad Sci U S A. 1980 Jul;77(7):3937-41 [6254003.001]
  • [Cites] Cell. 1980 Nov;22(2 Pt 2):379-86 [6256079.001]
  • [Cites] J Virol. 1980 Dec;36(3):692-700 [6162035.001]
  • [Cites] Proc Natl Acad Sci U S A. 1981 Jul;78(7):4299-303 [6270669.001]
  • [Cites] Cell. 1985 Jan;40(1):9-17 [2981635.001]
  • [Cites] Nature. 1985 Jan 24-30;313(6000):277-84 [2578615.001]
  • [Cites] Cell. 1985 Sep;42(2):573-80 [4028161.001]
  • [Cites] J Virol. 1987 Jun;61(6):1964-71 [2437326.001]
  • [Cites] J Mol Biol. 1988 Jan 5;199(1):47-59 [3351923.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 May;86(9):3065-9 [2524066.001]
  • [Cites] Cell. 1989 Jul 14;58(1):47-54 [2546673.001]
  • [Cites] J Mol Biol. 1989 Aug 5;208(3):445-56 [2477553.001]
  • [Cites] J Virol. 1989 Dec;63(12):5319-27 [2555556.001]
  • [Cites] Cell. 1990 Aug 24;62(4):829-37 [2167180.001]
  • [Cites] J Virol. 1990 Oct;64(10):4903-6 [1697909.001]
  • [Cites] J Virol. 1991 Jul;65(7):3906-10 [2041100.001]
  • [Cites] Biochemistry. 1991 Jul 23;30(29):7041-6 [1713059.001]
  • [Cites] J Virol. 1992 Jan;66(1):367-73 [1370087.001]
  • [Cites] J Virol. 1992 Aug;66(8):5092-5 [1629963.001]
  • [Cites] J Virol. 1996 Jun;70(6):3571-80 [8648691.001]
  • [Cites] J Virol. 1996 Aug;70(8):5288-96 [8764039.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] Mol Cell Biol. 2001 Oct;21(20):6758-67 [11564861.001]
  • (PMID = 16352569.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / RNA primers; 0 / RNA, Small Nuclear; 0 / U5 small nuclear RNA; 63231-63-0 / RNA; 9014-25-9 / RNA, Transfer; EC 3.1.26.4 / Ribonuclease H
  • [Other-IDs] NLM/ PMC1317513
  •  go-up   go-down


36. Chang KW, Julias JG, Alvord WG, Oh J, Hughes SH: Alternate polypurine tracts (PPTs) affect the rous sarcoma virus RNase H cleavage specificity and reveal a preferential cleavage following a GA dinucleotide sequence at the PPT-U3 junction. J Virol; 2005 Nov;79(21):13694-704
Hazardous Substances Data Bank. GUANINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Alternate polypurine tracts (PPTs) affect the rous sarcoma virus RNase H cleavage specificity and reveal a preferential cleavage following a GA dinucleotide sequence at the PPT-U3 junction.
  • We replaced the endogenous PPT from RSVP(A)Z, a replication-competent shuttle vector based on Rous sarcoma virus (RSV), with alternate retroviral PPTs and the duck hepatitis B virus "PPT."

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Apr;74(7):3245-52 [10708441.001]
  • [Cites] J Virol. 2004 Dec;78(23):13315-24 [15542682.001]
  • [Cites] J Virol. 2000 Nov;74(22):10293-303 [11044073.001]
  • [Cites] EMBO J. 2001 Mar 15;20(6):1449-61 [11250910.001]
  • [Cites] J Virol. 2001 Jun;75(11):4973-83 [11333876.001]
  • [Cites] J Virol. 2002 Feb;76(4):1762-8 [11799171.001]
  • [Cites] J Biol Chem. 2002 May 10;277(19):16689-96 [11875059.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9515-20 [12093908.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10090-5 [12119402.001]
  • [Cites] J Mol Biol. 2003 Mar 14;327(1):19-30 [12614605.001]
  • [Cites] J Virol. 2003 Oct;77(20):11150-7 [14512562.001]
  • [Cites] J Mol Biol. 2003 Dec 5;334(4):653-65 [14636594.001]
  • [Cites] J Virol. 2004 Jun;78(12):6112-21 [15163704.001]
  • [Cites] Int J Biochem Cell Biol. 2004 Sep;36(9):1752-66 [15183342.001]
  • [Cites] J Virol. 1984 Mar;49(3):686-91 [6199510.001]
  • [Cites] J Virol. 1987 Oct;61(10):3004-12 [3041020.001]
  • [Cites] J Virol. 1990 Feb;64(2):592-7 [1688626.001]
  • [Cites] J Virol. 1990 Dec;64(12):6274-7 [2173791.001]
  • [Cites] Annu Rev Cell Biol. 1992;8:275-306 [1282352.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1276-80 [7679498.001]
  • [Cites] J Biol Chem. 1993 Mar 25;268(9):6221-7 [7681062.001]
  • [Cites] J Mol Biol. 1993 Oct 5;233(3):509-23 [8411159.001]
  • [Cites] J Virol. 1996 Aug;70(8):5288-96 [8764039.001]
  • [Cites] J Biol Chem. 1997 Aug 29;272(35):22023-9 [9268341.001]
  • [Cites] J Mol Biol. 1998 Apr 3;277(3):559-72 [9533880.001]
  • [Cites] EMBO J. 1998 Jul 1;17(13):3766-74 [9649446.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] J Virol. 1999 Feb;73(2):948-57 [9882295.001]
  • [Cites] J Virol. 2000 May;74(10):4755-64 [10775614.001]
  • (PMID = 16227289.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / N01CO12400; United States / NCI NIH HHS / CO / N01-CO-12400; United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Purines; 5Z93L87A1R / Guanine; EC 2.7.7.49 / RNA-Directed DNA Polymerase; EC 3.1.26.4 / Ribonuclease H; JAC85A2161 / Adenine
  • [Other-IDs] NLM/ PMC1262584
  •  go-up   go-down


37. Majhen D, Brozovic A, Buger T, Gabrilovac J, Osmak M, Ambriović-Ristov A: Vincristine-resistant human laryngeal carcinoma cells demonstrate increased Rous sarcoma virus promoter activity. Life Sci; 2010 Oct 9;87(15-16):468-74
Hazardous Substances Data Bank. VINCRISTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vincristine-resistant human laryngeal carcinoma cells demonstrate increased Rous sarcoma virus promoter activity.
  • [MeSH-major] Adenoviridae / genetics. Gene Expression Regulation, Neoplastic. Gene Transfer Techniques. Laryngeal Neoplasms / therapy. Rous sarcoma virus / genetics
  • [MeSH-minor] Antineoplastic Agents, Phytogenic / pharmacology. Cell Line, Tumor. Coxsackie and Adenovirus Receptor-Like Membrane Protein. Drug Resistance, Neoplasm. Genetic Therapy / methods. Genetic Vectors. Humans. Promoter Regions, Genetic. Receptors, Virus / metabolism. Reverse Transcriptase Polymerase Chain Reaction. Transgenes. Vincristine / pharmacology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20837033.001).
  • [ISSN] 1879-0631
  • [Journal-full-title] Life sciences
  • [ISO-abbreviation] Life Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / CLMP protein, human; 0 / Coxsackie and Adenovirus Receptor-Like Membrane Protein; 0 / Receptors, Virus; 5J49Q6B70F / Vincristine
  •  go-up   go-down


38. Vana ML, Chen A, Boross P, Weber I, Colman D, Barklis E, Leis J: Mutations affecting cleavage at the p10-capsid protease cleavage site block Rous sarcoma virus replication. Retrovirology; 2005 Sep 27;2:58
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mutations affecting cleavage at the p10-capsid protease cleavage site block Rous sarcoma virus replication.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Structure. 2000 Jun 15;8(6):617-28 [10873863.001]
  • [Cites] J Virol. 2000 Sep;74(18):8452-9 [10954545.001]
  • [Cites] J Virol. 2000 Nov;74(21):10260-8 [11024160.001]
  • [Cites] J Virol. 2001 Jul;75(13):6016-21 [11390603.001]
  • [Cites] J Virol. 2004 Feb;78(3):1411-20 [14722296.001]
  • [Cites] J Virol. 1987 Oct;61(10):3004-12 [3041020.001]
  • [Cites] AIDS. 1991 Jun;5(6):639-54 [1883539.001]
  • [Cites] J Biol Chem. 1993 Jun 5;268(16):11711-20 [8389361.001]
  • [Cites] J Biol Chem. 1996 Mar 22;271(12):6781-8 [8636100.001]
  • [Cites] Science. 1996 Jul 12;273(5272):231-5 [8662505.001]
  • [Cites] J Virol. 1998 Jun;72(6):4798-810 [9573245.001]
  • [Cites] EMBO J. 1998 Mar 16;17(6):1555-68 [9501077.001]
  • [Cites] J Virol. 1997 Oct;71(10):7648-56 [9311847.001]
  • [Cites] J Virol. 1997 Jun;71(6):4425-35 [9151833.001]
  • [Cites] J Virol. 1997 Mar;71(3):2083-91 [9032340.001]
  • [Cites] Cell. 1996 Dec 27;87(7):1285-94 [8980234.001]
  • [Cites] Nat Struct Biol. 1996 Sep;3(9):763-70 [8784350.001]
  • [Cites] Eur J Biochem. 1999 Jul;263(1):238-45 [10429209.001]
  • (PMID = 16188035.001).
  • [ISSN] 1742-4690
  • [Journal-full-title] Retrovirology
  • [ISO-abbreviation] Retrovirology
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA052047; United States / NIGMS NIH HHS / GM / R01 GM062920; United States / NCI NIH HHS / CA / CA58166; United States / NCI NIH HHS / CA / CA52047; United States / NIGMS NIH HHS / GM / GM60170; United States / NIGMS NIH HHS / GM / R01 GM060170
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Capsid Proteins; 0 / Gene Products, gag; EC 3.4.23.- / Aspartic Acid Endopeptidases; EC 3.4.23.- / Rous sarcoma virus protease
  • [Other-IDs] NLM/ PMC1262776
  •  go-up   go-down


39. Butan C, Lokhandwala PM, Purdy JG, Cardone G, Craven RC, Steven AC: Suppression of a morphogenic mutant in Rous sarcoma virus capsid protein by a second-site mutation: a cryoelectron tomography study. J Virol; 2010 Jul;84(13):6377-86
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Suppression of a morphogenic mutant in Rous sarcoma virus capsid protein by a second-site mutation: a cryoelectron tomography study.
  • Gag is then processed proteolytically, releasing the capsid protein (CA) to assemble de novo inside maturing virions.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Mol Biol. 2009 Jun 5;389(2):438-51 [19361521.001]
  • [Cites] Structure. 2009 May 13;17(5):737-48 [19446529.001]
  • [Cites] J Struct Biol. 2005 Oct;152(1):36-51 [16182563.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):633-49 [10669613.001]
  • [Cites] Structure. 2000 Jun 15;8(6):617-28 [10873863.001]
  • [Cites] J Virol. 2001 Jan;75(1):242-50 [11119594.001]
  • [Cites] J Mol Biol. 2001 Mar 2;306(4):783-97 [11243788.001]
  • [Cites] J Virol. 2001 Aug;75(15):6850-6 [11435564.001]
  • [Cites] J Struct Biol. 2001 Sep;135(3):239-50 [11722164.001]
  • [Cites] J Virol. 2003 May;77(9):5439-50 [12692245.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):672-5 [15208690.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):676-7 [15208693.001]
  • [Cites] Nature. 2004 Sep 23;431(7007):481-5 [15386017.001]
  • [Cites] J Virol. 1992 Dec;66(12):7021-32 [1279197.001]
  • [Cites] J Virol. 1994 Aug;68(8):4927-36 [8035491.001]
  • [Cites] J Virol. 1995 Jul;69(7):4213-27 [7769681.001]
  • [Cites] J Virol. 1996 Jun;70(6):3440-8 [8648676.001]
  • [Cites] Science. 1996 Jul 12;273(5272):231-5 [8662505.001]
  • [Cites] J Struct Biol. 1996 Jan-Feb;116(1):71-6 [8742726.001]
  • [Cites] Virology. 1996 Aug 15;222(2):339-51 [8806518.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19123-7 [17146053.001]
  • [Cites] J Struct Biol. 2007 Jan;157(1):3-18 [17011211.001]
  • [Cites] J Gen Virol. 1997 Mar;78 ( Pt 3):637-40 [9049415.001]
  • [Cites] EMBO J. 1999 Mar 1;18(5):1124-36 [10064580.001]
  • [Cites] J Mol Biol. 1999 Aug 13;291(2):491-505 [10438634.001]
  • [Cites] J Struct Biol. 2005 Aug;151(2):117-29 [15964766.001]
  • [Cites] EMBO J. 2007 Apr 18;26(8):2218-26 [17396149.001]
  • [Cites] Cell. 2007 Oct 5;131(1):70-9 [17923088.001]
  • [Cites] J Mol Biol. 2008 Feb 29;376(4):1168-81 [18206161.001]
  • [Cites] J Virol. 2008 Jun;82(12):5951-61 [18400856.001]
  • [Cites] Virology. 2008 Jun 20;376(1):191-8 [18433823.001]
  • [Cites] Microbiol Immunol. 2008 May;52(5):287-95 [18557900.001]
  • [Cites] Cell Host Microbe. 2008 Dec 11;4(6):592-9 [19064259.001]
  • [Cites] Nature. 2009 Feb 5;457(7230):694-8 [19194444.001]
  • [Cites] Cell. 2009 Jun 26;137(7):1282-92 [19523676.001]
  • (PMID = 20427531.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA100322; United States / NCI NIH HHS / CA / CA100322; United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Capsid Proteins
  • [Other-IDs] NLM/ PMC2903260
  •  go-up   go-down


40. Senigl F, Plachý J, Hejnar J: The core element of a CpG island protects avian sarcoma and leukosis virus-derived vectors from transcriptional silencing. J Virol; 2008 Aug;82(16):7818-27
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The core element of a CpG island protects avian sarcoma and leukosis virus-derived vectors from transcriptional silencing.
  • We report here the insertion of this CpG island core element, IE, into the long terminal repeat of a retroviral vector derived from Rous sarcoma virus, which normally suffers from progressive transcriptional silencing in mammalian cells.
  • [MeSH-major] Avian Leukosis Virus / metabolism. CpG Islands. Gene Silencing. Sarcoma, Avian / genetics. Sarcoma, Avian / virology. Transcription, Genetic
  • [MeSH-minor] Animals. Binding Sites. Birds. Flow Cytometry. Genes, Reporter. Humans. Models, Biological. Mutation. Rous sarcoma virus / metabolism. Sp1 Transcription Factor / metabolism. Terminal Repeat Sequences

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Mar;74(6):2671-8 [10684282.001]
  • [Cites] Gene. 1998 Feb 16;208(1):73-82 [9479051.001]
  • [Cites] Gene. 2000 Dec 30;261(1):181-8 [11164049.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):565-9 [11209056.001]
  • [Cites] EMBO J. 2001 Apr 2;20(7):1726-38 [11285236.001]
  • [Cites] J Virol. 2001 Jun;75(11):4973-83 [11333876.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Gene. 1998 Nov 26;223(1-2):157-63 [9858717.001]
  • [Cites] Virology. 1999 Mar 1;255(1):171-81 [10049832.001]
  • [Cites] Nat Genet. 1999 Jun;22(2):203-6 [10369268.001]
  • [Cites] J Biol Chem. 2005 Jan 7;280(1):64-72 [15509558.001]
  • [Cites] J Virol. 2005 Apr;79(8):4610-8 [15795247.001]
  • [Cites] J Virol. 2005 Aug;79(16):10408-19 [16051833.001]
  • [Cites] J Virol. 2005 Nov;79(21):13497-508 [16227270.001]
  • [Cites] Hum Gene Ther. 2005 Nov;16(11):1241-6 [16259557.001]
  • [Cites] Cell. 2007 Feb 23;128(4):721-33 [17320509.001]
  • [Cites] J Virol. 2007 Mar;81(6):2592-604 [17202206.001]
  • [Cites] Gene Ther. 2007 May;14(9):741-51 [17330088.001]
  • [Cites] Blood. 2007 Sep 1;110(5):1448-57 [17456723.001]
  • [Cites] Hum Gene Ther. 2007 Aug;18(8):691-700 [17655493.001]
  • [Cites] J Virol. 2008 Mar;82(5):2313-23 [18094192.001]
  • [Cites] J Biol Chem. 2008 Apr 25;283(17):11509-15 [18308728.001]
  • [Cites] Mol Cell Biol. 2000 Feb;20(3):842-50 [10629041.001]
  • [Cites] J Virol. 2001 Oct;75(19):9526-31 [11533215.001]
  • [Cites] Science. 2001 Dec 14;294(5550):2368-71 [11743206.001]
  • [Cites] J Virol. 2002 Jun;76(11):5422-34 [11991971.001]
  • [Cites] Mol Ther. 2002 May;5(5 Pt 1):589-98 [11991750.001]
  • [Cites] FEBS Lett. 2002 Apr 24;517(1-3):285-6 [12062454.001]
  • [Cites] Cell. 2002 Aug 23;110(4):521-9 [12202041.001]
  • [Cites] Science. 2003 Jun 13;300(5626):1749-51 [12805549.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8764-9 [12857957.001]
  • [Cites] Science. 2003 Oct 17;302(5644):415-9 [14564000.001]
  • [Cites] J Biol Chem. 2004 Jan 2;279(1):34-41 [14559924.001]
  • [Cites] J Virol. 2004 May;78(9):4902-6 [15078971.001]
  • [Cites] Gene Ther. 2004 May;11(10):819-28 [14985785.001]
  • [Cites] PLoS Biol. 2004 Aug;2(8):E234 [15314653.001]
  • [Cites] J Virol. 2004 Nov;78(21):11656-63 [15479807.001]
  • [Cites] Int J Cancer. 1967 Mar 15;2(2):143-52 [6039764.001]
  • [Cites] Cell. 1977 May;11(1):95-103 [194709.001]
  • [Cites] Nucleic Acids Res. 1984 Jul 11;12(13):5193-210 [6205359.001]
  • [Cites] J Virol. 1991 Feb;65(2):904-12 [1702844.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2567-71 [8146155.001]
  • [Cites] Cell Growth Differ. 1994 Mar;5(3):277-85 [8018560.001]
  • [Cites] Virology. 1994 Sep;203(2):211-20 [8053145.001]
  • [Cites] Nature. 1994 Sep 29;371(6496):435-8 [8090226.001]
  • [Cites] Genes Dev. 1994 Oct 1;8(19):2282-92 [7958895.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11241-5 [7972042.001]
  • [Cites] J Virol. 1995 Feb;69(2):748-55 [7815539.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 May 14;93(10):4931-6 [8643506.001]
  • [Cites] J Virol. 1996 Jun;70(6):3922-9 [8648729.001]
  • [Cites] Cell. 1997 May 16;89(4):619-28 [9160753.001]
  • [Cites] J Virol. 2000 May;74(10):4679-87 [10775605.001]
  • (PMID = 18550662.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Sp1 Transcription Factor
  • [Other-IDs] NLM/ PMC2519551
  •  go-up   go-down


41. Oh J, Chang KW, Hughes SH: Integration of rous sarcoma virus DNA: a CA dinucleotide is not required for integration of the U3 end of viral DNA. J Virol; 2008 Nov;82(22):11480-3
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Integration of rous sarcoma virus DNA: a CA dinucleotide is not required for integration of the U3 end of viral DNA.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2001 Apr;75(8):3556-67 [11264345.001]
  • [Cites] J Virol. 2008 Sep;82(17):8592-604 [18562520.001]
  • [Cites] J Virol. 2003 Oct;77(20):11150-7 [14512562.001]
  • [Cites] Nucleic Acids Res. 2004;32(4):1539-47 [15004241.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 May;86(9):3065-9 [2524066.001]
  • [Cites] Cell. 1989 Jul 14;58(1):47-54 [2546673.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Jul;87(13):5119-23 [2164223.001]
  • [Cites] Cell. 1990 Aug 24;62(4):829-37 [2167180.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1339-43 [1847518.001]
  • [Cites] J Virol. 1991 Sep;65(9):4636-44 [1870194.001]
  • [Cites] J Virol. 1991 Oct;65(10):5624-30 [1895409.001]
  • [Cites] J Virol. 1992 Apr;66(4):2359-68 [1548767.001]
  • [Cites] J Virol. 1995 May;69(5):3233-6 [7707558.001]
  • [Cites] J Virol. 1995 Sep;69(9):5904-7 [7637038.001]
  • [Cites] J Virol. 1996 Aug;70(8):5288-96 [8764039.001]
  • [Cites] J Virol. 1996 Dec;70(12):9069-73 [8971046.001]
  • [Cites] J Virol. 1997 Feb;71(2):1025-35 [8995622.001]
  • [Cites] J Virol. 1998 Oct;72(10):8396-402 [9733892.001]
  • [Cites] J Virol. 2004 Dec;78(23):13315-24 [15542682.001]
  • [Cites] J Virol. 2005 Nov;79(21):13694-704 [16227289.001]
  • [Cites] J Virol. 2006 Jan;80(1):451-9 [16352569.001]
  • [Cites] J Virol. 2006 Oct;80(20):10281-4 [17005708.001]
  • [Cites] J Virol. 2008 Jan;82(1):503-12 [17959663.001]
  • [Cites] J Virol. 2003 Jun;77(11):6482-92 [12743305.001]
  • (PMID = 18768972.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; EC 2.7.7.- / Integrases
  • [Other-IDs] NLM/ PMC2573277
  •  go-up   go-down


42. Morita T, Mayanagi T, Yoshio T, Sobue K: Changes in the balance between caldesmon regulated by p21-activated kinases and the Arp2/3 complex govern podosome formation. J Biol Chem; 2007 Mar 16;282(11):8454-63
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here we studied the regulatory mode of caldesmon in podosome formation in Rous sarcoma virus-transformed fibroblasts.
  • Taken together, we conclude that in Rous sarcoma virus-transformed cells, changes in the balance between PAK1/2-regulated caldesmon and the Arp2/3 complex govern the formation of podosomes.
  • [MeSH-minor] Actins / chemistry. Animals. Fibroblasts / metabolism. Genetic Vectors. Models, Biological. Phosphorylation. Protein Binding. Rats. Rous sarcoma virus / metabolism. Transfection. Tropomyosin / chemistry. Wiskott-Aldrich Syndrome Protein, Neuronal / chemistry. p21-Activated Kinases

  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17224451.001).
  • [ISSN] 0021-9258
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actin-Related Protein 2; 0 / Actin-Related Protein 3; 0 / Actins; 0 / Calmodulin-Binding Proteins; 0 / Tropomyosin; 0 / Wiskott-Aldrich Syndrome Protein, Neuronal; EC 2.7.11.1 / Pak1 protein, rat; EC 2.7.11.1 / Protein-Serine-Threonine Kinases; EC 2.7.11.1 / p21-Activated Kinases
  •  go-up   go-down


43. Veselý P, Blase C, Matouskova E, Bereiter-Hahn J: Arising podosomal structures are associated with neoplastic cell morphological phenotype induced by the microenvironment. Anticancer Res; 2006 Mar-Apr;26(2A):967-72

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Increased numbers of rosettes of podosomes were observed in overgrown rat Rous sarcoma RsK4 cells.
  • [MeSH-major] Cell Movement / physiology. Cell Surface Extensions / physiology. Sarcoma, Avian / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16619494.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Actins; 0 / Culture Media
  •  go-up   go-down


44. Kohoutová Z, Rumlová M, Andreánsky M, Sakalian M, Hunter E, Pichová I, Ruml T: The impact of altered polyprotein ratios on the assembly and infectivity of Mason-Pfizer monkey virus. Virology; 2009 Feb 5;384(1):59-68

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To investigate the requirements for individual precursors in retrovirus assembly, we modified the polyprotein repertoire of Mason-Pfizer monkey virus (M-PMV) by mutating the frameshift sites to imitate the polyprotein organization of Rous sarcoma virus (Gag-Pro and Gag-Pro-Pol) or Human immunodeficiency virus (Gag and Gag-Pro-Pol).
  • For the "Rous-like" virus, assembly was impaired with no incorporation of Gag-Pro-Pol into particles and for the "HIV-like" virus an altered morphogenesis was observed.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5331-6 [11959986.001]
  • [Cites] J Virol. 2002 May;76(9):4321-30 [11932398.001]
  • [Cites] J Virol. 2003 Jul;77(14):7779-85 [12829817.001]
  • [Cites] J Mol Biol. 2003 Aug 15;331(3):571-83 [12899829.001]
  • [Cites] Traffic. 2003 Oct;4(10):660-70 [12956869.001]
  • [Cites] Traffic. 2003 Oct;4(10):671-80 [12956870.001]
  • [Cites] J Virol. 2004 May;78(10):5023-31 [15113883.001]
  • [Cites] Virology. 1984 Oct 30;138(2):260-75 [6333757.001]
  • [Cites] Proc Natl Acad Sci U S A. 1985 Mar;82(6):1618-22 [3885215.001]
  • [Cites] Science. 1985 Dec 13;230(4731):1237-42 [2416054.001]
  • [Cites] Cell. 1986 May 9;45(3):375-85 [2421920.001]
  • [Cites] Proc Natl Acad Sci U S A. 1987 Jun;84(12):4298-302 [3035577.001]
  • [Cites] J Virol. 1988 Jun;62(6):2179-82 [2452901.001]
  • [Cites] Cell. 1988 Nov 4;55(3):447-58 [2846182.001]
  • [Cites] Cell. 1989 Oct 6;59(1):103-12 [2676191.001]
  • [Cites] J Virol. 1990 Jun;64(6):2653-9 [2186175.001]
  • [Cites] J Virol. 1991 Sep;65(9):5111-7 [1870215.001]
  • [Cites] J Gen Virol. 1991 Oct;72 ( Pt 10):2509-17 [1919528.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):713-7 [1309954.001]
  • [Cites] J Biol Chem. 1992 May 15;267(14):9481-90 [1315755.001]
  • [Cites] J Virol. 1992 Jun;66(6):3873-8 [1316486.001]
  • [Cites] J Virol. 1992 Jul;66(7):4220-7 [1602542.001]
  • [Cites] J Virol. 1992 Nov;66(11):6304-13 [1383561.001]
  • [Cites] J Virol. 1993 Apr;67(4):2266-75 [8445731.001]
  • [Cites] Virology. 1993 Apr;193(2):661-71 [7681610.001]
  • [Cites] Biotechniques. 1994 Apr;16(4):626-8, 630-3 [8024782.001]
  • [Cites] J Virol. 1995 Feb;69(2):1093-8 [7815488.001]
  • [Cites] FEBS Lett. 1995 May 1;364(1):1-4 [7750533.001]
  • [Cites] J Biol Chem. 1996 May 3;271(18):10538-44 [8631853.001]
  • [Cites] J Virol. 1996 Jun;70(6):3706-15 [8648705.001]
  • [Cites] Microbiol Rev. 1996 Mar;60(1):103-34 [8852897.001]
  • [Cites] J Virol. 1998 Jun;72(6):4819-24 [9573247.001]
  • [Cites] J Virol. 1999 Jul;73(7):5431-7 [10364290.001]
  • [Cites] J Biol Chem. 2005 Dec 23;280(51):42106-12 [16257973.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 May 30;103(22):8360-5 [16717193.001]
  • [Cites] Mol Cell. 2006 Oct 20;24(2):165-7 [17052449.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10565-70 [18647839.001]
  • [Cites] J Virol. 2000 Jan;74(2):784-95 [10623740.001]
  • [Cites] Prog Nucleic Acid Res Mol Biol. 2000;64:131-70 [10697409.001]
  • [Cites] J Virol. 2000 Sep;74(18):8452-9 [10954545.001]
  • [Cites] J Virol. 2001 Feb;75(4):1834-41 [11160682.001]
  • [Cites] J Virol. 2001 Mar;75(6):2526-34 [11222675.001]
  • [Cites] J Virol. 2001 Oct;75(19):9543-8 [11533218.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14631-6 [11724937.001]
  • [Cites] J Virol. 2002 Apr;76(7):3221-31 [11884546.001]
  • [Cites] Nucleic Acids Res. 2002 Dec 1;30(23):5094-102 [12466532.001]
  • (PMID = 19062065.001).
  • [ISSN] 1096-0341
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA027834-28; United States / NCI NIH HHS / CA / R37 CA027834; United States / NCI NIH HHS / CA / CA 27834; United States / NCI NIH HHS / CA / CA027834-28; United States / NCI NIH HHS / CA / R01 CA027834
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag; 0 / Gene Products, pol; 0 / RNA, Messenger; 0 / RNA, Viral; 0 / Viral Proteins
  • [Other-IDs] NLM/ NIHMS500971; NLM/ PMC3779691
  •  go-up   go-down


45. Hirayama E, Kim J: Identification and characterization of a novel neural cell adhesion molecule (NCAM)-associated protein from quail myoblasts: relationship to myotube formation and induction of neurite-like protrusions. Differentiation; 2008 Mar;76(3):253-66
SciCrunch. HGNC: Data: Gene Annotation .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We identified a novel neural cell adhesion molecule (NCAM)-associated protein, myogenesis-related and NCAM-associated protein (MYONAP), the expression of which increases during the formation of myotubes in quail myoblasts transformed with a temperature-sensitive mutant of Rous sarcoma virus (QM-RSV cells).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17825087.001).
  • [ISSN] 1432-0436
  • [Journal-full-title] Differentiation; research in biological diversity
  • [ISO-abbreviation] Differentiation
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA Primers; 0 / DNA, Complementary; 0 / Neural Cell Adhesion Molecules; 0 / RNA, Messenger
  •  go-up   go-down


46. Nouvion AL, Thibaut J, Lohez OD, Venet S, Colas P, Gillet G, Lalle P: Modulation of Nr-13 antideath activity by peptide aptamers. Oncogene; 2007 Feb 1;26(5):701-10
Xenbase. Xenbase .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumor cells are characterized by deregulated proliferation and resistance to proapoptotic stimuli.
  • In the present study, we took advantage of the peptide aptamer strategy to target Nr-13, a Bcl-2 antiapoptotic protein involved in neoplastic transformation by the Rous sarcoma virus.
  • [MeSH-minor] Amino Acid Sequence. Animals. COS Cells / drug effects. Caspase 3 / metabolism. Cercopithecus aethiops. Enzyme-Linked Immunosorbent Assay. Humans. Molecular Sequence Data. Oocytes / metabolism. Peptide Library. Poly(ADP-ribose) Polymerases / metabolism. Rous sarcoma virus / genetics. Two-Hybrid System Techniques. Xenopus laevis / metabolism

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16909120.001).
  • [ISSN] 0950-9232
  • [Journal-full-title] Oncogene
  • [ISO-abbreviation] Oncogene
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Aptamers, Peptide; 0 / Peptide Library; 0 / Proto-Oncogene Proteins c-bcl-2; EC 2.4.2.30 / Poly(ADP-ribose) Polymerases; EC 3.4.22.- / Caspase 3
  •  go-up   go-down


47. Butan C, Winkler DC, Heymann JB, Craven RC, Steven AC: RSV capsid polymorphism correlates with polymerization efficiency and envelope glycoprotein content: implications that nucleation controls morphogenesis. J Mol Biol; 2008 Feb 29;376(4):1168-81
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We used cryo-electron tomography to visualize Rous sarcoma virus, the prototypic alpharetrovirus.
  • We find that Rous sarcoma virus virions, like the human immunodeficiency virus, contain unassembled CA subunits and that the fraction of CA that is assembled correlates with core type; angular cores incorporate approximately 80% of the available subunits, and open-ended tubes, approximately 30%.
  • [MeSH-major] Capsid / chemistry. Polymers / chemistry. Rous sarcoma virus / chemistry. Viral Envelope Proteins / chemistry

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2001 Oct;75(19):9357-66 [11533199.001]
  • [Cites] EMBO J. 2007 Apr 18;26(8):2218-26 [17396149.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):633-49 [10669613.001]
  • [Cites] Structure. 2000 Jun 15;8(6):617-28 [10873863.001]
  • [Cites] Nature. 2000 Sep 21;407(6802):409-13 [11014200.001]
  • [Cites] J Virol. 2001 Jan;75(1):242-50 [11119594.001]
  • [Cites] J Virol. 2001 Jan;75(2):759-71 [11134289.001]
  • [Cites] J Virol. 2001 Mar;75(6):2753-64 [11222698.001]
  • [Cites] J Mol Biol. 2002 Feb 22;316(3):667-78 [11866525.001]
  • [Cites] J Virol. 2002 Jun;76(11):5667-77 [11991995.001]
  • [Cites] EMBO J. 2003 Apr 1;22(7):1707-15 [12660176.001]
  • [Cites] J Virol. 2003 May;77(9):5439-50 [12692245.001]
  • [Cites] EMBO J. 2003 Jun 16;22(12):2886-92 [12805204.001]
  • [Cites] J Virol. 2003 Dec;77(23):12592-602 [14610182.001]
  • [Cites] Science. 2003 Nov 21;302(5649):1396-8 [14631040.001]
  • [Cites] J Struct Biol. 2003 Oct-Nov;144(1-2):114-22 [14643214.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15812-7 [14668432.001]
  • [Cites] J Virol. 2004 Mar;78(5):2545-52 [14963157.001]
  • [Cites] J Virol. 2004 Mar;78(5):2606-8 [14963166.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):672-5 [15208690.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):676-7 [15208693.001]
  • [Cites] J Comput Chem. 2004 Oct;25(13):1605-12 [15264254.001]
  • [Cites] Virology. 1965 Aug;26(4):567-76 [5833315.001]
  • [Cites] Mol Gen Genet. 1968 May 17;101(4):333-45 [5684818.001]
  • [Cites] J Mol Biol. 1970 May 28;50(1):35-58 [4196078.001]
  • [Cites] J Supramol Struct. 1974;2(2-4):253-75 [4612249.001]
  • [Cites] J Mol Biol. 1976 Apr 15;102(3):373-400 [775106.001]
  • [Cites] AIDS Res Hum Retroviruses. 1992 Jan;8(1):1-7 [1736937.001]
  • [Cites] J Virol. 1995 Oct;69(10):6487-97 [7666550.001]
  • [Cites] J Struct Biol. 1996 Jan-Feb;116(1):71-6 [8742726.001]
  • [Cites] Nat Struct Biol. 1996 Sep;3(9):763-70 [8784350.001]
  • [Cites] J Virol. 1998 Jan;72(1):564-77 [9420260.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7299-304 [9636143.001]
  • [Cites] Science. 1999 Jan 1;283(5398):80-3 [9872746.001]
  • [Cites] J Struct Biol. 1999 Sep;127(2):169-76 [10527906.001]
  • [Cites] J Mol Biol. 2005 Feb 18;346(2):577-88 [15670606.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2772-7 [15699328.001]
  • [Cites] Curr Opin Struct Biol. 2005 Apr;15(2):227-36 [15837183.001]
  • [Cites] J Virol. 2005 Jun;79(11):6577-87 [15890896.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 May 17;102(20):7163-8 [15878991.001]
  • [Cites] Annu Rev Biochem. 2005;74:833-65 [15952904.001]
  • [Cites] J Struct Biol. 2005 Aug;151(2):117-29 [15964766.001]
  • [Cites] Nat Rev Microbiol. 2005 Aug;3(8):643-55 [16064056.001]
  • [Cites] J Struct Biol. 2005 Oct;152(1):36-51 [16182563.001]
  • [Cites] J Virol. 2005 Nov;79(21):13463-72 [16227267.001]
  • [Cites] J Mol Biol. 2006 Jan 6;355(1):157-68 [16289202.001]
  • [Cites] Structure. 2006 Jan;14(1):15-20 [16407061.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19123-7 [17146053.001]
  • [Cites] J Struct Biol. 2007 Jan;157(1):3-18 [17011211.001]
  • [Cites] J Struct Biol. 2001 Oct;136(1):67-80 [11858708.001]
  • (PMID = 18206161.001).
  • [ISSN] 1089-8638
  • [Journal-full-title] Journal of molecular biology
  • [ISO-abbreviation] J. Mol. Biol.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z01 AR027002-29; United States / NCI NIH HHS / CA / R01 CA100322; United States / Intramural NIH HHS / / Z99 AR999999; United States / NCI NIH HHS / CA / CA100322; United States / NCI NIH HHS / CA / R01 CA100322-05
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Capsid Proteins; 0 / Gene Products, gag; 0 / Polymers; 0 / Protein Subunits; 0 / Viral Envelope Proteins
  • [Other-IDs] NLM/ NIHMS41519; NLM/ PMC2268030
  •  go-up   go-down


48. Busschots K, Vercammen J, Emiliani S, Benarous R, Engelborghs Y, Christ F, Debyser Z: The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding. J Biol Chem; 2005 May 6;280(18):17841-7
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have previously shown that the p75 isoform of the transcriptional co-activator lens epithelium-derived growth factor (LEDGF) interacts tightly with human immunodeficiency virus (HIV)-1 integrase (IN) and is essential for nuclear targeting of this protein in human cells (Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., and Debyser, Z. (2003) J. Biol. Chem.
  • 278, 372-381; Maertens, G., Cherepanov, P., Pluymers, W., Busschots, K., De Clercq, E., Debyser, Z., and Engelborghs, Y. (2003) J. Biol. Chem.
  • In the pull-down assay LEDGF/p75 interacted with HIV-1, HIV-2, and feline immunodeficiency virus IN, but not with the IN of human T-cell lymphotropic virus type 2, Moloney murine leukemia virus, or Rous sarcoma virus.
  • LEDGF/p75 stimulated the binding of HIV-1 and HIV-2 IN, but not Moloney murine leukemia virus or Rous sarcoma virus IN, to an aspecific DNA.

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15749713.001).
  • [ISSN] 0021-9258
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / Intercellular Signaling Peptides and Proteins; 0 / Protein Isoforms; 0 / lens epithelium-derived growth factor; EC 2.7.7.- / Integrases
  •  go-up   go-down


49. Konsavage WM Jr, Sudol M, Katzman M: Effects of varying the spacing within the D,D-35-E motif in the catalytic region of retroviral integrase. Virology; 2008 Sep 30;379(2):223-33
Hazardous Substances Data Bank. MAGNESIUM, ELEMENTAL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have now made several mutations designed to alter the length or flexibility of a mobile loop within this 35-amino-acid spacer region in full-length Rous sarcoma virus integrase.
  • [MeSH-major] Integrases / chemistry. Integrases / metabolism. Rous sarcoma virus / enzymology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18687451.001).
  • [ISSN] 1096-0341
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / p31 integrase protein, Human immunodeficiency virus 1; EC 2.7.7.- / HIV Integrase; EC 2.7.7.- / Integrases; I38ZP9992A / Magnesium
  •  go-up   go-down


50. Néel BD, Aouacheria A, Nouvion AL, Ronot X, Gillet G: Distinct protease pathways control cell shape and apoptosis in v-src-transformed quail neuroretina cells. Exp Cell Res; 2005 Nov 15;311(1):106-16
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Neoplastic transformation of avian neuroretina cells by p60(v-src) tyrosine kinase results in dramatic morphological changes and deregulation of apoptosis.
  • To identify the proteases involved in the cellular response to p60(v-src), we evaluated the effect of specific inhibitors of caspases, calpains and the proteasome on cell shape changes and apoptosis induced by p60(v-src) inactivation in quail neuroretina cells transformed by tsNY68, a thermosensitive strain of Rous sarcoma virus.
  • [MeSH-minor] Animals. Avian Sarcoma Viruses / physiology. Blotting, Western. Calpain / antagonists & inhibitors. Calpain / metabolism. Caspase Inhibitors. Cells, Cultured. Coturnix. Cysteine Proteinase Inhibitors / pharmacology. Flow Cytometry. Microscopy, Phase-Contrast. Proteasome Endopeptidase Complex / metabolism. Proteasome Inhibitors. Ubiquitin / metabolism

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16202997.001).
  • [ISSN] 0014-4827
  • [Journal-full-title] Experimental cell research
  • [ISO-abbreviation] Exp. Cell Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Caspase Inhibitors; 0 / Cysteine Proteinase Inhibitors; 0 / Proteasome Inhibitors; 0 / Ubiquitin; EC 2.7.10.2 / Oncogene Protein pp60(v-src); EC 3.4.22.- / Calpain; EC 3.4.22.- / Caspases; EC 3.4.25.1 / Proteasome Endopeptidase Complex
  •  go-up   go-down


51. Bailey GD, Hyun JK, Mitra AK, Kingston RL: Proton-linked dimerization of a retroviral capsid protein initiates capsid assembly. Structure; 2009 May 13;17(5):737-48
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In contrast, other retroviral capsid proteins, including that of Rous sarcoma virus (RSV), do not dimerize with measurable affinity.
  • [MeSH-major] Capsid / metabolism. Capsid Proteins / chemistry. Protons. Rous sarcoma virus / metabolism. Viral Proteins / chemistry

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19446529.001).
  • [ISSN] 0969-2126
  • [Journal-full-title] Structure (London, England : 1993)
  • [ISO-abbreviation] Structure
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Capsid Proteins; 0 / Protons; 0 / Viral Proteins
  •  go-up   go-down


52. Lokhandwala PM, Nguyen TL, Bowzard JB, Craven RC: Cooperative role of the MHR and the CA dimerization helix in the maturation of the functional retrovirus capsid. Virology; 2008 Jun 20;376(1):191-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This study reports isolation of two substitutions in the dimerization helix of Rous sarcoma virus CA protein that have the ability to suppress lethal defects in core maturation imposed by alterations to the major homology region (MHR) motif just upstream.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] EMBO J. 1999 Mar 1;18(5):1124-36 [10064580.001]
  • [Cites] J Mol Biol. 1999 Feb 12;286(1):83-93 [9931251.001]
  • [Cites] J Mol Biol. 1999 Aug 13;291(2):491-505 [10438634.001]
  • [Cites] Mol Cell. 2005 Jan 7;17(1):137-43 [15629724.001]
  • [Cites] Mol Cell. 2005 Jan 21;17(2):166-7 [15664185.001]
  • [Cites] Nat Struct Mol Biol. 2005 Aug;12(8):678-82 [16041386.001]
  • [Cites] Chromosome Res. 2005;13(5):443-53 [16132810.001]
  • [Cites] Biochem J. 2006 Feb 15;394(Pt 1):345-53 [16259620.001]
  • [Cites] J Virol Methods. 2006 Jul;135(1):118-23 [16564579.001]
  • [Cites] J Mol Biol. 2007 Jan 19;365(3):799-811 [17098251.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4353-8 [17360528.001]
  • [Cites] EMBO J. 2007 Apr 18;26(8):2218-26 [17396149.001]
  • [Cites] Biophys J. 2007 Aug 15;93(4):1264-76 [17526561.001]
  • [Cites] Cell. 2007 Oct 5;131(1):70-9 [17923088.001]
  • [Cites] J Virol. 1995 Jul;69(7):4213-27 [7769681.001]
  • [Cites] J Virol. 2001 Aug;75(15):6850-6 [11435564.001]
  • [Cites] J Mol Biol. 2002 Feb 22;316(3):667-78 [11866525.001]
  • [Cites] J Mol Biol. 2002 Apr 26;318(2):519-31 [12051856.001]
  • [Cites] EMBO J. 2000 Jan 4;19(1):103-13 [10619849.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):633-49 [10669613.001]
  • [Cites] Structure. 2000 Jun 15;8(6):617-28 [10873863.001]
  • [Cites] J Virol. 2000 Sep;74(18):8692-9 [10954570.001]
  • [Cites] Nature. 2000 Sep 21;407(6802):409-13 [11014200.001]
  • [Cites] J Virol. 2001 Jan;75(1):242-50 [11119594.001]
  • [Cites] J Mol Biol. 2001 Mar 2;306(4):783-97 [11243788.001]
  • [Cites] Nat Struct Biol. 2002 Jul;9(7):537-43 [12032547.001]
  • [Cites] J Mol Biol. 2003 Jan 3;325(1):225-37 [12473464.001]
  • [Cites] J Mol Biol. 2003 Jan 24;325(4):759-72 [12507478.001]
  • [Cites] EMBO J. 2003 Apr 1;22(7):1707-15 [12660176.001]
  • [Cites] J Virol. 2003 May;77(9):5439-50 [12692245.001]
  • [Cites] EMBO J. 2003 Jun 16;22(12):2886-92 [12805204.001]
  • [Cites] J Virol. 2003 Sep;77(17):9388-98 [12915554.001]
  • [Cites] J Mol Biol. 2004 Jan 2;335(1):275-82 [14659756.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):676-7 [15208693.001]
  • [Cites] J Virol. 2004 Oct;78(19):10606-16 [15367628.001]
  • [Cites] Nature. 2004 Sep 23;431(7007):481-5 [15386017.001]
  • [Cites] AIDS. 1991 Jun;5(6):639-54 [1883539.001]
  • [Cites] Mol Biol Evol. 1991 Nov;8(6):835-56 [1663570.001]
  • [Cites] J Virol. 1992 Dec;66(12):7021-32 [1279197.001]
  • [Cites] J Virol. 1994 Aug;68(8):4927-36 [8035491.001]
  • [Cites] J Virol. 1996 Jun;70(6):3440-8 [8648676.001]
  • [Cites] Science. 1996 Jul 12;273(5272):231-5 [8662505.001]
  • [Cites] Nat Struct Biol. 1996 Sep;3(9):763-70 [8784350.001]
  • [Cites] Virology. 1996 Aug 15;222(2):339-51 [8806518.001]
  • [Cites] Proteins. 1996 Jul;25(3):354-65 [8844870.001]
  • [Cites] Cell. 1996 Dec 27;87(7):1285-94 [8980234.001]
  • [Cites] J Gen Virol. 1997 Mar;78 ( Pt 3):637-40 [9049415.001]
  • [Cites] Science. 1997 Oct 31;278(5339):849-53 [9346481.001]
  • [Cites] EMBO J. 1998 Mar 16;17(6):1555-68 [9501077.001]
  • [Cites] J Biol Chem. 1998 Mar 27;273(13):7177-80 [9516405.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7299-304 [9636143.001]
  • [Cites] FEBS Lett. 1998 Jul 24;431(3):301-4 [9714530.001]
  • [Cites] Science. 1999 Jan 1;283(5398):80-3 [9872746.001]
  • [Cites] Acta Crystallogr D Biol Crystallogr. 1999 Jan;55(Pt 1):85-92 [10089398.001]
  • (PMID = 18433823.001).
  • [ISSN] 0042-6822
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA100322-05; United States / NCI NIH HHS / CA / R01 CA100322; United States / NCI NIH HHS / CA / CA100322; United States / NCI NIH HHS / CA / R01 CA100322-05
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Capsid Proteins
  • [Other-IDs] NLM/ NIHMS53821; NLM/ PMC2474745
  •  go-up   go-down


53. Wessler S, Otto C, Wilck N, Stangl V, Fritzemeier KH: Identification of estrogen receptor ligands leading to activation of non-genomic signaling pathways while exhibiting only weak transcriptional activity. J Steroid Biochem Mol Biol; 2006 Jan;98(1):25-35
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Treatment of breast cancer cells and osteosarcoma cells with estradiol, estren, substance A and substance B led to non-genomic activation of Akt (protein kinase B) and extracellular signal-regulated kinase 1/2 (ERK1/2) signaling cascades mediated by Src (Rous Sarcoma Virus, non-receptor tyrosine kinase) and phosphatidylinositol-3-kinase (PI3K) stimulation.
  • [MeSH-minor] Animals. Aorta / drug effects. Blotting, Western. Bone Neoplasms / drug therapy. Bone Neoplasms / metabolism. Bone Neoplasms / pathology. Breast Neoplasms / drug therapy. Breast Neoplasms / metabolism. Breast Neoplasms / pathology. Estradiol / pharmacology. Humans. Immunoprecipitation. Ligands. Male. Mitogen-Activated Protein Kinase 1 / metabolism. Mitogen-Activated Protein Kinase 3 / metabolism. Osteosarcoma / drug therapy. Osteosarcoma / metabolism. Osteosarcoma / pathology. Phosphatidylinositol 3-Kinases / metabolism. Phosphorylation. Proto-Oncogene Proteins c-akt / metabolism. Rats. Rats, Wistar. Tumor Cells, Cultured. Vasodilation / drug effects. src-Family Kinases / metabolism

  • Hazardous Substances Data Bank. ESTRADIOL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16203130.001).
  • [ISSN] 0960-0760
  • [Journal-full-title] The Journal of steroid biochemistry and molecular biology
  • [ISO-abbreviation] J. Steroid Biochem. Mol. Biol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Ligands; 0 / Receptors, Estrogen; 4TI98Z838E / Estradiol; EC 2.7.1.- / Phosphatidylinositol 3-Kinases; EC 2.7.1.137 / PIK3CA protein, human; EC 2.7.10.2 / src-Family Kinases; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 1; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 3
  •  go-up   go-down


54. Becsei-Kilborn E: Scientific discovery and scientific reputation: the reception of Peyton Rous' discovery of the chicken sarcoma virus. J Hist Biol; 2010;43(1):111-57

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Scientific discovery and scientific reputation: the reception of Peyton Rous' discovery of the chicken sarcoma virus.
  • This article concerns itself with the reception of Rous' 1911 discovery of what later came to be known as the Rous Sarcoma Virus (RSV).
  • Rous made his discovery at the Rockefeller Institute for Medical Research which had been primarily established to conduct research into infectious diseases.
  • Rous' chance discovery of a chicken tumor led him to a series of conjectures about cancer causation and about whether cancer could have an extrinsic cause.
  • Rous' finding was received with some scepticism by the scientific community that held that cancer was not infectious and favored explanations which located the origins of cancer in the inner mechanism of the cell.
  • After 4 years of unsuccessful effort to isolate and further determine the virus Rous felt compelled to discontinue his work on cancer viruses.
  • When 55 years later, the significance of Rous's discovery was attested by the award of the Nobel Prize, it opened up debates about the issues of delayed recognition and scientific reputation.
  • This article also considers why Rous' hypothesis of a viral origin of cancer could not be incorporated into the existing body of knowledge about cancer before the 1950s.
  • [MeSH-major] Infection / history. Neoplasms / history. Rous sarcoma virus. Virology / history

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20503720.001).
  • [ISSN] 0022-5010
  • [Journal-full-title] Journal of the history of biology
  • [ISO-abbreviation] J Hist Biol
  • [Language] eng
  • [Publication-type] Biography; Historical Article; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Personal-name-as-subject] Rous FP
  •  go-up   go-down


55. Svoboda J: Foundations in cancer research. The turns of life and science. Adv Cancer Res; 2008;99:1-32
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It covers the period of the rise of Hasek's immunologic school and application of immunologic tolerance to Rous sarcoma virus (RSV) heterotransmission.
  • Mammalian cells transformed by the reverse transcript of v-src mRNA were characterized, and the resulting provirus was shown to be highly oncogenic for chickens and to carry tumor-specific transplantation antigen.
  • Other areas covering epigenetic reversion of RSV-transformed cells and long-term persistence of chicken leucosis viruses in foreign avian species are discussed.
  • [MeSH-minor] Animals. Cell Transformation, Viral. Czechoslovakia. Genes, src. History, 20th Century. Oncogenic Viruses / physiology. Rous sarcoma virus / physiology. Virus Integration

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18037405.001).
  • [ISSN] 0065-230X
  • [Journal-full-title] Advances in cancer research
  • [ISO-abbreviation] Adv. Cancer Res.
  • [Language] eng
  • [Publication-type] Historical Article; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


56. Salva MZ, Himeda CL, Tai PW, Nishiuchi E, Gregorevic P, Allen JM, Finn EE, Nguyen QG, Blankinship MJ, Meuse L, Chamberlain JS, Hauschka SD: Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle. Mol Ther; 2007 Feb;15(2):320-9
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The strongest cassette, MHCK7 (770 bp), directs high-level expression comparable to cytomegalovirus and Rous sarcoma virus promoters in fast and slow skeletal and cardiac muscle, and low expression in the liver, lung, and spleen following systemic rAAV6 delivery in mice.

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17235310.001).
  • [ISSN] 1525-0016
  • [Journal-full-title] Molecular therapy : the journal of the American Society of Gene Therapy
  • [ISO-abbreviation] Mol. Ther.
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / T32 HD007183; United States / NICHD NIH HHS / HD / 1 U54 HD047175; United States / NIAMS NIH HHS / AR / R01 AR18860; United States / NHLBI NIH HHS / HL / R24 HL64387
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.3.2 / Creatine Kinase; EC 3.6.1.- / Ventricular Myosins
  •  go-up   go-down


57. Suerth JD, Maetzig T, Galla M, Baum C, Schambach A: Self-inactivating alpharetroviral vectors with a split-packaging design. J Virol; 2010 Jul;84(13):6626-35
SciCrunch. The Antibody Registry: Reagent: Antibodies .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Comparative analyses of integration sites of different retroviral vectors have elucidated distinct target site preferences, highlighting vectors based on the alpharetrovirus Rous sarcoma virus (RSV) as those with the most neutral integration spectrum.

  • MedlinePlus Health Information. consumer health - Genes and Gene Therapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2002 Feb;76(3):1488-95 [11773421.001]
  • [Cites] Gene Ther. 2010 Mar;17(3):400-11 [19847204.001]
  • [Cites] Cell. 2002 Aug 23;110(4):521-9 [12202041.001]
  • [Cites] Nucleic Acids Res. 2001 May 1;29(9):e45 [11328886.001]
  • [Cites] Science. 2003 Jun 13;300(5626):1749-51 [12805549.001]
  • [Cites] Blood. 2003 Dec 1;102(12):3934-7 [12881303.001]
  • [Cites] Genomics. 2004 Jan;83(1):76-84 [14667811.001]
  • [Cites] Gene Ther. 2004 Jun;11(11):879-81 [15057265.001]
  • [Cites] J Virol. 2004 Aug;78(16):8421-36 [15280451.001]
  • [Cites] PLoS Biol. 2004 Aug;2(8):E234 [15314653.001]
  • [Cites] Folia Biol (Praha). 2004;50(3-4):107-19 [15373344.001]
  • [Cites] J Virol. 1982 Nov;44(2):725-30 [6183452.001]
  • [Cites] J Virol. 1983 Dec;48(3):667-75 [6313966.001]
  • [Cites] Virology. 1984 Jul 15;136(1):89-99 [6330999.001]
  • [Cites] EMBO J. 1985 Apr;4(4):949-56 [2990916.001]
  • [Cites] J Virol. 1987 Oct;61(10):3004-12 [3041020.001]
  • [Cites] Cell. 1988 Nov 4;55(3):447-58 [2846182.001]
  • [Cites] J Exp Med. 1992 Oct 1;176(4):1125-35 [1383375.001]
  • [Cites] Methods Cell Biol. 1994;43 Pt A:99-112 [7823872.001]
  • [Cites] Nucleic Acids Res. 1995 Feb 25;23(4):628-33 [7899083.001]
  • [Cites] J Virol. 1995 Dec;69(12):7541-7 [7494260.001]
  • [Cites] J Virol. 1996 Jun;70(6):3834-43 [8648719.001]
  • [Cites] J Virol. 1996 Oct;70(10):6642-52 [8794299.001]
  • [Cites] J Virol. 1998 Nov;72(11):8463-71 [9765382.001]
  • [Cites] J Virol. 1998 Dec;72(12):9873-80 [9811723.001]
  • [Cites] J Mol Biol. 1998 Nov 27;284(2):205-25 [9813113.001]
  • [Cites] Mol Ther. 2006 Feb;13(2):391-400 [16226060.001]
  • [Cites] Gene Ther. 2006 Apr;13(7):641-5 [16355114.001]
  • [Cites] Exp Hematol. 2006 May;34(5):588-92 [16647564.001]
  • [Cites] Blood. 2006 Oct 15;108(8):2545-53 [16825499.001]
  • [Cites] Gene Ther. 2006 Nov;13(21):1524-33 [16763662.001]
  • [Cites] Hum Gene Ther. 2007 Aug;18(8):691-700 [17655493.001]
  • [Cites] Mol Ther. 2008 Mar;16(3):590-8 [18180772.001]
  • [Cites] Mol Ther. 2008 Apr;16(4):718-25 [18334985.001]
  • [Cites] Mol Ther. 2008 Sep;16(9):1617-23 [18578011.001]
  • [Cites] Gene Ther. 2000 Jun;7(12):1063-6 [10871756.001]
  • [Cites] J Virol. 2000 Nov;74(22):10822-6 [11044131.001]
  • [Cites] Gene Ther. 2001 Mar;8(6):477-86 [11313827.001]
  • [Cites] DNA Res. 2001 Oct 31;8(5):221-6 [11759842.001]
  • [Cites] J Clin Invest. 2008 Sep;118(9):3132-42 [18688285.001]
  • [Cites] J Clin Invest. 2008 Sep;118(9):3143-50 [18688286.001]
  • [Cites] J Virol. 2009 Jan;83(1):283-94 [18945765.001]
  • [Cites] J Clin Invest. 2009 Apr;119(4):964-75 [19307726.001]
  • [Cites] Expert Opin Biol Ther. 2009 Nov;9(11):1427-36 [19743892.001]
  • [Cites] Mol Ther. 2009 Nov;17(11):1919-28 [19672245.001]
  • [Cites] Blood. 2002 Aug 1;100(3):823-32 [12130492.001]
  • (PMID = 20410274.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Viral
  • [Other-IDs] NLM/ PMC2903275
  •  go-up   go-down


58. Konsavage WM Jr, Sudol M, Lee NE, Katzman M: Retroviral integrases that are improved for processing but impaired for joining. Virus Res; 2007 May;125(2):198-210
Hazardous Substances Data Bank. MANGANESE, ELEMENTAL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We previously showed that Rous sarcoma virus integrase with a serine-to-aspartate substitution at amino acid 124 was markedly improved for processing but dramatically impaired for joining, making it the first mutant to separate the activities of integrase in this way.
  • [MeSH-major] Integrases / physiology. Rous sarcoma virus / enzymology. Virus Integration

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. MAGNESIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17289204.001).
  • [ISSN] 0168-1702
  • [Journal-full-title] Virus research
  • [ISO-abbreviation] Virus Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / DNA, Viral; 42Z2K6ZL8P / Manganese; EC 2.7.7.- / Integrases; I38ZP9992A / Magnesium
  •  go-up   go-down


59. Bowers WJ, Mastrangelo MA, Howard DF, Southerland HA, Maguire-Zeiss KA, Federoff HJ: Neuronal precursor-restricted transduction via in utero CNS gene delivery of a novel bipartite HSV amplicon/transposase hybrid vector. Mol Ther; 2006 Mar;13(3):580-8
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cotransduction with a Rous sarcoma virus promoter-driven beta-galactosidase-neomycin (betageo) fusion flanked by SB terminal repeats (HSVT-betageo) and a second expressing the SB transposase gene under HSV immediate-early 4/5 gene promoter control (HSVsb) resulted in integration and extension of expression duration.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Mol Ther. 2006 Mar;13(3):457-8 [16461007.001]
  • (PMID = 16412694.001).
  • [ISSN] 1525-0016
  • [Journal-full-title] Molecular therapy : the journal of the American Society of Gene Therapy
  • [ISO-abbreviation] Mol. Ther.
  • [Language] eng
  • [Grant] United States / NINDS NIH HHS / NS / R01-NS36420A; United States / NINDS NIH HHS / NS / U54-NS045309
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.7.- / Transposases; EC 2.7.7.- / sleeping beauty transposase, human; EC 3.2.1.23 / beta-Galactosidase
  •  go-up   go-down


60. Minemura M, Shimizu Y, Hirano K, Nakayama Y, Tokimitsu Y, Tajiri K, Yamada K, Xue F, Takahara T, Watanabe A, Sugiyama T: Functional analysis of transactivation by mutants of hepatitis B virus X gene in human hepatocellular carcinoma. Oncol Rep; 2005 Aug;14(2):495-9
Genetic Alliance. consumer health - Hepatitis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Functional analysis of the mutants of the X gene was performed on the long terminal repeat of the Rous sarcoma virus in a transient transfection assay.
  • [MeSH-minor] Animals. Avian Sarcoma Viruses / genetics. Base Sequence. Carcinoma, Hepatocellular / genetics. Carcinoma, Hepatocellular / pathology. Cell Line, Tumor. Cell-Free System. Genetic Vectors / genetics. Humans. Molecular Sequence Data. Protein Biosynthesis / genetics. Rabbits. Reticulocytes / metabolism. Sequence Homology, Nucleic Acid. Transcription, Genetic / genetics. Transfection

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16012736.001).
  • [ISSN] 1021-335X
  • [Journal-full-title] Oncology reports
  • [ISO-abbreviation] Oncol. Rep.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Trans-Activators; 0 / hepatitis B virus X protein
  •  go-up   go-down


61. Halbert CL, Lam SL, Miller AD: High-efficiency promoter-dependent transduction by adeno-associated virus type 6 vectors in mouse lung. Hum Gene Ther; 2007 Apr;18(4):344-54
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Of the strong viral promoters examined, the Rous sarcoma virus (RSV) promoter performed significantly better than a human cytomegalovirus (CMV) promoter in the airway epithelium.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17430088.001).
  • [ISSN] 1043-0342
  • [Journal-full-title] Human gene therapy
  • [ISO-abbreviation] Hum. Gene Ther.
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / P30 DK047754; United States / NHLBI NIH HHS / HL / U01 HL066947; United States / NIDDK NIH HHS / DK / DK47754; United States / NHLBI NIH HHS / HL / HL66947
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 9004-22-2 / Globins; EC 3.1.3.1 / Alkaline Phosphatase
  • [Other-IDs] NLM/ NIHMS652207; NLM/ PMC4285347
  •  go-up   go-down


62. Shirodkar MV, Sehgal PB: Is the anti-sarcoma and anti-viral cytokine "plasma factor" a novel chicken Y-box protein? Indian J Exp Biol; 2006 Oct;44(10):777-82

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Is the anti-sarcoma and anti-viral cytokine "plasma factor" a novel chicken Y-box protein?
  • A line of research beginning in the early 1960s with the observation that West Nile virus and, later, several strains of rabies virus could inhibit the development of the Rous sarcoma virus-induced tumor in the wing-web of chicken (a "sarcoma-blockade") eventually culminated in the characterization of a 14-kDa circulating anti-sarcoma and anti-viral activity christened "plasma factor" (PF) which, unlike the interferons, inhibited the replication of diverse RNA-containing viruses, but not of any DNA-containing viruses.
  • [MeSH-major] Avian Proteins / physiology. Cytokines / physiology. DNA-Binding Proteins / physiology. Sarcoma, Avian / physiopathology. Transcription Factors / physiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17131907.001).
  • [ISSN] 0019-5189
  • [Journal-full-title] Indian journal of experimental biology
  • [ISO-abbreviation] Indian J. Exp. Biol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] India
  • [Chemical-registry-number] 0 / Avian Proteins; 0 / Cytokines; 0 / DNA-Binding Proteins; 0 / Transcription Factors; 0 / YB-2 protein, Gallus gallus
  • [Number-of-references] 39
  •  go-up   go-down


63. Butterfield-Gerson KL, Scheifele LZ, Ryan EP, Hopper AK, Parent LJ: Importin-beta family members mediate alpharetrovirus gag nuclear entry via interactions with matrix and nucleocapsid. J Virol; 2006 Feb;80(4):1798-806
Saccharomyces Genome Database. Saccharomyces Genome Database .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We previously reported that nuclear transport of the Rous sarcoma virus (RSV) Gag protein is intrinsic to the virus assembly pathway.
  • NC also possesses nuclear targeting activity in avian cells and contains the primary signal for the import of the Gag polyprotein.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Microbiol. 2003 Sep;49(5):1297-307 [12940988.001]
  • [Cites] J Biol Chem. 2004 Feb 13;279(7):5049-52 [14676199.001]
  • [Cites] Annu Rev Cell Dev Biol. 2004;20:395-425 [15473846.001]
  • [Cites] Mol Cell Biol. 1987 Nov;7(11):4048-57 [3123916.001]
  • [Cites] Genetics. 1989 May;122(1):19-27 [2659436.001]
  • [Cites] Methods Enzymol. 1991;194:3-21 [2005794.001]
  • [Cites] Gene. 1992 Nov 16;121(2):203-12 [1280240.001]
  • [Cites] Protein Sci. 1993 Feb;2(2):231-43 [8443601.001]
  • [Cites] Mol Cell Biol. 1993 Aug;13(8):4691-702 [8336709.001]
  • [Cites] EMBO J. 1994 Feb 15;13(4):973-81 [7509280.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):6880-4 [8041713.001]
  • [Cites] Mol Cell Biol. 1994 Dec;14(12):8399-407 [7969175.001]
  • [Cites] J Cell Biol. 1996 Jun;133(6):1163-76 [8682856.001]
  • [Cites] Science. 1996 Oct 25;274(5287):624-7 [8849456.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8590-5 [9238021.001]
  • [Cites] Cell. 1997 Sep 19;90(6):1041-50 [9323132.001]
  • [Cites] J Cell Biol. 1997 Dec 29;139(7):1645-53 [9412460.001]
  • [Cites] EMBO J. 1998 Apr 15;17(8):2196-207 [9545233.001]
  • [Cites] Virology. 1998 Jun 20;246(1):1-23 [9656989.001]
  • [Cites] FEBS Lett. 1998 Aug 21;433(3):185-90 [9744791.001]
  • [Cites] Mol Cell Biol. 1998 Nov;18(11):6805-15 [9774694.001]
  • [Cites] Gene. 1998 Nov 26;223(1-2):157-63 [9858717.001]
  • [Cites] Genetics. 1999 Jan;151(1):57-75 [9872948.001]
  • [Cites] J Cell Sci. 1999 Feb;112 ( Pt 3):339-47 [9885287.001]
  • [Cites] Microbiol Mol Biol Rev. 2001 Dec;65(4):570-94, table of contents [11729264.001]
  • [Cites] Mol Cell Biol. 2002 Feb;22(4):1266-75 [11809816.001]
  • [Cites] Microbes Infect. 2002 Jan;4(1):67-73 [11825777.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3944-9 [11891341.001]
  • [Cites] J Virol. 2002 Jun;76(11):5422-34 [11991971.001]
  • [Cites] J Cell Sci. 2002 Jul 15;115(Pt 14):2997-3005 [12082159.001]
  • [Cites] Nature. 2002 Jul 25;418(6896):387-91 [12140549.001]
  • [Cites] J Virol. 2002 Oct;76(20):10444-54 [12239321.001]
  • [Cites] EMBO J. 2002 Dec 2;21(23):6527-38 [12456659.001]
  • [Cites] EMBO Rep. 2003 Mar;4(3):278-83 [12634846.001]
  • [Cites] J Mol Biol. 2003 Jun 6;329(3):411-21 [12767826.001]
  • [Cites] J Virol. 2003 Sep;77(17):9388-98 [12915554.001]
  • [Cites] J Biol Chem. 1999 Jun 11;274(24):17103-8 [10358064.001]
  • [Cites] J Cell Biol. 1999 Jun 14;145(6):1145-52 [10366588.001]
  • [Cites] EMBO J. 1999 Jul 1;18(13):3746-56 [10393189.001]
  • [Cites] Genes Dev. 1999 Aug 15;13(16):2118-33 [10465789.001]
  • [Cites] Mol Cell Biol. 2004 Dec;24(23):10479-91 [15542855.001]
  • [Cites] J Cell Biol. 2004 Nov 22;167(4):649-59 [15545318.001]
  • [Cites] J Virol. 2004 Dec;78(24):13534-42 [15564464.001]
  • [Cites] J Cell Biol. 2000 Feb 21;148(4):635-51 [10684247.001]
  • [Cites] J Hum Virol. 2000 Jan-Feb;3(1):16-26 [10774803.001]
  • [Cites] Mol Cell Biol. 2000 Jul;20(14):5140-8 [10866670.001]
  • [Cites] EMBO J. 2000 Oct 16;19(20):5502-13 [11032817.001]
  • [Cites] J Virol. 2000 Dec;74(23):11222-9 [11070020.001]
  • [Cites] Mol Biol Cell. 2000 Nov;11(11):3777-89 [11071906.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13069-74 [11087861.001]
  • [Cites] J Virol. 2001 Jan;75(1):260-8 [11119596.001]
  • [Cites] Mol Biol Cell. 2001 May;12(5):1381-92 [11359929.001]
  • [Cites] Genome Biol. 2001;2(6):REVIEWS3008 [11423015.001]
  • [Cites] J Virol. 2001 Oct;75(19):9526-31 [11533215.001]
  • (PMID = 16439536.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA076534; United States / NIGMS NIH HHS / GM / R01 GM027930; United States / NCI NIH HHS / CA / R01CA76534; United States / NIGMS NIH HHS / GM / R01GM27930
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag; 0 / KAP120 protein, S cerevisiae; 0 / Karyopherins; 0 / MTR10 protein, S cerevisiae; 0 / Nuclear Localization Signals; 0 / Nucleocytoplasmic Transport Proteins; 0 / RNA-Binding Proteins; 0 / Receptors, Cytoplasmic and Nuclear; 0 / Saccharomyces cerevisiae Proteins; 0 / Viral Matrix Proteins; 0 / beta Karyopherins; 0 / exportin 1 protein
  • [Other-IDs] NLM/ PMC1367160
  •  go-up   go-down


64. Gudleski N, Flanagan JM, Ryan EP, Bewley MC, Parent LJ: Directionality of nucleocytoplasmic transport of the retroviral gag protein depends on sequential binding of karyopherins and viral RNA. Proc Natl Acad Sci U S A; 2010 May 18;107(20):9358-63
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Before membrane transport, the multidomain Gag protein of Rous sarcoma virus (RSV) undergoes importin-mediated nuclear import and CRM1-dependent nuclear export, an intrinsic step in the assembly pathway.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nature. 1996 Aug 15;382(6592):638-42 [8757136.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2587-91 [8146159.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4451-6 [9114010.001]
  • [Cites] Cell. 1998 Jul 24;94(2):193-204 [9695948.001]
  • [Cites] Mol Cell Biol. 1999 Feb;19(2):1218-25 [9891056.001]
  • [Cites] J Cell Biol. 1999 Feb 22;144(4):645-55 [10037787.001]
  • [Cites] J Cell Biol. 1999 Jun 28;145(7):1407-17 [10385521.001]
  • [Cites] Mol Cell Biol. 1999 Aug;19(8):5768-84 [10409764.001]
  • [Cites] Traffic. 2005 Mar;6(3):187-98 [15702987.001]
  • [Cites] J Biol. 2005;4(1):3 [15720724.001]
  • [Cites] J Biol Chem. 2005 Mar 18;280(11):10599-606 [15611084.001]
  • [Cites] Protein Expr Purif. 2005 May;41(1):207-34 [15915565.001]
  • [Cites] J Mol Biol. 2005 Jun 24;349(5):976-88 [15907938.001]
  • [Cites] J Virol. 2005 Jul;79(14):8732-41 [15994767.001]
  • [Cites] J Virol. 2006 Feb;80(4):1798-806 [16439536.001]
  • [Cites] J Virol. 2006 Oct;80(19):9608-18 [16973564.001]
  • [Cites] J Cell Biol. 2006 Sep 25;174(7):951-61 [16982803.001]
  • [Cites] J Cell Biol. 2006 Nov 20;175(4):579-93 [17116750.001]
  • [Cites] Traffic. 2007 Apr;8(4):347-58 [17286805.001]
  • [Cites] Trends Cell Biol. 2007 Apr;17(4):193-201 [17317185.001]
  • [Cites] J Virol. 2007 Jun;81(12):6623-31 [17392359.001]
  • [Cites] J Virol. 2007 Oct;81(19):10718-28 [17634229.001]
  • [Cites] Virology. 2007 Dec 20;369(2):263-80 [17888478.001]
  • [Cites] Science. 2007 Nov 30;318(5855):1412-6 [18048681.001]
  • [Cites] J Virol. 2008 Jan;82(2):683-91 [17977961.001]
  • [Cites] J Virol. 2008 Jun;82(12):5951-61 [18400856.001]
  • [Cites] J Virol. 2008 Oct;82(20):10129-42 [18684831.001]
  • [Cites] Mol Cell Biol. 2009 Mar;29(6):1487-97 [19124606.001]
  • [Cites] J Virol. 2009 Jul;83(13):6790-7 [19369339.001]
  • [Cites] J Virol. 2000 Jan;74(1):456-64 [10590135.001]
  • [Cites] Nature. 1999 Dec 9;402(6762):681-5 [10604476.001]
  • [Cites] RNA. 1999 Dec;5(12):1645-55 [10606274.001]
  • [Cites] EMBO J. 2000 Oct 16;19(20):5502-13 [11032817.001]
  • [Cites] J Virol. 2000 Dec;74(23):11222-9 [11070020.001]
  • [Cites] J Virol. 2001 Jan;75(1):260-8 [11119596.001]
  • [Cites] EMBO J. 2001 Feb 1;20(3):510-9 [11157757.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):12896-901 [11698677.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3944-9 [11891341.001]
  • [Cites] J Virol. 2002 Jun;76(11):5452-62 [11991973.001]
  • [Cites] J Virol. 2003 Mar;77(6):3734-48 [12610148.001]
  • [Cites] J Virol. 2003 Sep;77(17):9388-98 [12915554.001]
  • [Cites] J Mol Biol. 2004 Jan 2;335(1):275-82 [14659756.001]
  • [Cites] J Virol. 2004 Jan;78(1):52-60 [14671087.001]
  • [Cites] RNA. 2004 Feb;10(2):299-307 [14730028.001]
  • [Cites] J Biol Chem. 2004 Aug 20;279(34):35822-8 [15210704.001]
  • [Cites] Traffic. 2004 Nov;5(11):847-54 [15479450.001]
  • [Cites] Virology. 1978 Jan;84(1):87-98 [74124.001]
  • [Cites] J Mol Biol. 1982 Sep 15;160(2):147-61 [6294305.001]
  • [Cites] J Virol. 1985 May;54(2):278-84 [2985796.001]
  • [Cites] J Virol. 1990 Feb;64(2):847-55 [2153248.001]
  • [Cites] J Virol. 1994 Aug;68(8):4946-54 [8035493.001]
  • [Cites] J Virol. 1995 Oct;69(10):6487-97 [7666550.001]
  • [Cites] J Virol. 1996 Apr;70(4):2664-8 [8642704.001]
  • [Cites] J Virol. 2009 Dec;83(23):12526-34 [19776129.001]
  • [Cites] J Virol. 1990 Sep;64(9):4169-79 [2166812.001]
  • [Cites] J Virol. 1993 Mar;67(3):1350-6 [8437220.001]
  • [Cites] J Virol. 1993 Sep;67(9):5550-61 [8394460.001]
  • [Cites] J Virol. 1993 Oct;67(10):6246-52 [8396679.001]
  • [Cites] Nature. 1997 Feb 6;385(6616):548-52 [9020363.001]
  • (PMID = 20435918.001).
  • [ISSN] 1091-6490
  • [Journal-full-title] Proceedings of the National Academy of Sciences of the United States of America
  • [ISO-abbreviation] Proc. Natl. Acad. Sci. U.S.A.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA076534-14; United States / NCI NIH HHS / CA / R01 CA076534; United States / NCI NIH HHS / CA / R01 CA076534-14; United States / NCI NIH HHS / CA / R01CA076534
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag; 0 / Karyopherins; 0 / RNA, Viral; 0 / Ribonucleoproteins
  • [Other-IDs] NLM/ PMC2889109
  •  go-up   go-down


65. Takayama K, Torashima T, Horiuchi H, Hirai H: Purkinje-cell-preferential transduction by lentiviral vectors with the murine stem cell virus promoter. Neurosci Lett; 2008 Sep 26;443(1):7-11
MedlinePlus Health Information. consumer health - Stem Cells.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, we prepared lentiviral vectors that express GFP under the control of various ubiquitous promoters derived from murine stem cell virus (MSCV), cytomegalovirus (CMV), CMV early enhancer/chicken beta actin (CAG), and Rous sarcoma virus (RSV) and compared their potential to transduce Purkinje cells.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18675313.001).
  • [ISSN] 0304-3940
  • [Journal-full-title] Neuroscience letters
  • [ISO-abbreviation] Neurosci. Lett.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / RNA, Messenger; 0 / Viral Proteins; 147336-22-9 / Green Fluorescent Proteins
  •  go-up   go-down


66. Purdy JG, Flanagan JM, Ropson IJ, Rennoll-Bankert KE, Craven RC: Critical role of conserved hydrophobic residues within the major homology region in mature retroviral capsid assembly. J Virol; 2008 Jun;82(12):5951-61
Hazardous Substances Data Bank. (L)-Tryptophan .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To test the roles of specific MHR residues in mature capsid assembly, an in vitro system was developed that allowed for the first-time formation of Rous sarcoma virus CA into structures resembling authentic capsids.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Phys Rev Lett. 2006 Feb 24;96(7):078102 [16606144.001]
  • [Cites] Virology. 2006 Apr 10;347(2):364-71 [16427108.001]
  • [Cites] J Virol. 2006 Jun;80(12):5716-22 [16731910.001]
  • [Cites] J Virol. 2007 Feb;81(3):1288-96 [17093186.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4353-8 [17360528.001]
  • [Cites] EMBO J. 2007 Apr 18;26(8):2218-26 [17396149.001]
  • [Cites] J Virol. 2007 Jul;81(13):6957-72 [17442718.001]
  • [Cites] Biophys J. 2007 Aug 15;93(4):1264-76 [17526561.001]
  • [Cites] Antimicrob Agents Chemother. 2007 Oct;51(10):3574-81 [17638699.001]
  • [Cites] J Mol Biol. 2007 Oct 19;373(2):355-66 [17826792.001]
  • [Cites] Cell. 2007 Oct 5;131(1):70-9 [17923088.001]
  • [Cites] Biophys J. 2008 Jan 15;94(2):L8-10 [17981892.001]
  • [Cites] Biochemistry. 2008 Feb 26;47(8):2289-97 [18220423.001]
  • [Cites] J Mol Biol. 2008 Feb 29;376(4):1168-81 [18206161.001]
  • [Cites] Virology. 2008 Jun 20;376(1):191-8 [18433823.001]
  • [Cites] J Mol Biol. 1999 Feb 12;286(1):83-93 [9931251.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):676-7 [15208693.001]
  • [Cites] EMBO J. 1999 Mar 1;18(5):1124-36 [10064580.001]
  • [Cites] Acta Crystallogr D Biol Crystallogr. 1999 Jan;55(Pt 1):85-92 [10089398.001]
  • [Cites] J Mol Biol. 1999 Aug 13;291(2):491-505 [10438634.001]
  • [Cites] Mol Cell. 2005 Jan 7;17(1):137-43 [15629724.001]
  • [Cites] Mol Cell. 2005 Jan 21;17(2):166-7 [15664185.001]
  • [Cites] J Mol Biol. 2005 Feb 18;346(2):577-88 [15670606.001]
  • [Cites] J Biol Chem. 2005 Feb 25;280(8):6792-801 [15569685.001]
  • [Cites] Protein Expr Purif. 2005 May;41(1):207-34 [15915565.001]
  • [Cites] Nat Struct Mol Biol. 2005 Aug;12(8):678-82 [16041386.001]
  • [Cites] Nat Struct Mol Biol. 2005 Aug;12(8):671-7 [16041387.001]
  • [Cites] Virology. 2005 Sep 15;340(1):33-45 [16045955.001]
  • [Cites] J Virol. 2005 Nov;79(21):13463-72 [16227267.001]
  • [Cites] J Virol. 2005 Nov;79(22):14271-81 [16254362.001]
  • [Cites] J Virol. 2005 Dec;79(23):14498-506 [16282449.001]
  • [Cites] J Mol Biol. 2006 Jan 6;355(1):157-68 [16289202.001]
  • [Cites] Structure. 2006 Jan;14(1):15-20 [16407061.001]
  • [Cites] EMBO J. 2000 Jan 4;19(1):103-13 [10619849.001]
  • [Cites] J Virol. 2000 Feb;74(3):1168-77 [10627527.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):633-49 [10669613.001]
  • [Cites] Biophys J. 2000 Mar;78(3):1551-60 [10692339.001]
  • [Cites] Structure. 2000 Jun 15;8(6):617-28 [10873863.001]
  • [Cites] Nature. 2000 Sep 21;407(6802):409-13 [11014200.001]
  • [Cites] J Virol. 2001 Jan;75(1):242-50 [11119594.001]
  • [Cites] J Virol. 2001 Jan;75(2):759-71 [11134289.001]
  • [Cites] J Mol Biol. 2001 Mar 2;306(4):783-97 [11243788.001]
  • [Cites] J Virol. 2001 Aug;75(15):6850-6 [11435564.001]
  • [Cites] J Virol. 2001 Oct;75(19):9357-66 [11533199.001]
  • [Cites] J Struct Biol. 2001 Oct;136(1):67-80 [11858708.001]
  • [Cites] J Mol Biol. 2002 Feb 22;316(3):667-78 [11866525.001]
  • [Cites] J Virol. 2002 Jun;76(11):5667-77 [11991995.001]
  • [Cites] J Virol. 2002 Jul;76(14):6900-8 [12072491.001]
  • [Cites] Nat Struct Biol. 2002 Jul;9(7):537-43 [12032547.001]
  • [Cites] J Mol Biol. 2003 Jan 3;325(1):225-37 [12473464.001]
  • [Cites] J Mol Biol. 2003 Jan 24;325(4):759-72 [12507478.001]
  • [Cites] EMBO J. 2003 Apr 1;22(7):1707-15 [12660176.001]
  • [Cites] J Mol Biol. 2003 Apr 11;327(5):1013-20 [12662926.001]
  • [Cites] J Virol. 2003 May;77(9):5439-50 [12692245.001]
  • [Cites] EMBO J. 2003 Jun 16;22(12):2886-92 [12805204.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13555-60 [14573704.001]
  • [Cites] J Mol Biol. 2004 Jan 2;335(1):275-82 [14659756.001]
  • [Cites] J Virol. 2004 Mar;78(5):2545-52 [14963157.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):672-5 [15208690.001]
  • [Cites] Nature. 2004 Sep 23;431(7007):481-5 [15386017.001]
  • [Cites] Mol Gen Genet. 1968 May 17;101(4):333-45 [5684818.001]
  • [Cites] J Mol Biol. 1974 Nov 15;89(4):755-8 [4449130.001]
  • [Cites] Proc Natl Acad Sci U S A. 1979 Jun;76(6):2745-9 [288062.001]
  • [Cites] J Biol Chem. 1985 Aug 5;260(16):9479-90 [4019481.001]
  • [Cites] J Virol. 1992 Dec;66(12):7021-32 [1279197.001]
  • [Cites] Biophys J. 1993 Mar;64(3):824-35 [8471727.001]
  • [Cites] J Virol. 1994 Aug;68(8):4927-36 [8035491.001]
  • [Cites] J Virol. 1995 Jul;69(7):4213-27 [7769681.001]
  • [Cites] J Virol. 1995 Oct;69(10):6430-8 [7666544.001]
  • [Cites] J Virol. 1996 Jun;70(6):3440-8 [8648676.001]
  • [Cites] Science. 1996 Jul 12;273(5272):231-5 [8662505.001]
  • [Cites] J Virol. 1997 Jun;71(6):4425-35 [9151833.001]
  • [Cites] Science. 1997 Oct 31;278(5339):849-53 [9346481.001]
  • [Cites] Eur J Biochem. 1997 Oct 15;249(2):592-600 [9370371.001]
  • [Cites] Virology. 1997 Nov 10;238(1):79-84 [9375011.001]
  • [Cites] J Virol. 1998 Jan;72(1):564-77 [9420260.001]
  • [Cites] EMBO J. 1998 Mar 16;17(6):1555-68 [9501077.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7299-304 [9636143.001]
  • [Cites] Science. 1999 Jan 1;283(5398):80-3 [9872746.001]
  • [Cites] Biochem J. 2006 Feb 15;394(Pt 1):345-53 [16259620.001]
  • (PMID = 18400856.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA100322; United States / NCI NIH HHS / CA / CA100322
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Capsid Proteins; 8DUH1N11BX / Tryptophan
  • [Other-IDs] NLM/ PMC2395126
  •  go-up   go-down


67. Wiegand HL, Cullen BR: Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteins. J Virol; 2007 Dec;81(24):13694-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here, we have examined whether the alpharetrovirus Rous sarcoma virus (RSV) is susceptible to inhibition by a range of human APOBEC3 proteins.
  • These data represent the first report of inhibition of retroviral infectivity and induction of proviral DNA editing by human APOBEC3A and reveal that alpharetroviruses, which do not normally encounter APOBEC3 proteins in their avian hosts, are susceptible to inhibition by all human APOBEC3 proteins tested.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2004 Nov;78(21):12058-61 [15479846.001]
  • [Cites] J Biol Chem. 2006 Jun 23;281(25):16837-41 [16648136.001]
  • [Cites] J Virol. 1987 Oct;61(10):3004-12 [3041020.001]
  • [Cites] J Virol. 1990 Sep;64(9):4169-79 [2166812.001]
  • [Cites] J Virol. 1993 Aug;67(8):4945-55 [8331734.001]
  • [Cites] Genomics. 2002 Mar;79(3):285-96 [11863358.001]
  • [Cites] Nature. 2002 Aug 8;418(6898):646-50 [12167863.001]
  • [Cites] Cell. 2003 Jun 13;113(6):803-9 [12809610.001]
  • [Cites] Nature. 2003 Jul 3;424(6944):94-8 [12808465.001]
  • [Cites] Nature. 2003 Jul 3;424(6944):99-103 [12808466.001]
  • [Cites] Cell. 2003 Jul 11;114(1):21-31 [12859895.001]
  • [Cites] J Biol Chem. 2003 Nov 7;278(45):44412-6 [12970355.001]
  • [Cites] Nat Med. 2003 Nov;9(11):1404-7 [14528300.001]
  • [Cites] Nat Med. 2003 Nov;9(11):1398-403 [14528301.001]
  • [Cites] Science. 2003 Nov 7;302(5647):1056-60 [14564014.001]
  • [Cites] Curr Biol. 2003 Nov 11;13(22):2009-13 [14614829.001]
  • [Cites] J Biol Chem. 2004 Feb 27;279(9):7792-8 [14672928.001]
  • [Cites] J Biol Chem. 2006 Aug 4;281(31):22161-72 [16735504.001]
  • [Cites] J Virol. 2006 Sep;80(17):8450-8 [16912295.001]
  • [Cites] J Virol. 2006 Dec;80(23):11710-22 [16971427.001]
  • [Cites] J Virol. 2006 Dec;80(24):12102-8 [17035335.001]
  • [Cites] J Biol Chem. 2007 Jan 26;282(4):2587-95 [17121840.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2915-20 [17299050.001]
  • [Cites] J Virol. 2007 May;81(9):4465-72 [17314171.001]
  • [Cites] Virology. 2007 Aug 1;364(2):486-93 [17434555.001]
  • [Cites] J Virol. 2007 Jul;81(13):7238-48 [17428847.001]
  • [Cites] J Virol. 2007 Jul;81(13):7099-110 [17428871.001]
  • [Cites] J Virol. 2007 Jul;81(13):7048-60 [17459941.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3927-32 [14978281.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3770-4 [14999100.001]
  • [Cites] Science. 2004 Mar 19;303(5665):1829 [15031497.001]
  • [Cites] Nat Struct Mol Biol. 2004 May;11(5):435-42 [15098018.001]
  • [Cites] EMBO J. 2004 Jun 16;23(12):2451-8 [15152192.001]
  • [Cites] J Virol. 2004 Aug;78(15):8238-44 [15254195.001]
  • [Cites] Hum Mol Genet. 2004 Aug 15;13(16):1785-91 [15198990.001]
  • [Cites] J Biol Chem. 2004 Aug 6;279(32):33177-84 [15159405.001]
  • [Cites] Curr Biol. 2004 Aug 10;14(15):1385-91 [15296757.001]
  • [Cites] Curr Biol. 2004 Aug 10;14(15):1392-6 [15296758.001]
  • [Cites] J Biol Chem. 2004 Aug 13;279(33):34083-6 [15215254.001]
  • [Cites] PLoS Biol. 2004 Sep;2(9):E275 [15269786.001]
  • [Cites] Virology. 2004 Oct 25;328(2):163-8 [15464836.001]
  • [Cites] J Virol. 1996 Aug;70(8):5297-305 [8764040.001]
  • [Cites] Methods Cell Biol. 1997;52:179-214 [9379950.001]
  • [Cites] Mol Biol Evol. 2005 Feb;22(2):367-77 [15496550.001]
  • [Cites] J Biol Chem. 2004 Dec 17;279(51):53379-86 [15466872.001]
  • [Cites] Curr Biol. 2005 Jan 26;15(2):166-70 [15668174.001]
  • [Cites] Nature. 2005 Jan 27;433(7024):430-3 [15674295.001]
  • [Cites] Virology. 2005 Mar 15;333(2):374-86 [15721369.001]
  • [Cites] J Biol Chem. 2005 Mar 25;280(12):10920-4 [15647250.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 May 31;102(22):7982-7 [15911774.001]
  • [Cites] J Virol. 2005 Jul;79(13):8201-7 [15956565.001]
  • [Cites] Hepatology. 2005 Aug;42(2):301-9 [16025511.001]
  • [Cites] Virology. 2005 Sep 1;339(2):281-8 [15993456.001]
  • [Cites] Nucleic Acids Res. 2006;34(1):89-95 [16407327.001]
  • [Cites] J Virol. 2006 Feb;80(3):1067-76 [16414984.001]
  • [Cites] Curr Biol. 2006 Mar 7;16(5):480-5 [16527742.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8780-5 [16728505.001]
  • [Cites] Proc Natl Acad Sci U S A. 1983 May;80(10):2946-50 [6574464.001]
  • (PMID = 17913830.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI065301; United States / NIAID NIH HHS / AI / AI065301
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] EC 3.5.4.1 / APOBEC3 protein, human; EC 3.5.4.1 / APOBEC3F protein, human; EC 3.5.4.1 / Cytosine Deaminase; EC 3.5.4.5 / APOBEC3B protein, human; EC 3.5.4.5 / APOBEC3G protein, human; EC 3.5.4.5 / Cytidine Deaminase
  • [Other-IDs] NLM/ PMC2168862
  •  go-up   go-down


68. Boulos S, Meloni BP, Arthur PG, Bojarski C, Knuckey NW: Assessment of CMV, RSV and SYN1 promoters and the woodchuck post-transcriptional regulatory element in adenovirus vectors for transgene expression in cortical neuronal cultures. Brain Res; 2006 Aug 2;1102(1):27-38
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In order to investigate protein function in rat primary cortical neuronal cultures, we modified an adenoviral vector expression system and assessed the strength and specificity of the cytomegalovirus (CMV), rous sarcoma virus (RSV), and rat and human synapsin 1 (SYN1) promoters to drive DsRed-X expression.
  • [MeSH-major] Avian Sarcoma Viruses / genetics. Cytomegalovirus / genetics. Genetic Vectors / physiology. Hepatitis B Virus, Woodchuck / genetics. Neurons / metabolism. Synapsins / metabolism

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CUMENE HYDROPEROXIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16806110.001).
  • [ISSN] 0006-8993
  • [Journal-full-title] Brain research
  • [ISO-abbreviation] Brain Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Benzene Derivatives; 0 / Synapsins; 147336-22-9 / Green Fluorescent Proteins; PG7JD54X4I / cumene hydroperoxide
  •  go-up   go-down


69. Schambach A, Mueller D, Galla M, Verstegen MM, Wagemaker G, Loew R, Baum C, Bohne J: Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Ther; 2006 Nov;13(21):1524-33
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • When using the promoter of Rous sarcoma virus or a tetracycline-inducible promoter to generate full-length transcripts, we obtained a strong enhancement in titer (up to 4 x 10(7) transducing units per ml of unconcentrated supernatant).

  • MedlinePlus Health Information. consumer health - Genes and Gene Therapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16763662.001).
  • [ISSN] 0969-7128
  • [Journal-full-ti